BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liang W, Guan W, Chen R, Wang W, Li J, Xu K, Li C, Ai Q, Lu W, Liang H, Li S, He J. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335-337. [PMID: 32066541 DOI: 10.1016/s1470-2045(20)30096-6] [Cited by in Crossref: 2034] [Cited by in F6Publishing: 2336] [Article Influence: 1017.0] [Reference Citation Analysis]
Number Citing Articles
1 Ishibashi N, Maebayashi T, Aizawa T, Sakaguchi M, Okada M. Coronavirus disease 2019 (COVID-19) in patients before, during, or after lung irradiation, and serum SP-A and SP-D levels. Thorac Cancer 2022. [PMID: 36178187 DOI: 10.1111/1759-7714.14677] [Reference Citation Analysis]
2 Li X, Liang W, Yu C, Meng Q, Zhang W, Wu X, Xue J, Deng S, Wang H. Potential therapeutic strategies for quercetin targeting critical pathological mechanisms associated with colon adenocarcinoma and COVID-19. Front Pharmacol 2022;13:988153. [DOI: 10.3389/fphar.2022.988153] [Reference Citation Analysis]
3 Özyer Y. Experiences of Patients in Turkey with Breast Cancer throughout the COVID-19 Pandemic and their Coping Mechanisms: A Qualitative Study. J Relig Health 2022. [PMID: 36168020 DOI: 10.1007/s10943-022-01675-6] [Reference Citation Analysis]
4 Koca GY, Aylaz R. The effect of music on pain and anxiety in patients receiving chemotherapy during COVID-19. Eur J Cancer Care (Engl) 2022;:e13715. [PMID: 36168097 DOI: 10.1111/ecc.13715] [Reference Citation Analysis]
5 Gangeri L, Alfieri S, Greco M, Bosisio M, Petrigliano R, Murru L, Borreani C. Construction process and development stages of pandemic emotions questionnaire in cancer patients (PEQ-CP). BMC Psychol 2022;10:226. [PMID: 36167563 DOI: 10.1186/s40359-022-00930-5] [Reference Citation Analysis]
6 Wang Y, Li Q, Zhang J, Xie H, Kolla J. Exploration of the Potential Link, Hub Genes, and Potential Drugs for Coronavirus Disease 2019 and Lung Cancer Based on Bioinformatics Analysis. Journal of Oncology 2022;2022:1-12. [DOI: 10.1155/2022/8124673] [Reference Citation Analysis]
7 Yue X, Ye Y, Choi YC, Zhang D, Krueger WS. Risk of Severe COVID-19 Outcomes Among Patients with Immune-Mediated Inflammatory Diseases or Malignancies: A Retrospective Analysis of Real-World Data in the United States. Adv Ther 2022. [PMID: 36153800 DOI: 10.1007/s12325-022-02293-0] [Reference Citation Analysis]
8 Ailioaie LM, Ailioaie C, Litscher G. Light as a Cure in COVID-19: A Challenge for Medicine. Photonics 2022;9:686. [DOI: 10.3390/photonics9100686] [Reference Citation Analysis]
9 de Brito BB, Marques HS, Silva FAFD, Cordeiro Santos ML, Araújo GRL, Valente LA, Freire de Melo F. Influence of the COVID-19 pandemic in the gastrointestinal oncology setting: An overview. World J Gastrointest Pathophysiol 2022; 13(5): 157-169 [DOI: 10.4291/wjgp.v13.i5.157] [Reference Citation Analysis]
10 Tamari K, Nagata Y, Mizowaki T, Kodaira T, Onishi H, Ogawa K, Shioyama Y, Shigematsu N, Uno T. The impact of the COVID-19 pandemic on radiotherapy in Japan: nationwide surveys from May 2020 through June 2021. Journal of Radiation Research 2022. [DOI: 10.1093/jrr/rrac055] [Reference Citation Analysis]
11 Peixoto D, Callia JPB, Bittencourt MS, Generoso G, Anastácio VM, Alves-Jr JL, Silva TLD, Belizário JC, Araújo BLM, Ho W, Diz MDPE, Hoff PM, Abdala E, Ibrahim KY. Clinical presentation and in-hospital prognosis of lung cancer patients presenting with suspected and confirmed COVID-19. Braz J Med Biol Res 2022;55:e12140. [PMID: 36102415 DOI: 10.1590/1414-431X2022e12140] [Reference Citation Analysis]
12 Yahi F, Lequesne J, Rigal O, Morel A, Leheurteur M, Grellard J, Leconte A, Clarisse B, Joly F, Lefèvre-arbogast S. Post-traumatic stress disorder symptoms and associated factors in breast cancer patients during the first COVID-19 lockdown in France. Front Psychol 2022;13:768043. [DOI: 10.3389/fpsyg.2022.768043] [Reference Citation Analysis]
13 Liu W, Wu Y, Yang R, Chen R, Huang Y, Zhao X, Xie M, Li Q, Wang Q, Chen J. COVID-19 Vaccination Status and Hesitancy among Breast Cancer Patients after Two Years of Pandemic: A Cross-Sectional Survey. Vaccines 2022;10:1530. [DOI: 10.3390/vaccines10091530] [Reference Citation Analysis]
14 Zheng Q, Wang D, Lin R, Lv Q, Wang W. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol 2022;13:1013322. [DOI: 10.3389/fimmu.2022.1013322] [Reference Citation Analysis]
15 Li Z, Hu Y, Zeng M, Hu Q, Ye F, Liu R, Cai H, Li Q, Wang X. The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era. Front Oncol 2022;12:976143. [DOI: 10.3389/fonc.2022.976143] [Reference Citation Analysis]
16 Otake S, Chubachi S, Namkoong H, Nakagawara K, Tanaka H, Lee H, Morita A, Fukushima T, Watase M, Kusumoto T, Masaki K, Kamata H, Ishii M, Hasegawa N, Harada N, Ueda T, Ueda S, Ishiguro T, Arimura K, Saito F, Yoshiyama T, Nakano Y, Mutoh Y, Suzuki Y, Murakami K, Okada Y, Koike R, Kitagawa Y, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K; The Japan COVID-19 Task Force. Clinical clustering with prognostic implications in Japanese COVID-19 patients: report from Japan COVID-19 Task Force, a nation-wide consortium to investigate COVID-19 host genetics. BMC Infect Dis 2022;22. [DOI: 10.1186/s12879-022-07701-y] [Reference Citation Analysis]
17 Parray AM, Chaudhari VA, Bhandare MS, Madhabananda K, Muduly DK, Sudhindran S, Mathews J, Pradeep R, Thammineedi SR, Amal K, Chaudhary D, Jitender R, Pandey D, Amar P, Penumadu P, Kalayarasan R, Elamurugan TP, Kantharia C, Pujari S, Ramesh H, Somashekhar SP, Fernandes A, Sexena R, Singh RK, Lattoo MR, Shah OJ, Jeswanth S, Roy M, Thambudorai R, Shrikhande SV. Impact of Covid-19 on gastrointestinal cancer surgery: A National Survey. Langenbecks Arch Surg 2022. [PMID: 36098808 DOI: 10.1007/s00423-022-02675-6] [Reference Citation Analysis]
18 Alhumaid S, Al Mutair A, Busubaih JS, Al Dossary N, Alsuliman M, Baltyour SA, Alissa I, Al Hassar HI, Al Aithan NA, Albassri HA, AlOmran SA, ALGhazal RM, Busbaih A, Alsalem NA, Alagnam W, Alyousef MY, Alseffay AU, Al Aish HA, Aldiaram A, Al Eissa HA, Alhumaid MA, Bukhamseen AN, Al Mutared KM, Aljwisim AH, Twibah AM, AlSaeed MM, Alkhalaf HA, ALShakhs FM, Koritala T, Al-Tawfiq JA, Dhama K, Rabaan AA, Al-Omari A. Colorectal cancer in patients with SARS-CoV-2: a systematic review and meta-analysis. Infect Agent Cancer 2022;17:49. [PMID: 36096812 DOI: 10.1186/s13027-022-00459-7] [Reference Citation Analysis]
19 Lau MC, Yi Y, Goh D, Cheung CCL, Tan B, Lim JCT, Joseph CR, Wee F, Lee JN, Lim X, Lim CJ, Leow WQ, Lee JY, Ng CCY, Bashiri H, Cheow PC, Chan CY, Koh YX, Tan TT, Kalimuddin S, Tai WMD, Ng JL, Low JG, Lim TKH, Liu J, Yeong JPS. Case report: Understanding the impact of persistent tissue-localization of SARS-CoV-2 on immune response activity via spatial transcriptomic analysis of two cancer patients with COVID-19 co-morbidity. Front Immunol 2022;13:978760. [DOI: 10.3389/fimmu.2022.978760] [Reference Citation Analysis]
20 Grajek M, Krupa-Kotara K, Rozmiarek M, Sobczyk K, Działach E, Górski M, Kobza J. The Level of COVID-19 Anxiety among Oncology Patients in Poland. Int J Environ Res Public Health 2022;19:11418. [PMID: 36141692 DOI: 10.3390/ijerph191811418] [Reference Citation Analysis]
21 Demir G, Seki Öz H. Psychological Experiences of Elderly Patients With Covid-19 Diagnosis in Intensive Care: A Qualitative Study. Omega (Westport) 2022;:302228221126212. [PMID: 36069594 DOI: 10.1177/00302228221126212] [Reference Citation Analysis]
22 Abraham S, Manohar SA, Patel R, Saji AM, Dani SS, Ganatra S. Strategies for Cardio-Oncology Care During the COVID-19 Pandemic. Curr Treat Options Cardio Med. [DOI: 10.1007/s11936-022-00965-2] [Reference Citation Analysis]
23 Bouleftour W, Bonjean P, Grangeon K, Magné N. COVID-19 vaccine-related adverse events in solid cancer patients treated with immunotherapy. Cancer Invest 2022;:1-10. [PMID: 36062881 DOI: 10.1080/07357907.2022.2121966] [Reference Citation Analysis]
24 Moubarak S, Merheb D, Basbous L, Chamseddine N, Bou Zerdan M, Assi HI. COVID-19 and lung cancer: update on the latest screening, diagnosis, management and challenges. J Int Med Res 2022;50:3000605221125047. [PMID: 36154328 DOI: 10.1177/03000605221125047] [Reference Citation Analysis]
25 Gopalakrishnan D, Sarode SC, Sarode GS, Sengupta N. COVID-19 and oral cancer: Critical viewpoint. World J Clin Oncol 2022; 13(8): 725-728 [DOI: 10.5306/wjco.v13.i8.725] [Reference Citation Analysis]
26 Bain N, Nguyen M, Grech L, Day D, Mccartney A, Webber K, Kwok A, Harris S, Chau H, Chan B, Nott L, Hamad N, Tognela A, Underhill C, Loe BS, Freeman D, Segelov E; on behalf of the CANVACCS Investigators. COVID-19 Vaccine Hesitancy in Australian Patients with Solid Organ Cancers. Vaccines 2022;10:1373. [DOI: 10.3390/vaccines10091373] [Reference Citation Analysis]
27 Souliotis K, Peppou LE, Giannouchos TV, Samara M, Sifaki-Pistolla D, Economou M, Maltezou HC. COVID-19 Vaccination and Mental Health Outcomes among Greek Adults in 2021: Preliminary Evidence. Vaccines (Basel) 2022;10:1371. [PMID: 36016258 DOI: 10.3390/vaccines10081371] [Reference Citation Analysis]
28 Nguyen HTH, Duong KL, Nguyen ST, Trinh Q, Hoang HTL, Phung TQ, Lin HW, Nguyen HTL. Quality of Life and Its Associated Factors Among Cancer Patients Receiving Chemotherapy at Oncology Hospitals in Vietnam After the Third Wave of the COVID-19 Pandemic. Cancer Manag Res 2022;14:2429-44. [PMID: 35979066 DOI: 10.2147/CMAR.S370034] [Reference Citation Analysis]
29 De Placido P, Pietroluongo E, De Angelis C, Tafuro M, Barraco C, Giannatiempo R, Buonaiuto R, Schettini F, Iervolino A, Vozzella EA, Giuliano M, Bianco R, Arpino G. Safety and immunogenicity of the COVID-19 vaccine BNT162b2 for patients with breast and gynecological cancer on active anticancer therapy: Results of a prospective observational study. Front Oncol 2022;12:951026. [DOI: 10.3389/fonc.2022.951026] [Reference Citation Analysis]
30 Asghar K, Abu Bakar M, Ashfaq S, Alvi AM, Shafiq W, Azmat U, Siddiqi AI, Farooq A, Raza R, Siddique K. COVID-19 in cancer patients with diabetes in Pakistan: Clinical features and management. Front Oncol 2022;12:922579. [DOI: 10.3389/fonc.2022.922579] [Reference Citation Analysis]
31 Fu L, Wu S, Wang B, Zheng W, Sun Y, Tian T, Zhang X, Xu L, Sun Y, Zhan J, Peng Z, Chen Y, Zou H. COVID-19 vaccination perception and uptake among cancer patients in Guangzhou, China. Hum Vaccin Immunother 2022;:2102329. [PMID: 35976684 DOI: 10.1080/21645515.2022.2102329] [Reference Citation Analysis]
32 Temena MA, Acar A. Increased TRIM31 gene expression is positively correlated with SARS-CoV-2 associated genes TMPRSS2 and TMPRSS4 in gastrointestinal cancers. Sci Rep 2022;12:11763. [PMID: 35970857 DOI: 10.1038/s41598-022-15911-2] [Reference Citation Analysis]
33 Takahashi N, Takeda K, Suzuki Y, Kishida K, Teramura S, Jingu K. A case of COVID-19 vaccination during radiotherapy for breast cancer. J Egypt Natl Canc Inst 2022;34. [DOI: 10.1186/s43046-022-00134-3] [Reference Citation Analysis]
34 Yang S, Zhao H, Cui R, Ma L, Ge X, Fu Q, Yu D, Niu X. Comparison of clinical outcomes and risk factors for COVID-19 infection in cancer patients without anticancer treatment and noncancer patients. Front Public Health 2022;10:925519. [DOI: 10.3389/fpubh.2022.925519] [Reference Citation Analysis]
35 Yu M, Cheng Y, Zhang R, Wen T, Huai S, Wei X, Zhang L. Evaluating treatment strategies for non-small cell lung cancer during COVID-19: A propensity score matching analysis. Medicine (Baltimore) 2022;101:e30051. [PMID: 35960071 DOI: 10.1097/MD.0000000000030051] [Reference Citation Analysis]
36 da Silva SJR, do Nascimento JCF, Germano Mendes RP, Guarines KM, Targino Alves da Silva C, da Silva PG, de Magalhães JJF, Vigar JRJ, Silva-Júnior A, Kohl A, Pardee K, Pena L. Two Years into the COVID-19 Pandemic: Lessons Learned. ACS Infect Dis 2022. [PMID: 35940589 DOI: 10.1021/acsinfecdis.2c00204] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Habbous S, Tai X, Beca JM, Arias J, Raphael MJ, Parmar A, Crespo A, Cheung MC, Eisen A, Eskander A, Singh S, Trudeau M, Gavura S, Dai WF, Irish J, Krzyzanowska M, Lapointe-Shaw L, Naipaul R, Peacock S, Yeung L, Forbes L, Chan KKW. Comparison of Use of Neoadjuvant Systemic Treatment for Breast Cancer and Short-term Outcomes Before vs During the COVID-19 Era in Ontario, Canada. JAMA Netw Open 2022;5:e2225118. [PMID: 35917122 DOI: 10.1001/jamanetworkopen.2022.25118] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Laracy JC, Kamboj M, Vardhana SA. Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside. Curr Opin Infect Dis 2022;35:271-9. [PMID: 35849516 DOI: 10.1097/QCO.0000000000000841] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Leuva H, Zhou M, Brau N, Brown ST, Mundi P, Rosenberg TM, Luhrs C, Bates SE, Park YA, Fojo T. Influence of cancer on COVID-19 incidence, outcomes, and vaccine effectiveness: A Prospective Cohort Study of U.S. Veterans. Seminars in Oncology 2022. [DOI: 10.1053/j.seminoncol.2022.07.005] [Reference Citation Analysis]
40 Vicinanza F, Ippolito E, Sisto A, Santo B, Fiore M, Trodella LE, Silipigni S, Quintiliani L, Ramella S. The psychological impact of the covid-19 pandemic on radiotherapy cancer patients. Translational Oncology 2022;22:101457. [DOI: 10.1016/j.tranon.2022.101457] [Reference Citation Analysis]
41 Liu L, Ross NM, Handorf EA, Meeker CR, Chen G, Baldwin D, Vijayvergia N. Incidence of asymptomatic COVID-19 positivity in cancer patients and effects on therapy. J Cancer Res Clin Oncol 2022. [PMID: 35904602 DOI: 10.1007/s00432-022-04231-7] [Reference Citation Analysis]
42 Tso FY, Lidenge SJ, Ngowi JR, Peña PB, Clegg AA, Ngalamika O, Mwita CJ, Mwaiselage J, Wood C. Lower SARS-CoV-2 Seroprevalence among Cancer Patients in Sub-Saharan Africa. JCM 2022;11:4428. [DOI: 10.3390/jcm11154428] [Reference Citation Analysis]
43 Llanos AAM, Fong AJ, Ghosh N, Devine KA, O'Malley D, Paddock LE, Bandera EV, Hudson SV, Evens AM, Manne SL. COVID-19 perceptions, impacts, and experiences: a cross-sectional analysis among New Jersey cancer survivors. J Cancer Surviv 2022. [PMID: 35904727 DOI: 10.1007/s11764-022-01236-6] [Reference Citation Analysis]
44 Souan L, Sughayer MA, Abu Alhowr MM. Establishing the First COVID-19 Convalescent Plasma Biobank in Jordan. Biopreserv Biobank 2022. [PMID: 35904406 DOI: 10.1089/bio.2022.0072] [Reference Citation Analysis]
45 Prasad K, Gour P, Raghuvanshi S, Kumar V. The SARS-CoV-2 targeted human RNA binding proteins network biology to investigate COVID-19 associated manifestations. Int J Biol Macromol 2022;217:853-63. [PMID: 35907451 DOI: 10.1016/j.ijbiomac.2022.07.200] [Reference Citation Analysis]
46 Tanabe Y, Shukuya T, Nagata Y, Watanabe T, Seto K, Takahashi R, Masuda K, Miura K, Tajima K, Hiki M, Hayashi T, Suzuki K, Takahashi K. Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID-19 infection. Thorac Cancer 2022. [PMID: 35903864 DOI: 10.1111/1759-7714.14593] [Reference Citation Analysis]
47 Cox RE, Parish M, Oxencis C, Mckenna E, Thapa B, Chakrabarti S. Short term safety of coronavirus disease 2019 vaccines in patients with solid tumors receiving systemic therapy. World J Clin Oncol 2022; 13(7): 599-608 [DOI: 10.5306/wjco.v13.i7.599] [Reference Citation Analysis]
48 Piras A, Venuti V, D’aviero A, Cusumano D, Pergolizzi S, Daidone A, Boldrini L. Covid-19 and radiotherapy: a systematic review after 2 years of pandemic. Clin Transl Imaging. [DOI: 10.1007/s40336-022-00513-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Dias TR, Dias F, Teixeira AL, Sousa H, Oliveira J, Medeiros R. MicroRNAs as Potential Tools for Predicting Cancer Patients’ Susceptibility to SARS-CoV-2 Infection and Vaccination Response. Cells 2022;11:2279. [DOI: 10.3390/cells11152279] [Reference Citation Analysis]
50 Souan L, Sughayer MA, Abu Alhowr M, Ammar K, Bader SA. An update on the impact of SARS-CoV-2 pandemic public awareness on cancer patients' COVID-19 vaccine compliance: Outcomes and recommendations. Front Public Health 2022;10:923815. [DOI: 10.3389/fpubh.2022.923815] [Reference Citation Analysis]
51 Moss WD, Pires GR, Samlowski E, Webb J, DeAngelo MM, Eddington D, Brintz BJ, Agarwal J, Kwok AC. Characterizing the volume of surgery and post-operative complications during the COVID-19 pandemic. Langenbecks Arch Surg 2022. [PMID: 35857096 DOI: 10.1007/s00423-022-02605-6] [Reference Citation Analysis]
52 Russell B, Moss C, Monroy-Iglesias M, Roberts G, Dickinson H, Haire K, Innes K, Mulji-Shah B, Castell F, Al-Salihi O, Lei M, Francis A, Dann B, Jogia V, Hamid H, Challacombe B, Simo R, Fraser S, Gousis C, Sawyer E, Tsotra E, Roca J, Khan M, Josephs D, Enting D, Van Hemelrijck M, Harris V, Dolly S. Radical cancer treatment is safe during COVID-19: the real-world experience of a large London-based Comprehensive Cancer Centre during the first wave. Br J Cancer 2022. [PMID: 35840733 DOI: 10.1038/s41416-022-01909-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Bashkin O, Nahmias R, Attar S, Moshe R, Asna N. Perspectives of cancer patients during the COVID-19 outbreak in Israel: The long-term implications on support and well-being in an exploratory qualitative study. Eur J Cancer Care (Engl) 2022;:e13657. [PMID: 35838182 DOI: 10.1111/ecc.13657] [Reference Citation Analysis]
54 Taylor JK, Mady LJ, Baddour K, Iheagwara UK, Zhai S, Ohr JP, Zandberg DP, Gorantla VC, Ferris RL, Kim S, Duvvuri U, Kubik MW, Sridharan S, Johnson JT, Holeva KD, Quinn AE, Clump DA. A phase Ⅱ prospective trial of photobiomodulation therapy in limiting oral mucositis in the treatment of locally advanced head and neck cancer patients. World j otorhinolaryngol -head neck surg . [DOI: 10.1002/wjo2.18] [Reference Citation Analysis]
55 Kiani P, Mulder KEW, Balikji J, Kraneveld AD, Garssen J, Verster JC. Pandemic Preparedness: Maintaining Adequate Immune Fitness by Attaining a Normal, Healthy Body Weight. JCM 2022;11:3933. [DOI: 10.3390/jcm11143933] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
56 Kloecker G, Nolan J, Korbee L, Calhoun R, Logan B, Flora D, Flora D, Hartman P. Social Distancing to Avoid SARS-CoV-2 Infection in Cancer and Noncancer Patients. J Patient Saf 2022. [PMID: 35797588 DOI: 10.1097/PTS.0000000000001058] [Reference Citation Analysis]
57 Knight JM, Taylor MR, Rentscher KE, Henley EC, Uttley HA, Nelson AM, Turcotte LM, Mcandrew NS, Amonoo HL, Mohanraj L, Kelly DL, Costanzo ES. Biobehavioral Implications of Covid-19 for Transplantation and Cellular Therapy Recipients. Front Immunol 2022;13:877558. [DOI: 10.3389/fimmu.2022.877558] [Reference Citation Analysis]
58 Muraro AP, Oliveira LR, Andrade ACS, Terças-Trettel ACP, Guimarães LV, Souza BDSN. Factors associated with death among cancer patients hospitalized for COVID-19 in Mato Grosso, Brazil. Rev Bras Epidemiol 2022;25:e220020. [PMID: 35766777 DOI: 10.1590/1980-549720220020.supl.1] [Reference Citation Analysis]
59 Fang R, Liao H, Mardani A. How to aggregate uncertain and incomplete cognitive evaluation information in lung cancer treatment plan selection? A method based on Dempster-Shafer theory. Information Sciences 2022;603:222-43. [DOI: 10.1016/j.ins.2022.04.060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
60 Pakvisal N, Sainamthip P, Teeyapun N, Luangdilok S, Wanlapakorn N, Yorsaeng R, Poovorawan Y, Pakvisal P, Susiriwatananont T, Zungsontiporn N, Sriuranpong V, Tanasanvimon S, Wanchaijiraboon P. Vaccine-Related adverse events following AZD1222 (ChAdOx1-nCoV-19) Covid-19 vaccine in solid malignancy patients receiving cancer treatment, as compared to age-matched healthy controls. Hum Vaccin Immunother 2022;:2094149. [PMID: 35776836 DOI: 10.1080/21645515.2022.2094149] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Li S, Chen S, Zhu Q, Ben S, Gao F, Xin J, Du M, Chu H, Gu D, Zhang Z, Wang M. The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer. Clin Transl Med 2022;12:e967. [PMID: 35866260 DOI: 10.1002/ctm2.967] [Reference Citation Analysis]
62 Mullangi S, Aviki EM, Chen Y, Robson M, Hershman DL. Factors Associated With Cancer Treatment Delay Among Patients Diagnosed With COVID-19. JAMA Netw Open 2022;5:e2224296. [PMID: 35900758 DOI: 10.1001/jamanetworkopen.2022.24296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Albahrani S, Alghamdi M, Zakary N, Jebakumar AZ, Alzahrani SJ, Elgezery MH, Abdallah KO, Al-tawfiq JA. Initial viral cycle threshold values in patients with COVID-19 and their clinical significance. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00729-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Khattak S, Faheem M, Nawaz B, Khan M, Khan NH, Ullah N, Khan TA, Khan RU, Haleem KS, Ren Z, Wu D, Ji X. Knowledge, Attitude, and Perception of Cancer Patients towards COVID-19 in Pakistan: A Cross-Sectional Study. IJERPH 2022;19:7926. [DOI: 10.3390/ijerph19137926] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
65 Silvestris N, Belleudi V, Addis A, Pimpinelli F, Morrone A, Sciacchitano S, Mancini R, Garrisi VM, Costantini M, Ciliberto G, Frisardi V, Piaggio G. Development of Approaches and Metrics to Measure the Impact and Improve the Clinical Outcomes of Patients With Frailty in the Era of COVID-19. The COMETA Italian Protocol. Front Oncol 2022;12:828660. [PMID: 35756683 DOI: 10.3389/fonc.2022.828660] [Reference Citation Analysis]
66 Yu S, Qian L, Ma J. Genetic alterations, RNA expression profiling and DNA methylation of HMGB1 in malignancies. J Cell Mol Med 2022. [PMID: 35765707 DOI: 10.1111/jcmm.17454] [Reference Citation Analysis]
67 Agostinelli V, De Filippis C, Torniai M, Rocchi MBL, Pagliacci A, Ricci G, Corsi R, Luzi P, Caporossi M, Berardi R. Primum non Nocere: How to ensure continuity of care and prevent cancer patients from being overlooked during the COVID- 19 pandemic. Cancer Med 2022. [PMID: 35754357 DOI: 10.1002/cam4.4986] [Reference Citation Analysis]
68 Wang G, Pan L, Zhao J, Tang J, Fang Y, Sun H, Seesaha PK, Chen W, Chen X. Case fatality rate of the adult in-patients with COVID-19 and digestive system tumors: A systematic review and meta-analysis. Medicine (Baltimore) 2022;101:e29364. [PMID: 35758367 DOI: 10.1097/MD.0000000000029364] [Reference Citation Analysis]
69 Bigdelou B, Sepand MR, Najafikhoshnoo S, Negrete JAT, Sharaf M, Ho JQ, Sullivan I, Chauhan P, Etter M, Shekarian T, Liang O, Hutter G, Esfandiarpour R, Zanganeh S. COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes. Front Immunol 2022;13:890517. [PMID: 35711466 DOI: 10.3389/fimmu.2022.890517] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
70 Wang K, Deng H, Song B, He J, Liu S, Fu J, Zhang L, Li D, Balaji KS, Mei Z, Cheng J, Fu J. The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. Front Immunol 2022;13:923516. [PMID: 35720350 DOI: 10.3389/fimmu.2022.923516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
71 Zhang K, Wang K, Zhang C, Teng X, Li D, Chen M. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses. BMC Cancer 2022;22:687. [PMID: 35733175 DOI: 10.1186/s12885-022-09763-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Zhuang Z, Zhong X, Chen Q, Chen H, Liu Z. Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19. Front Pharmacol 2022;13:857730. [PMID: 35721149 DOI: 10.3389/fphar.2022.857730] [Reference Citation Analysis]
73 Jiang M, Hu Y, Lin G, Chen C. Dosing Regimens of Immune Checkpoint Inhibitors: Attempts at Lower Dose, Less Frequency, Shorter Course. Front Oncol 2022;12:906251. [DOI: 10.3389/fonc.2022.906251] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
74 Babtain F, Bajafar A, Nazmi O, Badawi M, Basndwah A, Bushnag A, Cupler E, Hassan A. The disease course of multiple sclerosis before and during COVID-19 pandemic: A retrospective five-year study. Mult Scler Relat Disord 2022;65:103985. [PMID: 35759904 DOI: 10.1016/j.msard.2022.103985] [Reference Citation Analysis]
75 Li J, Chen S, Li Y, Zhu Z, Huang H, Wang W, Yang Y, Liang Y, Shu L. Comprehensive Profiling Analysis of CD209 in Malignancies Reveals the Therapeutic Implication for Tumor Patients Infected With SARS-CoV-2. Front Genet 2022;13:883234. [DOI: 10.3389/fgene.2022.883234] [Reference Citation Analysis]
76 Manzano JM, Muthu M, Kheder E, Mohammed A, Halm J, Dickson K, Ali N, Leung C, Koom-Dadzie K, Rubio D, Odaro O, Sibille M, Etchegaray M, Wilson K, Lin H, George M. Hospitalization characteristics and outcomes of patients with cancer and COVID-19 at a comprehensive cancer center. Support Care Cancer 2022. [PMID: 35705751 DOI: 10.1007/s00520-022-07209-w] [Reference Citation Analysis]
77 Du G, Xu X, Wang J, Wang X, Ding Y, Li F, Sun Y, Tao H, Luo Y, Li H, Bo X, Chen H. The accessible promoter-mediated supplementary effect of host factors provides new insight into the tropism of SARS-CoV-2. Mol Ther Nucleic Acids 2022;28:249-58. [PMID: 35313658 DOI: 10.1016/j.omtn.2022.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Liang W, Li X, Yao Y, Meng Q, Wu X, Wang H, Xue J. Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection. Front Pharmacol 2022;13:921517. [PMID: 35677450 DOI: 10.3389/fphar.2022.921517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Hassan AM, Chu CK, Liu J, Angove R, Rocque G, Gallagher KD, Momoh AO, Caston NE, Williams CP, Wheeler S, Butler CE, Offodile AC. Determinants of telemedicine adoption among financially distressed patients with cancer during the COVID-19 pandemic: insights from a nationwide study. Support Care Cancer 2022. [PMID: 35689108 DOI: 10.1007/s00520-022-07204-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Durkee-Shock J, Lazarski CA, Jensen-Wachspress MA, Zhang A, Son A, Kankate VV, Field NE, Webber K, Lang H, Conway SR, Hanley PJ, Bollard CM, Keller MD, Schwartz DM. Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products. Mol Ther Methods Clin Dev 2022;25:439-47. [PMID: 35506060 DOI: 10.1016/j.omtm.2022.04.013] [Reference Citation Analysis]
81 Kazazian K, Bogach J, Johnston W, Ng D, Swallow CJ. Challenges in virtual collection of patient-reported data: a prospective cohort study conducted in COVID-19 era. Support Care Cancer 2022. [PMID: 35670865 DOI: 10.1007/s00520-022-07191-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
82 Carle C, Hughes S, Freeman V, Campbell D, Egger S, Caruana M, Hui H, Yap S, Deandrea S, Onyeka TC, Jzerman MJI, Ginsburg O, Bray F, Sullivan R, Aggarwal A, Peacock SJ, Chan KKW, Hanna TP, Soerjomataram I, O'Connell DL, Canfell K, Steinberg J. The risk of contracting SARS-CoV-2 or developing COVID-19 for people with cancer: a systematic review of the early evidence. J Cancer Policy 2022;:100338. [PMID: 35671919 DOI: 10.1016/j.jcpo.2022.100338] [Reference Citation Analysis]
83 Nuzzo A, Manacorda S, Sammarco E, Sbrana A, Bazzurri S, Paolieri F, Manfredi F, Mercinelli C, Ferrari M, Massaro G, Bonato A, Salfi A, Galli L, Morganti R, Antonuzzo A, Cremolini C, Masi G. Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective Analysis. Vaccines 2022;10:892. [DOI: 10.3390/vaccines10060892] [Reference Citation Analysis]
84 Bjerre Real C, Dhawan V, Sharma M, Seier K, Tan KS, Matsoukas K, Maloy M, Voigt L, Alici Y, Chawla S. Delirium in Critically Ill Cancer Patients with COVID-19. J Acad Consult Liaison Psychiatry 2022:S2667-2960(22)00273-7. [PMID: 35660676 DOI: 10.1016/j.jaclp.2022.05.005] [Reference Citation Analysis]
85 Shachar E, Hasson S, Ferro L, Pundak C, Nikolaevski-berlin A, Waller E, Safra T, Rubinek T, Wolf I. Real-life daily activity: the impact of misbeliefs on quality of life among cancer patients. ESMO Open 2022;7:100498. [DOI: 10.1016/j.esmoop.2022.100498] [Reference Citation Analysis]
86 Margalit O, Shacham-shmueli E, Itay A, Berger R, Halperin S, Jurkowicz M, Levin EG, Olmer L, Regev-yochay G, Lustig Y, Rahav G. Seropositivity and neutralising antibodies at six months after BNT162b2 vaccination in patients with solid tumours. European Journal of Cancer 2022;168:51-5. [DOI: 10.1016/j.ejca.2022.03.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
87 Fujii T, Hagihara M, Mitamura K, Nakashima S, Ohara S, Uchida T, Inoue M, Okuda M, Yasuhara A, Murakami J, Duong C, Iwatsuki-Horimoto K, Yamayoshi S, Kawaoka Y. Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan. Intern Med 2022;61:1681-6. [PMID: 35342138 DOI: 10.2169/internalmedicine.9209-21] [Reference Citation Analysis]
88 Udovica S, Müser N, Pechlaner A, Reichinger A, Aichinger C, Strasser-weippl K, Rumpold H, Petzer A, Wöll E, Hilbe W, Müldür E. High mortality in patients with active malignancy and severe COVID-19: Results from an Austrian multicenter registry during the first period of the COVID-19 pandemic. memo 2022;15:153-60. [DOI: 10.1007/s12254-022-00814-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
89 Zhou J, Lakhani I, Chou O, Leung KSK, Lee TTL, Wong MV, Li Z, Wai AKC, Chang C, Wong ICK, Zhang Q, Tse G, Cheung BMY. Clinical characteristics, risk factors and outcomes of cancer patients with COVID-19: A population-based study. Cancer Med 2022. [PMID: 35642123 DOI: 10.1002/cam4.4888] [Reference Citation Analysis]
90 George B, Moorthy M, Kulkarni U, Selvarajan S, Rupali P, Christopher DJ, Balamugesh T, Rose W, Lakshmi KM, Devasia AJ, Fouzia NA, Korula A, Lionel S, Abraham A, Mathews V. Single Dose of Ivermectin is not Useful in Patients with Hematological Disorders and COVID-19 Illness: A Phase II B Open Labelled Randomized Controlled Trial. Indian J Hematol Blood Transfus. [DOI: 10.1007/s12288-022-01546-w] [Reference Citation Analysis]
91 Pellicano C, Campagna R, Oliva A, Leodori G, Miglionico M, Colalillo A, Mezzaroma I, Mastroianni CM, Turriziani O, Rosato E. Antibody response to BNT162b2 SARS-CoV-2 mRNA vaccine in adult patients with systemic sclerosis. Clin Rheumatol 2022. [PMID: 35614287 DOI: 10.1007/s10067-022-06219-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
92 Akbulut S, Sahin TT, Ince V, Yilmaz S. Impact of COVID-19 pandemic on clinicopathological features of transplant recipients with hepatocellular carcinoma: A case-control study. World J Clin Cases 2022; 10(15): 4785-4798 [DOI: 10.12998/wjcc.v10.i15.4785] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
93 Narayan S, Talwar V, Goel V, Chaudhary K, Sharma A, Redhu P, Soni S, Jain A. Co-relation of SARS-CoV-2 related 30-d mortality with HRCT score and RT-PCR Ct value-based viral load in patients with solid malignancy. World J Clin Oncol 2022; 13(5): 339-351 [DOI: 10.5306/wjco.v13.i5.339] [Reference Citation Analysis]
94 Azhdari Tehrani H, Ramezaninejad S, Mardani M, Shokouhi S, Darnahal M, Hakamifard A. Hematologic malignancies and COVID‐19 infection: A monocenter retrospective study. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.638] [Reference Citation Analysis]
95 He S, Wang Y, Zhao X, Xu F, Li J, Huang T, Sun P, Li L, Ai X, Xiao H, Xue G, He S. Factors Influencing Delayed Treatment in Patients With Breast Cancer During COVID-19 Pandemic. Front Public Health 2022;10:808873. [PMID: 35570909 DOI: 10.3389/fpubh.2022.808873] [Reference Citation Analysis]
96 Wang S, Gao H, Wang X, Ma X, Zhang L, Xing Y, Jia Y, Wang Y. Network Pharmacology and Bioinformatics Analyses Identify Intersection Genes of Vitamin D3 and COVID-19 as Potential Therapeutic Targets. Front Pharmacol 2022;13:874637. [PMID: 35571107 DOI: 10.3389/fphar.2022.874637] [Reference Citation Analysis]
97 Merzon E, Weiss M, Krone B, Cohen S, Ilani G, Vinker S, Cohen-golan A, Green I, Israel A, Schneider T, Ashkenazi S, Weizman A, Manor I. Clinical and Socio-Demographic Variables Associated with the Diagnosis of Long COVID Syndrome in Youth: A Population-Based Study. IJERPH 2022;19:5993. [DOI: 10.3390/ijerph19105993] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
98 Alsalman AJ, Al Mohaini M, Malik MZ, Imran M, Alomar FA, Al Awwad N. Elevated Vulnerability of Chronic Leukemia Patients to COVID-19 Infection: A Systems Biology Approach. Dr Sulaiman Al Habib Med J. [DOI: 10.1007/s44229-022-00005-y] [Reference Citation Analysis]
99 Huang T, He W. Pan-Cancer Analysis, Reveals COVID-19-Related BSG as a Novel Marker for Treatment and Identification of Multiple Human Cancers. Front Cell Dev Biol 2022;10:876180. [DOI: 10.3389/fcell.2022.876180] [Reference Citation Analysis]
100 Pichler T, Frank T, Maier S, Batenhorst I, Albawi-Daltrozzo T, Harbeck N, Algül H, Heinemann V, Hermelink K, Mumm F, Dinkel A. [The views of cancer out-patients on the impact of the COVID-19 pandemic]. Dtsch Med Wochenschr 2022;147:e41-9. [PMID: 35545063 DOI: 10.1055/a-1746-7534] [Reference Citation Analysis]
101 Khalid Z, Khan AT, Alnajjar R, Santali E, Shakoori AR. In silico mutational analysis of ACE2 to check the susceptibility of lung cancer patients towards COVID-19. Sci Rep 2022;12:7798. [PMID: 35552474 DOI: 10.1038/s41598-022-11805-5] [Reference Citation Analysis]
102 Chen UI, Xu H, Krause TM, Greenberg R, Dong X, Jiang X. Factors Associated With COVID-19 Death in the United States: Cohort Study. JMIR Public Health Surveill 2022;8:e29343. [PMID: 35377319 DOI: 10.2196/29343] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
103 Sagnelli C, Sica A, Creta M, Borsetti A, Ciccozzi M, Sagnelli E. Prevention of HBV Reactivation in Hemato-Oncologic Setting during COVID-19. Pathogens 2022;11:567. [DOI: 10.3390/pathogens11050567] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Luta X, Diernberger K, Bowden J, Droney J, Hall P, Marti J. Intensity of care in cancer patients in the last year of life: a retrospective data linkage study. Br J Cancer 2022. [PMID: 35545681 DOI: 10.1038/s41416-022-01828-0] [Reference Citation Analysis]
105 Zambrano-Román M, Padilla-Gutiérrez JR, Valle Y, Muñoz-Valle JF, Valdés-Alvarado E. Non-Melanoma Skin Cancer: A Genetic Update and Future Perspectives. Cancers (Basel) 2022;14:2371. [PMID: 35625975 DOI: 10.3390/cancers14102371] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Ichikawa T, Torii S, Suzuki H, Takada A, Suzuki S, Nakajima M, Tampo A, Kakinoki Y. Mutations in the non-structural proteins of SARS-CoV-2 may contribute to adverse clinical outcome in COVID-19 patients. Int J Infect Dis 2022:S1201-9712(22)00275-2. [PMID: 35562044 DOI: 10.1016/j.ijid.2022.05.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
107 Kim Y, Zhu L, Zhu H, Li X, Huang Y, Gu C, Bush H, Chung C, Zhang GQ. Characterizing cancer and COVID-19 outcomes using electronic health records. PLoS One 2022;17:e0267584. [PMID: 35507598 DOI: 10.1371/journal.pone.0267584] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Chiruvella V, Ullah A, Elhelf I, Patel N, Karim NA. Would the Addition of Immunotherapy Impact the Prognosis of Patients With Malignant Pericardial Effusion? Front Oncol 2022;12:871132. [DOI: 10.3389/fonc.2022.871132] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Elnaggar M, Abomhya A, Elkhattib I, Dawoud N, Doshi R. COVID-19 and liver diseases, what we know so far. World J Clin Cases 2022; 10(13): 3969-3980 [DOI: 10.12998/wjcc.v10.i13.3969] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
110 Della Vecchia C, Girodet M, Ginguené S, Carpentier C, Leroy T, Siméone A, Vayre E, Mabire X, Ferraz D, Morin-Messabel C, Préau M. At the heart of the COVID-19 crisis: Perceived concerns of changes in long-term cancer care in French women with cancer. Eur J Cancer Care (Engl) 2022;:e13599. [PMID: 35523418 DOI: 10.1111/ecc.13599] [Reference Citation Analysis]
111 Bliss JW, Lavery JA, Underwood WP, Chun SS, Fickera GA, Lee CP, Corcoran S, Maloy MA, Polubriaginof FC, Kelly DW, Scott JM, Boutros PC, Moskowitz CS, Jones LW. Impact of Exercise on Susceptibility and Severity of COVID-19 in Patients with Cancer: A Retrospective Study. Cancer Epidemiol Biomarkers Prev 2022;31:1036-42. [PMID: 35506245 DOI: 10.1158/1055-9965.EPI-21-1186] [Reference Citation Analysis]
112 Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. COVID-19 vaccine development: milestones, lessons and prospects. Signal Transduct Target Ther 2022;7:146. [PMID: 35504917 DOI: 10.1038/s41392-022-00996-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
113 Khoury E, Nevitt S, Madsen WR, Turtle L, Davies G, Palmieri C. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis. JAMA Netw Open 2022;5:e2210880. [PMID: 35532936 DOI: 10.1001/jamanetworkopen.2022.10880] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
114 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
115 Pence MC, Avdan Aslan A, Tunccan OG, Erbas G. Prognostic value of semi-quantitative CT-based score integrated with cardiovascular risk factors during the first peak of the COVID-19 pandemic: A new score to predict poor outcome. European Journal of Radiology 2022;150:110238. [DOI: 10.1016/j.ejrad.2022.110238] [Reference Citation Analysis]
116 Levi M, van Es N. COVID-19 associated coagulopathy and thrombosis in cancer. Thrombosis Research 2022;213:S72-6. [DOI: 10.1016/j.thromres.2021.12.006] [Reference Citation Analysis]
117 Bhayana S, Kalra M, Sachdeva A. Covid-19 in pediatric hematology-oncology and stem cell transplant patients –The spectrum of illness, complications and comparison of first two waves. Pediatric Hematology Oncology Journal 2022. [DOI: 10.1016/j.phoj.2022.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
118 Javed AA, Habib JR, Kinny-köster B, Hodgin M, Parish L, Cunningham D, Hacker-prietz A, Burkhart RA, Burns WR, Shubert CR, Cameron JL, Zaheer A, Chu LCH, Kawamoto S, Thompson ED, Shin EJ, Narang A, Zheng L, Laheru DA, Hruban RH, He J, Wolfgang CL, Fishman EK, Lafaro K. The Impact of the COVID-19 Pandemic on Multidisciplinary Clinics: A High-Volume Pancreatic Cancer Center Experience. Current Problems in Diagnostic Radiology 2022. [DOI: 10.1067/j.cpradiol.2022.05.001] [Reference Citation Analysis]
119 Castelo-branco L, Tsourti Z, Gennatas S, Rogado J, Sekacheva M, Viñal D, Lee R, Croitoru A, Vitorino M, Khallaf S, Šušnjar S, Soewoto W, Cardeña A, Djerouni M, Rossi M, Alonso-gordoa T, Ngelangel C, Whisenant JG, Choueiri TK, Dimopoulou G, Pradervand S, Arnold D, Harrington K, Michielin O, Dafni U, Pentheroudakis G, Peters S, Romano E. COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO CoCARE). ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Zhang C, Wu Y, Zhong W. New Normal for Lung Cancer Clinical Trials Under Coronavirus Disease 2019. Journal of Thoracic Oncology 2022;17:588-91. [DOI: 10.1016/j.jtho.2022.03.001] [Reference Citation Analysis]
121 Lichiello S, Rainwater L, Russell GB, Pulgar C, Clark J, Daniel S, Mccall MH, Bentley P, Duckworth KE. Cancer during a pandemic: A psychosocial telehealth intervention for young adults. Current Problems in Cancer 2022. [DOI: 10.1016/j.currproblcancer.2022.100865] [Reference Citation Analysis]
122 Nuñez DF, Leon L, Garcia AM, Arce JIC, Mucientes A, Gutierrez-fernandez B, Rodriguez L, Cristóbal IPS, Álvarez P, Prada CM, Abasolo L. Mortality related to COVID-19 in patients with rheumatic and musculoskeletal diseases, first wave of the outbreak: a single-center study. Therapeutic Advances in Musculoskeletal 2022;14:1759720X2210902. [DOI: 10.1177/1759720x221090296] [Reference Citation Analysis]
123 Sundberg E, Georgantzi K, Langenskiöld C, Król L, Nilsson F, Vogt H, Palle J, Ek T, Nilsson A. Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society. Pediatr Blood Cancer 2022;:e29750. [PMID: 35484955 DOI: 10.1002/pbc.29750] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Mina A, Galvez C, Karmali R, Mulcahy M, Mi X, Kocherginsky M, Gurley MJ, Katam N, Gradishar W, Altman JK, Ison MG, Tsarwhas D, George C, Winter JN, Gordon LI, Wehbe FH, Platanias LC. Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area. Cancers (Basel) 2022;14:2209. [PMID: 35565336 DOI: 10.3390/cancers14092209] [Reference Citation Analysis]
125 Joerger M, Metaxas Y, Zaman K, Michielin O, Mach N, Bettini A, Schmitt AM, Cantoni N, Caspar CB, Stettler S, Malval R, Pless M, Britschgi C, Renner C, Koeberle D, Schulz JD, Kopp C, Hayoz S, Stathis A, von Moos R; Swiss Group for Clinical Cancer Research (SAKK). Outcome and Prognostic Factors of COVID-19 Infection in Swiss Cancer Patients: Final Results of SAKK 80/20 (CaSA). Cancers (Basel) 2022;14:2191. [PMID: 35565320 DOI: 10.3390/cancers14092191] [Reference Citation Analysis]
126 Naderi M, Soltani SA, Rad AT, Mehrbakhsh Z, Sodagar S, Tahamtan A, Hosseini SS. Recurrent viral RNA positivity and candidiasis findings in hospitalized patients with COVID-19. Future Microbiol 2022;17:673-82. [PMID: 35465729 DOI: 10.2217/fmb-2022-0041] [Reference Citation Analysis]
127 Talens A, López-Pintor E, Bejerano M, Guilabert M, Aznar MT, Aznar-Lou I, Lumbreras B. Influence of the COVID-19 Pandemic on Adherence to Orally Administered Antineoplastics. J Clin Med 2022;11:2436. [PMID: 35566561 DOI: 10.3390/jcm11092436] [Reference Citation Analysis]
128 Müller J, Szűcs-Farkas D, Szegedi I, Csóka M, Garami M, Tiszlavicz LG, Hauser P, Kriván G, Csanádi K, Ottóffy G, Nagy B Jr, Kiss C, Kovács G. Clinical Course of COVID-19 Disease in Children Treated With Neoplastic Diseases in Hungary. Pathol Oncol Res 2022;28:1610261. [PMID: 35431663 DOI: 10.3389/pore.2022.1610261] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
129 Pavithran K, Jayamohanan H, Philp A, Vijaykumar D, Kumar A, John D. Universal Screening of Patients with Cancer for COVID-19: Results from an Observational, Retrospective Cohort Study in Kerala, India. Indian J Med Paediatr Oncol. [DOI: 10.1055/s-0042-1742440] [Reference Citation Analysis]
130 Gabanelli P, Monzani D, Fiabane E, Quaquarini E, Frascaroli M, Balletti E, Bernardo A, Teragni CM, Grossi F, Pravettoni G, Gorini A. Perceived risk, illness perception and dispositional optimism related to COVID-19 among oncologic outpatients undergoing in-hospital treatments and healthy controls. Psychol Health 2022;:1-17. [PMID: 35435083 DOI: 10.1080/08870446.2022.2065275] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
131 Naik N, Hameed BMZ, Nayak SG, Gera A, Nandyal SR, Shetty DK, Shah M, Ibrahim S, Naik A, Kamath N, Mahdaviamiri D, D'costa KK, Rai BP, Chlosta P, Somani BK. Telemedicine and Telehealth in Urology—What Do the ‘Patients' Think About It? Front Surg 2022;9:863576. [DOI: 10.3389/fsurg.2022.863576] [Reference Citation Analysis]
132 Eidininkienė M, Cesarskaja J, Talačkaitė S, Traškaitė-juškevičienė V, Macas A. Mini Review: Co-Existing Diseases and COVID-19—A One Way Ticket? IJERPH 2022;19:4738. [DOI: 10.3390/ijerph19084738] [Reference Citation Analysis]
133 Kieran R, Moloney C, Alken S, Corrigan L, Gallagher D, Grant C, Kelleher F, Kennedy MJ, Lowery MA, McCarthy M, O'Donnell DM, Sukor S, Cuffe S. Patient knowledge, personal experience, and impact of the first wave of the COVD-19 pandemic in an Irish oncology cohort. Ir J Med Sci 2022. [PMID: 35411487 DOI: 10.1007/s11845-022-02999-8] [Reference Citation Analysis]
134 Ben Kridis W, Lajnef M, Khmeri S, Khanfir A. Milano Policlinico ONCOVID modified Score for risk evaluation in oncology during the COVID-19 pandemic: a prospective monocentric study. Support Care Cancer. [DOI: 10.1007/s00520-022-07040-3] [Reference Citation Analysis]
135 Chen MZ, Tay YK, Teoh WM, Kong JC, Carne P, D'Souza B, Chandra R, Bui A; Melbourne Colorectal Collaboration. Melbourne colorectal collaboration: a multicentre review of the impact of COVID-19 on colorectal cancer in Melbourne, Australia. ANZ J Surg 2022. [PMID: 35393720 DOI: 10.1111/ans.17603] [Reference Citation Analysis]
136 Al-Mozaini MA, Islam M, Noman ASM, Karim AR, Farhat WA, Yeger H, Islam SS. Decline in Respiratory Functions in Hospitalized SARS-CoV-2 Infected Cancer Patients Following Cytotoxic Chemotherapy-An Additional Risk for Post-chemotherapy Complications. Front Med (Lausanne) 2022;9:835098. [PMID: 35360723 DOI: 10.3389/fmed.2022.835098] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
137 Ghoreifi A, Sobhani S, Moghaddam FS, Djaladat H. The Challenges of Urological Research in COVID-19 Era: Lessons Learned for Immediate Response to the Pandemic. Urology 2022. [DOI: 10.1016/j.urology.2022.04.006] [Reference Citation Analysis]
138 Ladoire S, Rederstorff E, Goussot V, Parnalland S, Briot N, Ballot E, Truntzer C, Ayati S, Bengrine-lefevre L, Bremaud N, Coudert B, Desmoulins I, Favier L, Fraisse C, Fumet J, Hennequin A, Hervieu A, Ilie S, Kaderbhai C, Lagrange A, Martin N, Mazilu I, Mayeur D, Palmier R, Simonet-lamm A, Vincent J, Zanetta S, Arnould L, Coutant C, Bertaut A, Ghiringhelli F. Parallel evolution and differences in seroprevalence of SARS-CoV-2 antibody between patients with cancer and health care workers in a tertiary cancer centre during the first and second wave of COVID-19 pandemic: canSEROcov-II cross-sectional study. European Journal of Cancer 2022;165:13-24. [DOI: 10.1016/j.ejca.2022.01.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Ambroggi M, Citterio C, Vecchia S, Riva A, Mordenti P, Cavanna L. Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy. Support Care Cancer 2022;30:3225-31. [PMID: 34977981 DOI: 10.1007/s00520-021-06667-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
140 Lopes A, Pastore CBP, Deckers P, Halla IKMW, Dias ALR, da Mata MVM, do Nascimento Martins A, Viu MM, Lopez RVM, Yamada AD. ASO Author Reflections: Oncological Surgery during the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection. Ann Surg Oncol 2022;29:2163-4. [PMID: 34994888 DOI: 10.1245/s10434-021-11201-9] [Reference Citation Analysis]
141 García-Botella A, García-Lledó A, Gómez-Pavón J, González Del Castillo J, Hernández-Sampelayo T, Martín-Delgado MC, Martín Sánchez FJ, Martínez-Sellés M, Molero García JM, Moreno Guillén S, Rodríguez-Artalejo FJ, Ruiz-Galiana J, Cantón R, De Lucas Ramos P, Bouza E. Booster or additional vaccination doses in patients vaccinated against COVID-19. Rev Esp Quimioter 2022;35:105-14. [PMID: 34775740 DOI: 10.37201/req/149.2021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
142 Lou H, Li X, Gao S, Zhang Y, Chen H, Zhai X. Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma. IJGM 2022;Volume 15:4285-301. [DOI: 10.2147/ijgm.s356444] [Reference Citation Analysis]
143 Chiner-vives E, Cordovilla-pérez R, Rosa-carrillo DDL, García-clemente M, Izquierdo-alonso JL, Otero-candelera R, Llano LP, Sellares-torres J, Granda-orive JID. Short and Long-Term Impact of COVID-19 Infection on Previous Respiratory Diseases. Archivos de Bronconeumología 2022. [DOI: 10.1016/j.arbres.2022.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
144 Gupta A, Marzook H, Ahmad F. Comorbidities and clinical complications associated with SARS-CoV-2 infection: an overview. Clin Exp Med 2022. [PMID: 35362771 DOI: 10.1007/s10238-022-00821-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
145 Marino P, Touzani R, Pakradouni J, Ben Soussan P, Gravis G. The Psychological Distress of Cancer Patients following the COVID-19 Pandemic First Lockdown: Results from a Large French Survey. Cancers 2022;14:1794. [DOI: 10.3390/cancers14071794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
146 Wang F, Ma Y, Xu S, Liu H, Chen Y, Yang H, Shao M, Xu W, Kong J, Chen L, Xu S, Shuai Z, Pan F. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Clin Rheumatol 2022. [PMID: 35352217 DOI: 10.1007/s10067-022-06087-1] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
147 Bungaro M, Passiglia F, Scagliotti GV. COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery. Biomedicines 2022;10:776. [DOI: 10.3390/biomedicines10040776] [Reference Citation Analysis]
148 Stefan A, Petkovic M, König A, Koch J, Hagemann F, Wuerstlein R, Harbeck N, Mahner S, Kaltofen T. Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report. J Med Case Rep 2022;16:119. [PMID: 35313981 DOI: 10.1186/s13256-022-03340-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
149 Ergün S, Tunç E, Avcı T, Batur Ş, Kepil N, Uludağ SS, Özçelik MF. The Effect of the COVID-19 Pandemic on the Clinical and Pathological Stages of Colorectal Cancer Patients. tjcd 2022;32:36-40. [DOI: 10.4274/tjcd.galenos.2021.2021-9-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Alexander A, Fung S, Eichler M, Lehwald-Tywuschik N, Uthayakumar V, Safi SA, Vay C, Ashmawy H, Kalmuk S, Rehders A, Vaghiri S, Knoefel WT. Quality of Life in Patients with Pancreatic Cancer before and during the COVID-19 Pandemic. Int J Environ Res Public Health 2022;19:3731. [PMID: 35329416 DOI: 10.3390/ijerph19063731] [Reference Citation Analysis]
151 Noll J, Reichert M, Dietrich M, Riedel JG, Hecker M, Padberg W, Weigand MA, Hecker A. When to operate after SARS-CoV-2 infection? A review on the recent consensus recommendation of the DGC/BDC and the DGAI/BDA. Langenbecks Arch Surg. [DOI: 10.1007/s00423-022-02495-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
152 Alwan NAS, Lami F, Khaleel HA, Alhilfi RA. Impact of COVID-19 on Affected Individuals in Iraq Focusing on Deceased Cancer Patients. JCO Glob Oncol 2022;8:e2200001. [PMID: 35298294 DOI: 10.1200/GO.22.00001] [Reference Citation Analysis]
153 Jeba J, Thankachan AM, Jacob A, Kandasamy R, Susithra DN. COVID-19 – Initial Lockdown: Implications on Cancer Treatment among Palliative Care Outpatients. IJPC 2022;0:1-4. [DOI: 10.25259/ijpc_314_20] [Reference Citation Analysis]
154 McKay SC; COVIDSurg Collaborative. Outcomes of patients undergoing elective liver and pancreas cancer surgery during the SARS-CoV-2 pandemic: an international, multicentre, prospective cohort study. HPB (Oxford) 2022:S1365-182X(22)00076-4. [PMID: 35562256 DOI: 10.1016/j.hpb.2022.03.002] [Reference Citation Analysis]
155 Conod A, Silvano M, Ruiz I Altaba A. On the origin of metastases: Induction of pro-metastatic states after impending cell death via ER stress, reprogramming, and a cytokine storm. Cell Rep 2022;38:110490. [PMID: 35263600 DOI: 10.1016/j.celrep.2022.110490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
156 Kaya T, Dilek A, Ozaras R, Balcik OS, Leblebicioglu H. COVID 19 and febrile neutropenia: Case report and systematic review. Travel Med Infect Dis 2022;:102305. [PMID: 35272019 DOI: 10.1016/j.tmaid.2022.102305] [Reference Citation Analysis]
157 Bin HU, Jeong S, Lee H. Impact of COVID-19 Pandemic Declaration on New Oncology Trial Commencements: An Interrupted Time Series with Segmented Regression Analysis. Healthcare 2022;10:489. [DOI: 10.3390/healthcare10030489] [Reference Citation Analysis]
158 Bhatia RK, Lichter KE, Gurram L, Macduffie E, Lombe D, Sarria GR, Grover S. Gynecologic radiation therapy in low and middle income countries during the COVID-19 pandemic. Int J Gynecol Cancer 2022;32:446-50. [DOI: 10.1136/ijgc-2021-003039] [Reference Citation Analysis]
159 Gribkova Y, Davis CH, Greenbaum AA, Lu S, Berger AC. Effect of the COVID‐19 pandemic on surgical oncology practice—Results of an SSO survey. Journal of Surgical Oncology. [DOI: 10.1002/jso.26839] [Reference Citation Analysis]
160 Wu Q, Luo S, Xie X. The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants. BMC Cancer 2022;22:241. [PMID: 35246063 DOI: 10.1186/s12885-022-09320-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
161 Peoples AR, Oswald LB, Ose J, Daniels B, Himbert C, Hathaway CA, Gigic B, Kirchhoff AC, Lin T, Grossman D, Tward J, Varghese TK Jr, Figueiredo JC, Toriola AT, Beck A, Scaife C, Shibata D, LaStayo P, Gonzalez B, Salas K, Ashworth A, Matsen C, Christenson C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Schneider M, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM. Impact of the COVID-19 pandemic on rural and urban cancer patients' experiences, health behaviors, and perceptions. J Rural Health 2022. [PMID: 35243690 DOI: 10.1111/jrh.12648] [Reference Citation Analysis]
162 Messing I, Felps M, Goyal S, Rao YJ, Schreiner K, Scully D, Ojong-ntui M, Huynh-le M. COVID-19 testing trends: pre-radiation and throughout cancer care. J Radiother Pract. [DOI: 10.1017/s1460396922000012] [Reference Citation Analysis]
163 Miyashita N, Nakamori Y, Ogata M, Fukuda N, Yamura A, Ishiura Y, Nomura S. Clinical features of nursing and healthcare-associated pneumonia due to COVID-19. Journal of Infection and Chemotherapy 2022. [DOI: 10.1016/j.jiac.2022.03.010] [Reference Citation Analysis]
164 Joudi M, Moradi Binabaj M, Porouhan P, Peyroshabany B, Tabasi M, Fazilat-panah D, Khajeh M, Mehrabian A, Dehghani M, Welsh JS, Keykhosravi B, Akbari Yazdi A, Ariamanesh M, Ghasemi A, Ferns G, Javadinia SA. A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome? Front Endocrinol 2022;13:798975. [DOI: 10.3389/fendo.2022.798975] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 11.0] [Reference Citation Analysis]
165 González-escamilla M, Pérez-ibave DC, Burciaga-flores CH, Ortiz-murillo VN, Ramírez-correa GA, Rodríguez-niño P, Piñeiro-retif R, Rodríguez-gutiérrez HF, Alcorta-nuñez F, González-guerrero JF, Vidal-gutiérrez O, Garza-rodríguez ML. Epidemiological Algorithm for Early Detection of COVID-19 Cases in a Mexican Oncologic Center. Healthcare 2022;10:462. [DOI: 10.3390/healthcare10030462] [Reference Citation Analysis]
166 Lasagna A, Bergami F, Lilleri D, Percivalle E, Quaccini M, Alessio N, Comolli G, Sarasini A, Sammartino J, Ferrari A, Arena F, Secondino S, Cicognini D, Schiavo R, Lo Cascio G, Cavanna L, Baldanti F, Pedrazzoli P, Cassaniti I. Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study. ESMO Open 2022. [DOI: 10.1016/j.esmoop.2022.100458] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
167 Naguib R. Potential relationships between COVID-19 and the thyroid gland: an update. J Int Med Res 2022;50:3000605221082898. [PMID: 35226548 DOI: 10.1177/03000605221082898] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
168 Meijer J, Elferink MA, van Hoeve JC, Buijsen J, van Erning F, Nagtegaal ID, Tanis PJ, Vink GR, Wumkes ML, de Hingh IH, Siesling S, On-behalf-of-the-covid-and-cancer-nl Consortium. Impact of the COVID-19 pandemic on colorectal cancer care in the Netherlands: a population-based study. Clinical Colorectal Cancer 2022. [DOI: 10.1016/j.clcc.2022.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
169 Buyukkor M, Tay F, Ates O. Experiences of the combined use of Favipiravir in patients using Lorlatinib and Brigatinib. J Oncol Pharm Pract. [DOI: 10.1177/10781552221083321] [Reference Citation Analysis]
170 Manna PR, Gray ZC, Reddy PH. Healthy Immunity on Preventive Medicine for Combating COVID-19. Nutrients 2022;14:1004. [DOI: 10.3390/nu14051004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
171 Knowlton CA. Breast Cancer Management During the COVID-19 Pandemic: the Radiation Oncology Perspective. Curr Breast Cancer Rep. [DOI: 10.1007/s12609-022-00441-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
172 Tamalunas A, Schott M, Ivanova T, Rodler S, Heinemann V, Stief CG, Casuscelli J. Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population. Infection 2022. [PMID: 35201605 DOI: 10.1007/s15010-022-01775-1] [Reference Citation Analysis]
173 Guo G, Chen Q, Luo G, Meng Z, Lei P, Chen P, Drisko JA. High Dose Intravenous Vitamin C as Adjunctive Therapy for COVID-19 Patients with Cancer: Two Cases. Life 2022;12:335. [DOI: 10.3390/life12030335] [Reference Citation Analysis]
174 Schäffeler N, Lohmiller J, Mack I, Archid R, Zipfel S, Stengel A. Patients With Super Obesity Do Not Perceive Themselves as Being at Higher Risk for a More Severe Course of COVID-19 Infection. Front Psychiatry 2022;12:798662. [DOI: 10.3389/fpsyt.2021.798662] [Reference Citation Analysis]
175 Hoenemeyer TW, Cole WW, Oster RA, Pekmezi DW, Pye A, Demark-Wahnefried W. Test/Retest Reliability and Validity of Remote vs. In-Person Anthropometric and Physical Performance Assessments in Cancer Survivors and Supportive Partners. Cancers (Basel) 2022;14:1075. [PMID: 35205823 DOI: 10.3390/cancers14041075] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
176 Cao Y, Wu D, Zeng K, Chen L, Yu J, He W, Chen L, Ren W, Gao F, Chen W, Wang H, Gale RP, Chen Z, Li Q. COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes. Vaccines 2022;10:326. [DOI: 10.3390/vaccines10020326] [Reference Citation Analysis]
177 Aghamirza Moghim Aliabadi H, Eivazzadeh‐keihan R, Beig Parikhani A, Fattahi Mehraban S, Maleki A, Fereshteh S, Bazaz M, Zolriasatein A, Bozorgnia B, Rahmati S, Saberi F, Yousefi Najafabadi Z, Damough S, Mohseni S, Salehzadeh H, Khakyzadeh V, Madanchi H, Kardar GA, Zarrintaj P, Saeb MR, Mozafari M. COVID‐19: A systematic review and update on prevention, diagnosis, and treatment. MedComm 2022;3. [DOI: 10.1002/mco2.115] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
178 Jones BM, Lehrer EJ, Saraf A, Shafaee Z, Resende Salgado L, Osborn VW. Healthcare Disparities and Outcomes of Cancer Patients in a Community Setting from a COVID-19 Epicenter. Current Oncology 2022;29:1150-62. [DOI: 10.3390/curroncol29020098] [Reference Citation Analysis]
179 Aydın R, Bostan FS, Kabukcuoğlu K. Two wars on one front: Experiences of gynaecological cancer patients in the COVID-19 pandemic. Eur J Cancer Care (Engl) 2022;:e13562. [PMID: 35170125 DOI: 10.1111/ecc.13562] [Reference Citation Analysis]
180 Joseph A, Olatosi B, Haider MR, Adegboyega BC, Lasebikan NN, Aliyu UM, Ali-Gombe M, Jimoh MA, Biyi-Olutunde OA, Awofeso O, Fatiregun OA, Oboh EO, Nwachukwu E, Zubairu IH, Otene SA, Iyare OI, Andero T, Musbau AB, Ajose A, Onitilo AA. Patient's Perspective on the Impact of COVID-19 on Cancer Treatment in Nigeria. JCO Glob Oncol 2022;8:e2100244. [PMID: 35157511 DOI: 10.1200/GO.21.00244] [Reference Citation Analysis]
181 Mohapatra S, Das PK, Mishra B, Panigrahi A. Clinical review of COVID-19 in children and adolescents with cancer: Experience from a tertiary care center in East India. Pediatric Hematology and Oncology. [DOI: 10.1080/08880018.2022.2025963] [Reference Citation Analysis]
182 De-la-Rosa-Martinez D, Aranda-Audelo M, Martin-Onraet A, Islas-Muñoz B, Perez-Jimenez C, Alatorre-Fernandez P, Cornejo-Juarez P, Ruiz-Garcia E, Zinser-Peniche P, Ortiz-Luna L, Meneses-Garcia A, Herrera-Gomez A, Vilar-Compte D. Clinical characteristics and outcomes in a cohort of oncologic patients with COVID-19 during the first year of the pandemic in Mexico. Cancer Med 2022. [PMID: 35166033 DOI: 10.1002/cam4.4582] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
183 Mehrabi Nejad M, Moosaie F, Dehghanbanadaki H, Haji Ghadery A, Shabani M, Tabary M, Aryannejad A, Seyedalinaghi S, Rezaei N. Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis. Eur J Med Res 2022;27. [DOI: 10.1186/s40001-022-00648-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
184 Candoni A, Petruzzellis G, Sperotto A, Andreotti V, Giavarra M, Corvaja C, Minisini A, Comuzzi C, Tascini C, Fanin R, Fasola G. Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave. PLoS One 2022;17:e0262784. [PMID: 35108300 DOI: 10.1371/journal.pone.0262784] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
185 Sarode SC, Sharma NK, Sarode G. A critical appraisal on cancer prognosis and artificial intelligence. Future Oncol 2022. [PMID: 35137629 DOI: 10.2217/fon-2021-1528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Miyo M, Hata T, Sekido Y, Ogino T, Miyoshi N, Takahashi H, Uemura M, Nishimura J, Ikenaga M, Eguchi H, Doki Y, Mizushima T. Colorectal Surgery in the COVID-19 Pandemic Era. J Anus Rectum Colon 2022;6:1-8. [PMID: 35128131 DOI: 10.23922/jarc.2021-074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
187 Rugge M, Zorzi M, Guzzinati S, Stocco C, Avossa F, Del Zotto S, Clagnan E, Bricca L, Dal Maso L, Serraino D. Outcomes of SARS-CoV-2 infection in cancer versus non-cancer-patients: A population-based study in northeastern Italy. Tumori 2022;:3008916211073771. [PMID: 35130777 DOI: 10.1177/03008916211073771] [Reference Citation Analysis]
188 Han S, Zhuang Q, Chiang J, Tan SH, Chua GWY, Xie C, Chua MLK, Soon YY, Yang VS. Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis. BMJ Open 2022;12:e044661. [PMID: 35131810 DOI: 10.1136/bmjopen-2020-044661] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
189 Aznab M, Eskandari Roozbahani N, Moazen H. Clinical Characteristics and Risk Factors of COVID-19 in 60 Adult Cancer Patients. Clin Med Insights Oncol. 2022;16:11795549221074168. [PMID: 35110966 DOI: 10.1177/11795549221074168] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
190 Huang X, Liang H, Zhang H, Tian L, Cong P, Wu T, Zhang Q, Gao X, Li W, Chen A, Zhang Y, Dong Q, Wan H, He M, Dai D, Li Z, Xiong L. The Potential Mechanism of Cancer Patients Appearing More Vulnerable to SARS-CoV-2 and Poor Outcomes: A Pan-Cancer Bioinformatics Analysis. Front Immunol 2021;12:804387. [PMID: 35082790 DOI: 10.3389/fimmu.2021.804387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
191 Hermel DJ, Cham J, Spierling Bagsic SR, Hong LK, Costantini CL, Mason JR, Saven A, Sigal DS. An observational study of hospitalized COVID-19 patients with cancer in San Diego county. Future Oncol 2022. [PMID: 35105156 DOI: 10.2217/fon-2021-1116] [Reference Citation Analysis]
192 Harpur P, Hyseni F, Blanck P. Workplace health surveillance and COVID-19: algorithmic health discrimination and cancer survivors. J Cancer Surviv 2022. [PMID: 35107794 DOI: 10.1007/s11764-021-01144-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 Asghar MS, Yasmin F, Babar MS, Bin Zafar MD, Ismail Shah SM, Tahir MJ. Clinical characteristics and outcomes of cancer patients and their hospital course during the COVID-19 pandemic in a developing country. Annals of Medicine and Surgery 2022;74:103284. [DOI: 10.1016/j.amsu.2022.103284] [Reference Citation Analysis]
194 Várnai C, Palles C, Arnold R, Curley HM, Purshouse K, Cheng VWT, Booth S, Campton NA, Collins GP, Hughes DJ, Kulasekararaj AG, Lee AJX, Olsson-Brown AC, Sharma-Oates A, Van Hemelrijck M, Lee LYW, Kerr R, Middleton G, Cazier JB; UKCCMP Team. Mortality Among Adults With Cancer Undergoing Chemotherapy or Immunotherapy and Infected With COVID-19. JAMA Netw Open 2022;5:e220130. [PMID: 35188551 DOI: 10.1001/jamanetworkopen.2022.0130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
195 Pfeiler G, Demichele A, Dueck AC, Fesl C, Gnant M, Mayer EL. Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic. The Lancet Oncology 2022;23:195-7. [DOI: 10.1016/s1470-2045(21)00708-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
196 Boiardi F, Stebbing J. Developments in paediatric cancer care throughout the COVID-19 pandemic: Lessons from China. The Lancet Regional Health - Western Pacific 2022. [DOI: 10.1016/j.lanwpc.2022.100398] [Reference Citation Analysis]
197 Ljubimov VA, Ramesh A, Davani S, Danielpour M, Breunig JJ, Black KL. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. Adv Drug Deliv Rev 2022;181:114033. [PMID: 34808227 DOI: 10.1016/j.addr.2021.114033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
198 Caccese M, Imbevaro S, Feltrin A, Costardi D, Giordano N, Maran M, Martino R, Ottolitri K, Shams M, Vascon F, Roma A, Galiano A, Maruzzo M, Marino D, Lombardi G, Lonardi S, Brunello A, Zagonel V. Cancer Patient-Reported Experience Measures (PREMs) Regarding the Policies Implemented to Contain the Spread of Sars-CoV-2 and Vaccination Campaign at Veneto Institute of Oncology. PPA 2022;Volume 16:353-62. [DOI: 10.2147/ppa.s351771] [Reference Citation Analysis]
199 Ulugerger Avci G, Bektan Kanat B, Suzan V, Can G, Korkmazer B, Karaali R, Tabak F, Borekci S, Aygun G, Yavuzer H, Doventas A. Clinical outcomes of geriatric patients with COVID-19: review of one-year data. Aging Clin Exp Res 2022;34:465-74. [PMID: 35064542 DOI: 10.1007/s40520-021-02047-y] [Reference Citation Analysis]
200 Kieran R, Murphy C, Maher E, Buchalter J, Sukor S, Alken S. A permanent legacy of the pandemic? Outcomes of and staff views on the introduction of virtual clinics to an Irish oncology service. Ir J Med Sci. [DOI: 10.1007/s11845-021-02892-w] [Reference Citation Analysis]
201 Verma R, Kilgour HM, Haase KR. The Psychosocial Impact of COVID-19 on Older Adults with Cancer: A Rapid Review. Current Oncology 2022;29:589-601. [DOI: 10.3390/curroncol29020053] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
202 Bisceglia I, Canale ML, Gallucci G, Turazza FM, Lestuzzi C, Parrini I, Russo G, Maurea N, Quagliariello V, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Moreo A, Geraci G, Gabrielli D, Gulizia MM, Oliva F, Colivicchi F. Cardio-Oncology in the COVID Era (Co & Co): The Never Ending Story. Front Cardiovasc Med 2022;9:821193. [DOI: 10.3389/fcvm.2022.821193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
203 Yasin AI, Aydin SG, Sümbül B, Koral L, Şimşek M, Geredeli Ç, Öztürk A, Perkin P, Demirtaş D, Erdemoglu E, Hacıbekiroglu İ, Çakır E, Tanrıkulu E, Çoban E, Ozcelik M, Çelik S, Teker F, Aksoy A, Fırat ST, Tekin Ö, Kalkan Z, Türken O, Oven BB, Dane F, Bilici A, Isıkdogan A, Seker M, Türk HM, Gümüş M. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study. Future Oncol 2022. [PMID: 35081732 DOI: 10.2217/fon-2021-1248] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 8.0] [Reference Citation Analysis]
204 Sitanggang JS, Siregar KB, Sitanggang HH, Sprinse Vinolina N. Prevalence of cancer as a comorbid in COVID-19 patients and their characteristics: a meta-analysis study. F1000Res 2021;10:975. [DOI: 10.12688/f1000research.53539.2] [Reference Citation Analysis]
205 Huang Y, Li S, Huang S, Tu J, Chen X, Xiao L, Liu B, Yuan X. Comprehensive and Integrative Analysis of Two Novel SARS-CoV-2 Entry Associated Proteases CTSB and CTSL in Healthy Individuals and Cancer Patients. Front Bioeng Biotechnol 2022;10:780751. [DOI: 10.3389/fbioe.2022.780751] [Reference Citation Analysis]
206 Page A, Broom A, Kenny K, Lwin Z, Wakefield CE, Itchins M, Khasraw M. Experiencing the SARS-CoV-2 Pandemic Whilst Living With Cancer. Qual Health Res 2022;32:426-39. [PMID: 35068285 DOI: 10.1177/10497323211057082] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
207 Rahmadhan MA, Parenrengi MA, Suryaningtyas W. A Case Report of Pediatric Germinoma With SARS-CoV-2: Lessons Learned From an Academic Tertiary Referral Hospital in Asian COVID Epicentrum. Int J Surg Case Rep 2022;91:106774. [PMID: 35070644 DOI: 10.1016/j.ijscr.2022.106774] [Reference Citation Analysis]
208 Huang Y, Chen S, Xiao L, Qin W, Li L, Wang Y, Ma L, Yuan X. A Novel Prognostic Signature for Survival Prediction and Immune Implication Based on SARS-CoV-2–Related Genes in Kidney Renal Clear Cell Carcinoma. Front Bioeng Biotechnol 2022;9:744659. [DOI: 10.3389/fbioe.2021.744659] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
209 Zhang Y, Mao Q, Li Y, Cheng J, Xia Q, Chen G, Chen P, Jin S, Li D, Zhong C, Yang J, Fan X, Liang Y, Lin H. Cancer and COVID-19 Susceptibility and Severity: A Two-Sample Mendelian Randomization and Bioinformatic Analysis. Front Cell Dev Biol 2022;9:759257. [DOI: 10.3389/fcell.2021.759257] [Reference Citation Analysis]
210 Huang Y, Guo L, Chen J, Wu M, Zhang C, Liu Z, Li J, Li K, Xiong Z, Wu Q, Li Z, Luo K, Yuan W, Wu X. Serum Lactate Dehydrogenase Level as a Prognostic Factor for COVID-19: A Retrospective Study Based on a Large Sample Size. Front Med (Lausanne) 2021;8:671667. [PMID: 35059407 DOI: 10.3389/fmed.2021.671667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
211 Savabi-esfahani M, Zangeneh S, Sharbafchi MR. Cancer Patients’ Challenges During COVID-19 Pandemic: An Approach to Decision-Making in Management and Policy-Making. Arch Clin Infect Dis 2022;16. [DOI: 10.5812/archcid.104590] [Reference Citation Analysis]
212 Lommatzsch M, Rabe KF, Taube C, Joest M, Kreuter M, Wirtz H, Blum TG, Kolditz M, Geerdes-fenge H, Otto-knapp R, Häcker B, Schaberg T, Ringshausen FC, Vogelmeier CF, Reinmuth N, Reck M, Gottlieb J, Konstantinides S, Meyer J, Worth H, Windisch W, Welte T, Bauer T. Risk Assessment for Patients with Chronic Respiratory Conditions in the Context of the SARS-CoV-2 Pandemic Statement of the German Respiratory Society with the Support of the German Association of Chest Physicians. Respiration 2022;101:307-20. [DOI: 10.1159/000518896] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
213 Cavanna L, Proietto M, Citterio C, Anselmi E, Zaffignani E, Stroppa EM, Borsotti MT, Contini A, Di Girolamo G, Quitadamo VM, Bacchetta N, Muroni M, Brescia MG, Delledonne M. COVID-19 Vaccination in Cancer Patients Older Than 70 Years Undergoing Active Treatment. Seroconversion Rate and Safety. Vaccines 2022;10:164. [DOI: 10.3390/vaccines10020164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Zhang J, Dong X, Liu G, Gao Y. Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality. Clinic Rev Allerg Immunol. [DOI: 10.1007/s12016-022-08921-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
215 Mardani M. Possibility of Tumor Development in Cancer Patient with COVID-19. Arch Clin Infect Dis 2022;16. [DOI: 10.5812/archcid.122510] [Reference Citation Analysis]
216 Bilgi A, Avci F, Keser Şahin HH, Can B, Güler AH, Kulhan M, Celik C. Comparison of prognostic factors in patients diagnosed with endometrial cancer before and after COVID 19 pandemic: a retrospective study. Journal of Health Sciences and Medicine 2022;5:216-9. [DOI: 10.32322/jhsm.1017866] [Reference Citation Analysis]
217 Jahanafrooz Z, Chen Z, Bao J, Li H, Lipworth L, Guo X. An overview of human proteins and genes involved in SARS-CoV-2 infection. Gene 2022;808:145963. [PMID: 34530086 DOI: 10.1016/j.gene.2021.145963] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
218 Kian W, Zemel M, Kestenbaum EH, Rouvinov K, Alguayn W, Levitas D, Ievko A, Michlin R, Abod MA, Massalha I, Chernomordikov E, Sharb AA, Shalata W, Levison E, Roisman LC, Lavrenkov K, Peled N, Nesher L, Yakobson A. Safety of the BNT162b2 mRNA COVID-19 vaccine in oncologic patients undergoing numerous cancer treatment options: A retrospective single-center study. Medicine (Baltimore) 2022;101:e28561. [PMID: 35029223 DOI: 10.1097/MD.0000000000028561] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
219 Atkinson V, Robert C, Grob JJ, Gogas H, Dutriaux C, Demidov L, Gupta A, Menzies AM, Ryll B, Miranda F, Banerjee H, Lau M, Del Vecchio M. Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus. Eur J Cancer 2022;163:79-87. [PMID: 35042070 DOI: 10.1016/j.ejca.2021.12.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
220 Graves CE, Goyal N, Levin A, Nuño MA, Kim J, Campbell MJ, Shen WT, Gosnell JE, Roman SA, Sosa JA, Duh QY, Suh I. ANXIETY DURING THE COVID-19 PANDEMIC: A WEB-BASED SURVEY OF THYROID CANCER SURVIVORS. Endocr Pract 2022:S1530-891X(22)00002-7. [PMID: 35032648 DOI: 10.1016/j.eprac.2022.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
221 Tang W, Wang F, Wang JW, Huang Y, Liu L, Zhao SJ, Zhao XM, Wu N. Developing a Screening Procedure During the COVID-19 Pandemic: Process and Challenges Faced by a Low-Incidence Area. Front Med (Lausanne) 2021;8:654754. [PMID: 35004708 DOI: 10.3389/fmed.2021.654754] [Reference Citation Analysis]
222 Xiao H, Liu F, He Y, Dai X, Liu Z, Jian W, Unger JM. Unequal impact of the COVID-19 pandemic on paediatric cancer care: a population-based cohort study in China. Lancet Reg Health West Pac 2022;19:100347. [PMID: 35005670 DOI: 10.1016/j.lanwpc.2021.100347] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
223 Kamal M, Baudo M, Shmushkevich S, Geng Y, Hanna E, Goepfert RP, Lewis CM, Rahouma M. COVID-19 infection and its consequences among surgical oncology patients: A systematic analysis, meta-analysis and meta-regression. J Surg Oncol 2022. [PMID: 35014703 DOI: 10.1002/jso.26787] [Reference Citation Analysis]
224 Seebacher NA. The antibody response of haematological malignancies to COVID-19 infection and vaccination. Br J Cancer. [DOI: 10.1038/s41416-021-01682-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
225 Lopes A, Pastore CBP, Deckers P, Halla IKMW, Dias ALR, da Mata MVM, do Nascimento Martins A, Viu MM, Lopez RVM, Yamada AD. Oncological Surgery During the COVID-19 Pandemic: Effectiveness of Preoperative Screening and Factors Associated with Postoperative SARS-CoV-2 Infection. Ann Surg Oncol. [DOI: 10.1245/s10434-021-11195-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
226 Lamblin G, Chene G, Leaune E, Philip CA, Moret S, Nohuz E, Golfier F, Cortet M. The psychological impact of therapeutic changes during the COVID-19-lockdown for gynaecological and breast cancer patients. J Gynecol Obstet Hum Reprod 2022;51:102311. [PMID: 35007776 DOI: 10.1016/j.jogoh.2022.102311] [Reference Citation Analysis]
227 Tang A, Neeman E, Vuong B, Arasu VA, Liu R, Kuehner GE, Savitz AC, Lyon LL, Anshu P, Seaward SA, Patel MD, Habel LA, Kushi LH, Mentakis M, Thomas ES, Kolevska T, Chang SB; Permanente Medical Group Breast Research Collaborative. Care in the time of COVID-19: impact on the diagnosis and treatment of breast cancer in a large, integrated health care system. Breast Cancer Res Treat 2022. [PMID: 34988767 DOI: 10.1007/s10549-021-06468-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
228 Russell B, Moss C, Tsotra E, Gousis C, Josephs D, Enting D, Karampera C, Khan M, Roca J, Sita-Lumsden A, Owczarczyk K, Wylie H, Haire A, Smith D, Zaki K, Swampillai A, Lei M, Manik V, Michalarea V, Kristeleit R, Mera A, Sawyer E, Flanders L, De Francesco I, Papa S, Ross P, Spicer J, Dann B, Jogia V, Shaunak N, Kristeleit H, Rigg A, Montes A, Van Hemelrijck M, Dolly S. The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy's Cancer Centre. Cancers (Basel) 2022;14:266. [PMID: 35053432 DOI: 10.3390/cancers14020266] [Reference Citation Analysis]
229 García-escobar A, Vera-vera S, Jurado-román A, Jiménez-valero S, Galeote G, Moreno R. Calcium Signaling Pathway Is Involved in the Shedding of ACE2 Catalytic Ectodomain: New Insights for Clinical and Therapeutic Applications of ACE2 for COVID-19. Biomolecules 2022;12:76. [DOI: 10.3390/biom12010076] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
230 Hahn EE, Munoz-Plaza CE, Pounds D, Lyons LJ, Lee JS, Shen E, Hong BD, La Cava S, Brasfield FM, Durna LN, Kwan KW, Beard DB, Ferreira A, Padmanabhan A, Gould MK. Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA 2022;327:41-9. [PMID: 34982119 DOI: 10.1001/jama.2021.22596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
231 Gupta T, Debele TA, Wei YF, Gupta A, Murtaza M, Su WP. Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence. Cancers (Basel) 2022;14:213. [PMID: 35008377 DOI: 10.3390/cancers14010213] [Reference Citation Analysis]
232 Kim YI, Park IJ. Surgical safety in the COVID-19 era: present and future considerations. Ann Surg Treat Res 2022;102:295. [DOI: 10.4174/astr.2022.102.6.295] [Reference Citation Analysis]
233 Tamura N, Uchiyama S, Nishioka S, Tamura K, Yoshida M, Saito Z, Kuwano K. A Convenient Risk Prediction Score for COVID-19 for Determining Whether or Not Hospitalization is Recommended: Kanagawa Admission Priority Assessment Score. Intern Med . [DOI: 10.2169/internalmedicine.9262-21] [Reference Citation Analysis]
234 Singh N, Mishra N, Jayraj AS, Ghatage P. Management of Gynecologic Cancer During COVID-19 Pandemic: South Asian Perspective. Cancer Control 2022;29:10732748221119349. [PMID: 36036360 DOI: 10.1177/10732748221119349] [Reference Citation Analysis]
235 Noronha V, Shah D, Mokal S, Kapoor A, Patil V, Menon N, Chopade S, Shah S, Nawale K, Banavali S, Prabhash K. Deviation from standard cancer treatment during the first wave of the COVID-19 pandemic in India: A cross-sectional study. Cancer Res Stat Treat 2022;5:212. [DOI: 10.4103/crst.crst_115_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
236 Pavlushenko M, Liubota R, Vereshchako R, Anikusko N, Liubota I. Special aspects of medical care for cancer patients during COVID-19 pandemic. Arch Oncol 2022;28:7-12. [DOI: 10.2298/aoo210205002p] [Reference Citation Analysis]
237 Muraro AP, Oliveira LRD, Andrade ACDS, Terças-trettel ACP, Guimarães LV, Souza BDSND. Fatores associados ao óbito entre pacientes com câncer internados por COVID-19 em Mato Grosso, Brasil. Rev bras epidemiol 2022;25:e220020. [DOI: 10.1590/1980-549720220020.supl.1.1] [Reference Citation Analysis]
238 shen Q, wang J, zhao L. . MBE 2022;19:11172-94. [DOI: 10.3934/mbe.2022521] [Reference Citation Analysis]
239 Li Z, Li Q, Wang X, Li S, Chen W, Jin X, Liu X, Dai Z, Liu X, Zheng X, Li P, Zhang H, Zhang Q, Luo H, Liu R. Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis. Front Public Health 2021;9:767617. [PMID: 34957022 DOI: 10.3389/fpubh.2021.767617] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
240 Przekop D, Gruszewska E, Chrostek L. Liver function in COVID-19 infection . World J Hepatol 2021; 13(12): 1909-1918 [DOI: 10.4254/wjh.v13.i12.1909] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
241 Fründt T, Kuballa L, Lütgehetman M, Nörz D, Arend H, Brehm TT, Schulze Zur Wiesch J, Horvatits T, Horvatits K, Huber S, Wege H, Kluwe J. Low incidence of COVID-19 in a prospective cohort of patients with liver cirrhosis and hepatocellular carcinoma treated at a tertiary medical center during the 2020 pandemic. PLoS One 2021;16:e0258450. [PMID: 34941875 DOI: 10.1371/journal.pone.0258450] [Reference Citation Analysis]
242 Liu L, Qin JF, Zuo MZ, Zhou Q. Multi-omics of the expression and clinical outcomes of TMPRSS2 in human various cancers: A potential therapeutic target for COVID-19. J Cell Mol Med 2021. [PMID: 34951103 DOI: 10.1111/jcmm.17090] [Reference Citation Analysis]
243 Blaise D, Berger P, Mokart D, Camerlo J, Fougereau E, Giovannini M, Houvenaeghel G, Turrini O, Chabannon C, Piana G, Brenot-Rossi I, Tallet A, Gonçalves A, Charbonnier A, Vey N, Grossi S, Viens P. The Management of a Comprehensive Cancer Center during the First Six Months of the COVID-19 Pandemic in the South of France: Lessons from the Paoli-Calmettes Institute's Experience. Clin Hematol Int 2021;3:119-29. [PMID: 34938984 DOI: 10.2991/chi.k.210919.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Mohseni Afshar Z, Hosseinzadeh R, Barary M, Ebrahimpour S, Alijanpour A, Sayad B, Hosseinzadeh D, Miri SR, Sio TT, Sullman MJM, Carson-Chahhoud K, Babazadeh A. Challenges posed by COVID-19 in cancer patients: A narrative review. Cancer Med 2021. [PMID: 34951152 DOI: 10.1002/cam4.4519] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Lak E, Mohammadi MJ, Yousefi H. Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients. Toxicol Rep 2022;9:46-52. [PMID: 34934636 DOI: 10.1016/j.toxrep.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
246 Caruso P, Testa RS, Freitas ICL, Praça APA, Okamoto VN, Santana PV, Costa RT, Kawasaki AM, Fumis RRL, Pino Illanes WA, Costa ELV, Midega TD, Correa TD, de Carvalho FRT, Ferreira JC. Cancer-Related Characteristics Associated With Invasive Mechanical Ventilation or In-Hospital Mortality in Patients With COVID-19 Admitted to ICU: A Cohort Multicenter Study. Front Oncol 2021;11:746431. [PMID: 34917502 DOI: 10.3389/fonc.2021.746431] [Reference Citation Analysis]
247 Fathi M, Vakili K, Jazi K, Sadeghi MA, Hajiesmaeili M, Mohamadkhani A, Rezaei-Tavirani M, Tavasol A. Challenges of cancer immunotherapy and chemotherapy during the COVID-19 pandemic. Tumori 2021;:3008916211063939. [PMID: 34918602 DOI: 10.1177/03008916211063939] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
248 Zhang Y, Fan L, Yao R, He X, Zhao L, Lu B, Pang Z. ACEs family genes: Important molecular links between lung cancer and COVID-19. Clin Transl Med 2021;11:e615. [PMID: 34911166 DOI: 10.1002/ctm2.615] [Reference Citation Analysis]
249 Jafari M, Dastgheib SA, Ferdosian F, Mirjalili H, Aarafi H, Noorishadkam M, Mazaheri M, Neamatzadeh H. Proportion of Hematological Cancer Patients with SARS-CoV-2 Infection during the COVID-19 Pandemic: a Systematic Review and Meta-Analysis. Hematol Transfus Cell Ther 2021. [PMID: 34931178 DOI: 10.1016/j.htct.2021.09.020] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
250 Friedman MR, Kempf MC, Benning L, Adimora AA, Aouizerat B, Cohen MH, Hatfield Q, Merenstein D, Mimiaga MJ, Plankey MW, Sharma A, Sheth AN, Ramirez C, Stosor V, Wagner MCE, Wilson TE, D'Souza G, Weiss DJ. Prevalence of COVID-19-Related Social Disruptions and Effects on Psychosocial Health in a Mixed-Serostatus Cohort of Men and Women. J Acquir Immune Defic Syndr 2021;88:426-38. [PMID: 34757972 DOI: 10.1097/QAI.0000000000002799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Kassianos AP, Georgiou A, Kyprianidou M, Lamnisos D, Ļubenko J, Presti G, Squatrito V, Constantinou M, Nicolaou C, Papacostas S, Aydin G, Chong YY, Chien WT, Cheng HY, Ruiz FJ, Garcia-Martin MB, Obando D, Segura-Vargas MA, Vasiliou VS, McHugh L, Höfer S, Baban A, Neto DD, Silva AND, Monestès JL, Alvarez-Galvez J, Blarrina MP, Montesinos F, Salas SV, Őri D, Kleszcz B, Lappalainen R, Ivanović I, Gosar D, Dionne F, Merwin RM, Chatzittofis A, Konstantinou E, Economidou S, Gloster AT, Karekla M, Constantinidou A. Mental Health and Adherence to COVID-19 Protective Behaviors among Cancer Patients during the COVID-19 Pandemic: An International, Multinational Cross-Sectional Study. Cancers (Basel) 2021;13:6294. [PMID: 34944913 DOI: 10.3390/cancers13246294] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
252 Zhou J, Jiang D, Wang W, Huang K, Zheng F, Xie Y, Zhou Z, Sun J. Case Report: Clinical Features of a COVID-19 Patient With Cirrhosis. Front Med (Lausanne) 2021;8:678227. [PMID: 34901043 DOI: 10.3389/fmed.2021.678227] [Reference Citation Analysis]
253 Roy K, Agarwal S, Banerjee R, Paul MK, Purbey PK. COVID-19 and gut immunomodulation. World J Gastroenterol 2021; 27(46): 7925-7942 [DOI: 10.3748/wjg.v27.i46.7925] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
254 Wang H, Wu M, Liu H, Zhou H, Zhao Y, Geng Y, Jiang B, Zhang K, Zhang B, Han Z, Du X. Comparison of the Efficacy and Safety of PARP Inhibitors as a Monotherapy for Platinum-Sensitive Recurrent Ovarian Cancer: A Network Meta-Analysis. Front Oncol 2021;11:785102. [PMID: 34900739 DOI: 10.3389/fonc.2021.785102] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
255 Akingboye A, Mahmood F, Amiruddin N, Reay M, Nightingale P, Ogunwobi OO. Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort study. BMJ Open 2021;11:e053352. [PMID: 34903546 DOI: 10.1136/bmjopen-2021-053352] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
256 Cheung MC, Franco BB, Meti N, Thawer A, Tahmasebi H, Shankar A, Loblaw A, Wright FC, Fox C, Peek N, Sim V, Singh S. Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process. Curr Oncol 2021;28:5332-45. [PMID: 34940084 DOI: 10.3390/curroncol28060445] [Reference Citation Analysis]
257 Acquati C, Chen TA, Martinez Leal I, Connors SK, Haq AA, Rogova A, Ramirez S, Reitzel LR, McNeill LH. The Impact of the COVID-19 Pandemic on Cancer Care and Health-Related Quality of Life of Non-Hispanic Black/African American, Hispanic/Latina and Non-Hispanic White Women Diagnosed with Breast Cancer in the U.S.: A Mixed-Methods Study Protocol. Int J Environ Res Public Health 2021;18:13084. [PMID: 34948695 DOI: 10.3390/ijerph182413084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
258 Deo SVS, Kumar S, Ray M, Bhoriwal S, Mishra A, Sharma J, K R, Kumar N, Saikia J, Bansal B, Mandal A, Dhall K, Gaur M, Nandi S, Chhebbi M, Bhatnagar S, Mishra S, Garg R, Bharti S, Gupta N, Kumar V. Impact of COVID-19 Pandemic on Cancer Surgical Services-AIIMS, New Delhi Experience. Indian J Surg Oncol 2021;:1-7. [PMID: 34924731 DOI: 10.1007/s13193-021-01478-3] [Reference Citation Analysis]
259 McCarthy CJ, Sheth RA, Patel RJ, Cheung SH, Simon NZ, Huang SY, Gupta S. Deployment of an Interventional Radiology Telemedicine Program During the COVID-19 Pandemic: Initial Experience With 10,056 Visits. J Am Coll Radiol 2021:S1546-1440(21)00944-3. [PMID: 35016874 DOI: 10.1016/j.jacr.2021.10.022] [Reference Citation Analysis]
260 Lara OD, Smith M, Wang Y, O'Cearbhaill RE, Blank SV, Kolev V, Carr C, Knisely A, McEachron J, Gabor L, Chapman-Davis E, Cohen S, Fehniger J, Lee YC, Isani S, Liu M, Wright JD, Pothuri B. COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic. Gynecol Oncol 2021:S0090-8258(21)01629-2. [PMID: 34922769 DOI: 10.1016/j.ygyno.2021.12.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
261 Yao P, Cooley V, Kuhel W, Tassler A, Banuchi V, Long S, Savenkov O, Kutler DI. Times to Diagnosis, Staging, and Treatment of Head and Neck Cancer Before and During COVID-19. OTO Open 2021;5:2473974X211059429. [PMID: 34870063 DOI: 10.1177/2473974X211059429] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
262 Hassan M, Le UT, Grapatsas K, Passlick B, Schmid S. [Surgery for Thoracic Malignancies during the COVID-19 Pandemic: a Case-control Study Investigating the Risk for Postoperative Complications]. Zentralbl Chir 2021;146:579-85. [PMID: 34872113 DOI: 10.1055/a-1678-7533] [Reference Citation Analysis]
263 Ying X, Bi J, Ding Y, Wei X, Wei W, Xin F, Xiao C, Hu D, Verma V, Han G. Management and Outcomes of Patients With Radiotherapy Interruption During the COVID-19 Pandemic. Front Oncol 2021;11:754838. [PMID: 34868962 DOI: 10.3389/fonc.2021.754838] [Reference Citation Analysis]
264 Bai L, Yang W, Qian L, Cui JW. Regulating monocyte infiltration and differentiation: Providing new therapies for colorectal cancer patients with COVID-19. World J Clin Cases 2021; 9(34): 10392-10399 [PMID: 35004972 DOI: 10.12998/wjcc.v9.i34.10392] [Reference Citation Analysis]
265 Yadav K, Ginsburg O, Basu P, Mehrotra R. Telemedicine and Cancer Care in Low- and Middle-Income Countries During the SARS-CoV-2 Pandemic. JCO Glob Oncol 2021;7:1633-8. [PMID: 34860567 DOI: 10.1200/GO.21.00249] [Reference Citation Analysis]
266 Cai C, Zhang X, Liu Y, Shen E, Feng Z, Guo C, Han Y, Ouyang Y, Shen H. Gut microbiota imbalance in colorectal cancer patients, the risk factor of COVID-19 mortality. Gut Pathog 2021;13:70. [PMID: 34863291 DOI: 10.1186/s13099-021-00466-w] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
267 Hamaguchi M, Nojiri T, Okamura T, Hashimoto Y, Hanai A, Narisawa S, Ushigome E, Nakanishi N, Fukui M. Status of online diet management program users in Japan during the 2020 Coronavirus disease 2019 pandemic. J Clin Biochem Nutr 2021;69:305-10. [PMID: 34857994 DOI: 10.3164/jcbn.21-31] [Reference Citation Analysis]
268 Latif MB, Shukla S, Estrada PMDR, Ribeiro SP, Sekaly RP, Sharma AA. Immune mechanisms in cancer patients that lead to poor outcomes of SARS-CoV-2 infection. Transl Res 2021:S1931-5244(21)00284-X. [PMID: 34871809 DOI: 10.1016/j.trsl.2021.12.001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
269 Bader-Larsen KS, Larson EA, Dalamaga M, Magkos F. A Narrative Review of the Safety of Anti-COVID-19 Nutraceuticals for Patients with Cancer. Cancers (Basel) 2021;13:6094. [PMID: 34885202 DOI: 10.3390/cancers13236094] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
270 Arneiro AJ, Ramos MFKP, Pereira MA, Dias AR, Zilberstein B, Ribeiro Junior U, Nahas SC. Impact of COVID-19 pandemic on the surgical treatment of gastric cancer. Clinics (Sao Paulo) 2021;76:e3508. [PMID: 34852144 DOI: 10.6061/clinics/2021/e3508] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
271 Wong YNS, Sng CCT, Ottaviani D, Patel G, Chowdhury A, Earnshaw I, Sinclair A, Merry E, Wu A, Galazi M, Benafif S, Soosaipillai G, Chopra N, Roylance R, Shaw H, Lee AJX. Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital. Cancers (Basel) 2021;13:6085. [PMID: 34885194 DOI: 10.3390/cancers13236085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
272 Motlagh A, Elmi F, Yamrali M, Ranjbar M, Azmin M, Moshiri F, Hamelmann C, Slama S, Tavakoli N, Hammerich A, Pourghazian N, Soleymani Nejad M, Mafi A, Azadeh P, Aghajanizadeh M, Ostovar A, Raeisi A, Malekzadeh R. Routine COVID-19 testing may not be necessary for most cancer patients. Sci Rep 2021;11:23294. [PMID: 34857785 DOI: 10.1038/s41598-021-02692-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
273 Figuero-Pérez L, Olivares-Hernández A, Escala-Cornejo RA, Terán-Brage E, López-Gutiérrez Á, Cruz-Hernández JJ. Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab. Reumatol Clin (Engl Ed) 2021;17:559-61. [PMID: 34823820 DOI: 10.1016/j.reumae.2020.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
274 Ma Y, Liu N, Wang Y, Zeng J, Hu YY, Hao W, Shi H, Zhu P, Lv J, Fan W, Wang X. Immune checkpoint blocking impact and nomogram prediction of COVID-19 inactivated vaccine seroconversion in patients with cancer: a propensity-score matched analysis. J Immunother Cancer 2021;9:e003712. [PMID: 34845005 DOI: 10.1136/jitc-2021-003712] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
275 Srinivasan K, Pandey AK, Livingston A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target? Mol Biomed 2021;2:38. [PMID: 34841263 DOI: 10.1186/s43556-021-00060-1] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
276 Gao L, Li GS, Li JD, He J, Zhang Y, Zhou HF, Kong JL, Chen G. Identification of the susceptibility genes for COVID-19 in lung adenocarcinoma with global data and biological computation methods. Comput Struct Biotechnol J 2021;19:6229-39. [PMID: 34840672 DOI: 10.1016/j.csbj.2021.11.026] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
277 Liu Y, Yao Y, Wang Q, Liu Z, Gu Y, Zhang H, Yi F, Cao B. Dilemma and solutions of treatment delay in cancer patients during the COVID-19 pandemic: A single-center, prospective survey. Asia Pac J Clin Oncol 2021. [PMID: 34843160 DOI: 10.1111/ajco.13724] [Reference Citation Analysis]
278 Ali JK, Riches JC. The Impact of the COVID-19 Pandemic on Oncology Care and Clinical Trials. Cancers (Basel) 2021;13:5924. [PMID: 34885038 DOI: 10.3390/cancers13235924] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
279 Bonuomo V, Ferrarini I, Dell'Eva M, Sbisà E, Krampera M, Visco C. COVID-19 (SARS-CoV-2 infection) in lymphoma patients: A review. World J Virol 2021; 10(6): 312-325 [PMID: 34909405 DOI: 10.5501/wjv.v10.i6.312] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
280 Toquero P, Blanco Fernández C, López Martí MP, Hernández Marín B, Vera Cea EB, Garrido García A, Méndez Carrascosa E, Bañón Torres D, Donnay Candil O, Ballesteros García AI, Sánchez-Torres JM, Costas Rojo P, Mondéjar R, Colomer R, Romero-Laorden N. Emotional Distress in Cancer Patients During the First Wave of the COVID-19 Pandemic. Front Psychol 2021;12:755965. [PMID: 34803837 DOI: 10.3389/fpsyg.2021.755965] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
281 Leibold A, Papatla K, Zeligs KP, Blank SV. COVID-19 and Gynecologic Oncology: What Have We Learned? Curr Treat Options Oncol 2021;22:117. [PMID: 34812973 DOI: 10.1007/s11864-021-00905-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
282 de Joode K, Tol J, Hamberg P, Cloos M, Kastelijn EA, Borgers JSW, Nuij VJAA, Klaver Y, Herder GJM, Mutsaers PGNJ, Dumoulin DW, Oomen-de Hoop E, van Diemen NGJ, Libourel EJ, Geraedts EJ, Bootsma GP, van der Leest CH, Peerdeman AL, Herbschleb KH, Visser OJ, Bloemendal HJ, van Laarhoven HWM, de Vries EGE, Hendriks LEL, Beerepoot LV, Westgeest HM, van den Berkmortel FWPJ, Haanen JBAG, Dingemans AC, van der Veldt AAM; DOCC investigators. Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium. Eur J Cancer 2022;160:261-72. [PMID: 34799210 DOI: 10.1016/j.ejca.2021.10.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
283 Tran S, Truong TH, Narendran A. Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis. Eur J Cancer 2021;159:259-74. [PMID: 34798454 DOI: 10.1016/j.ejca.2021.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
284 Taje R, Elia S, Cristino B, Tacconi F, Natali G, Ambrogi V, Pompeo E. Thoracic surgery in the COVID-19 era: an Italian university hospital experience. Cardiothorac Surg 2021;29. [DOI: 10.1186/s43057-021-00059-y] [Reference Citation Analysis]
285 Mirgh SP, Gokarn A, Rajendra A, More A, Kamtalwar S, Katti KS, Singh A, Goli VB, Ravind R, Madala R, Kakoti S, Maitre P, Punatar S, Chichra A, Patil A, Trivedi B, Joshi A, Patkar N, Tembhare P, Khanka T, Rajpal S, Chatterjee G, Kannan S, Subramanian PG, Murthy V, Shetty N, Chavan P, Bhat V, Nair S, Khattry N, Gupta S. Clinical characteristics, laboratory parameters and outcomes of COVID-19 in cancer and non-cancer patients from a tertiary Cancer Centre in India. Cancer Med 2021;10:8777-88. [PMID: 34786866 DOI: 10.1002/cam4.4379] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
286 Mangesius J, Arnold CR, Seppi T, Mangesius S, Brüggl M, Eichberger P, Ganswindt U. Impact of COVID-19 on Radiation Oncology, an Austrian Experience. Curr Oncol 2021;28:4776-85. [PMID: 34898552 DOI: 10.3390/curroncol28060404] [Reference Citation Analysis]
287 Wang XA, Binder AF, Gergis U, Wilde L. COVID-19 in Patients With Hematologic Malignancies: A Single Center Retrospective Study. Front Oncol 2021;11:740320. [PMID: 34778057 DOI: 10.3389/fonc.2021.740320] [Reference Citation Analysis]
288 Kilgour HM, Galica J, Oliffe JL, Haase KR. The Needs of Older Adult Cancer Survivors During COVID-19: Implications for Oncology Nursing. Semin Oncol Nurs 2021;37:151229. [PMID: 34776292 DOI: 10.1016/j.soncn.2021.151229] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
289 Elsamany S, Elbaiomy M, Zeeneldin A, Tashkandi E, Hassanin F, Abdelhafeez N, O Al-Shamsi H, Bukhari N, Elemam O. Suggested Modifications to the Management of Patients With Breast Cancer During the COVID-19 Pandemic: Web-Based Survey Study. JMIR Cancer 2021;7:e27073. [PMID: 34726611 DOI: 10.2196/27073] [Reference Citation Analysis]
290 Stępień E, Koleśnik M, Mitura K, Malm M, Drop B, Jędrych M, Polz-Dacewicz M. SARS-CoV-2 Infection Prevalence in the Population of South-Eastern Poland. Diagnostics (Basel) 2021;11:2115. [PMID: 34829462 DOI: 10.3390/diagnostics11112115] [Reference Citation Analysis]
291 De Winter FHR, Hotterbeekx A, Huizing MT, Konnova A, Fransen E, Jongers B, Jairam RK, Van Averbeke V, Moons P, Roelant E, Le Blon D, Vanden Berghe W, Janssens A, Lybaert W, Croes L, Vulsteke C, Malhotra-Kumar S, Goossens H, Berneman Z, Peeters M, van Dam PA, Kumar-Singh S. Blood Cytokine Analysis Suggests That SARS-CoV-2 Infection Results in a Sustained Tumour Promoting Environment in Cancer Patients. Cancers (Basel) 2021;13:5718. [PMID: 34830872 DOI: 10.3390/cancers13225718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
292 Hong J, Xu XW, Yang J, Zheng J, Dai SM, Zhou J, Zhang QM, Ruan Y, Ling CQ. Knowledge about, attitude and acceptance towards, and predictors of intention to receive the COVID-19 vaccine among cancer patients in Eastern China: A cross-sectional survey. J Integr Med 2022;20:34-44. [PMID: 34774463 DOI: 10.1016/j.joim.2021.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
293 Liang X, Chen Y, Fan Y. Bioinformatics approach to identify common gene signatures of patients with coronavirus 2019 and lung adenocarcinoma. Environ Sci Pollut Res Int 2021. [PMID: 34775559 DOI: 10.1007/s11356-021-17321-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
294 Cotner CE, Balachandran M, Do D, Ferrell W, Khan N, Kopinsky M, McGettigan S, Morgan AU, Zinck L, Schuchter LM, Shulman LN, Asch DA, Manz CR, Parikh RB. Automated Text-Based Symptom Monitoring With Rapid Clinician Triage for Patients With Cancer and Suspected or Confirmed COVID-19. JCO Clin Cancer Inform 2021;5:1134-40. [PMID: 34767436 DOI: 10.1200/CCI.21.00069] [Reference Citation Analysis]
295 Banfill K, Croxford W, Fornacon-Wood I, Wicks K, Ahmad S, Britten A, Carson C, Dorey N, Hatton M, Hiley C, Thippu Jayaprakash K, Jegannathen A, Koh P, Panakis N, Peedell C, Pope A, Powell C, Stilwell C, Thomas B, Toy E, Wood V, Yahya S, Zhou SY, Price G, Faivre-Finn C. Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK. Clin Oncol (R Coll Radiol) 2022;34:19-27. [PMID: 34763964 DOI: 10.1016/j.clon.2021.10.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
296 Alpert JM, Campbell-Salome G, Gao C, Markham MJ, Murphy M, Harle CA, Paige SR, Krenz T, Bylund CL. Secure Messaging and COVID-19: A Content Analysis of Patient-Clinician Communication During the Pandemic. Telemed J E Health 2021. [PMID: 34767741 DOI: 10.1089/tmj.2021.0316] [Reference Citation Analysis]
297 Barros LADR, Magalhães Filho MAF, Alves RB, Rebouças CV, Rodrigues CM, Viu MM, Benedito VL, Yamada AMTD, Del Giglio A, Cruz FJSM. High mortality among patients with cancer and COVID-19 infection: the experience of a Brazilian cancer center. Einstein (Sao Paulo) 2021;19:eAO6254. [PMID: 34755809 DOI: 10.31744/einstein_journal/2021AO6254] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
298 Puri A, He L, Giri M, Wu C, Zhao Q. Comparison of comorbidities among severe and non-severe COVID-19 patients in Asian versus non-Asian populations: A systematic review and meta-analysis. Nurs Open 2021. [PMID: 34761532 DOI: 10.1002/nop2.1126] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
299 Brandi ML. Are sex hormones promising candidates to explain sex disparities in the COVID-19 pandemic? Rev Endocr Metab Disord 2021. [PMID: 34761329 DOI: 10.1007/s11154-021-09692-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
300 Smith HG, Jensen KK, Jørgensen LN, Krarup PM. Impact of the COVID-19 pandemic on the management of colorectal cancer in Denmark. BJS Open 2021;5:zrab108. [PMID: 34755189 DOI: 10.1093/bjsopen/zrab108] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
301 Dabkeviciene D, Vincerzevskiene I, Urbonas V, Venius J, Dulskas A, Brasiuniene B, Janulionis E, Burneckis A, Zileviciene A, Tiskevicius S, Vanseviciute-Petkeviciene R, Usinskiene J, Briediene R, Bulotiene G, Stratilatovas E, Ostapenko V, Gibaviciene J, Karnas I, Kekstaite S, Navickiene J, Ulys A, Zalimas A, Sruogis A, Kardelis Z, Zaremba S, Askinis R, Cicenas S, Tikuisis R, Ciurliene R, Jarmalaite S. The Impact of the COVID-19 Pandemic on Cancer Patient's Management-Lithuanian Cancer Center Experience. Healthcare (Basel) 2021;9:1522. [PMID: 34828568 DOI: 10.3390/healthcare9111522] [Reference Citation Analysis]
302 Nooh HA, Abdellateif MS, Refaat L, Kandeel EZ, Bayoumi A, Samra M, Khafagy M. The role of inflammatory indices in the outcome of COVID-19 cancer patients. Med Oncol 2021;39:6. [PMID: 34748094 DOI: 10.1007/s12032-021-01605-8] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
303 Dawood RM, Salum GM, El-Meguid MA. The Impact of COVID-19 on Liver Injury: COVID-19 and Liver Injury. Am J Med Sci 2021:S0002-9629(21)00400-6. [PMID: 34752738 DOI: 10.1016/j.amjms.2021.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
304 Toscani I, Troiani A, Citterio C, Rocca G, Cavanna L. Herpes Zoster Following COVID-19 Vaccination in Long-Term Breast Cancer Survivors. Cureus 2021;13:e18418. [PMID: 34733594 DOI: 10.7759/cureus.18418] [Reference Citation Analysis]
305 Ali K, Wajdi M, Al-Quteimat O. Hematology Oncology Patients' Care in a Pandemic Situation of COVID-19: Where Do We Stand? Hosp Pharm 2021;56:622-3. [PMID: 34732909 DOI: 10.1177/0018578720942229] [Reference Citation Analysis]
306 Nowara E, Działach E, Grajek M, Kolosza Z, Huszno J. Outcome of COVID-19 infection in cancer patients during active systemic anticancer treatment. Single-institution experience. A retrospective analysis. Contemp Oncol (Pozn) 2021;25:147-52. [PMID: 34729033 DOI: 10.5114/wo.2021.109362] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
307 Ruiz-Garcia E, Peña-Nieves A, Alegria-Baños J, Cornejo-Juarez P, Meneses-García A, Rivera SR, Sánchez JJ, Gerson-Cwilich R, Gerson DS, Franco HM, Buerba GA, Espinoza AA, Mijares NV, Fernández-Figueroa EA, Vázquez RA, Vilar-Compte D. Prognostic factors in cancer patients infected with SARS-CoV-2: a Latin American country results. Ther Adv Chronic Dis 2021;12:20406223211047755. [PMID: 34729153 DOI: 10.1177/20406223211047755] [Reference Citation Analysis]
308 Nikolopoulos M, Maheshwari MK, Doumouchtsis SK; CHORUS: An International Collaboration for Harmonising Outcomes, Research and Standards in Urogynaecology and Women’s Health (https://i-chorus.org/). Impact of COVID-19 in gynaecological oncology care: a systematic rapid review. Arch Gynecol Obstet 2021. [PMID: 34729631 DOI: 10.1007/s00404-021-06295-1] [Reference Citation Analysis]
309 Yousefi Afrashteh M, Masoumi S. Psychological well-being and death anxiety among breast cancer survivors during the Covid-19 pandemic: the mediating role of self-compassion. BMC Womens Health 2021;21:387. [PMID: 34732193 DOI: 10.1186/s12905-021-01533-9] [Reference Citation Analysis]
310 Abdel-Rahman O. Factors associated with fatal coronavirus disease 2019 infections among cancer patients in the US FDA Adverse Event Reporting System database. Future Oncol 2021;17:5045-51. [PMID: 34726930 DOI: 10.2217/fon-2021-0816] [Reference Citation Analysis]
311 Gurizzan C, Pedersini R, Fornaro C, Sardini C, Zamparini M, Monteverdi S, Tovazzi V, Cosentini D, Dalla Volta A, Baggi A, Turla A, Di Mauro P, Lorini L, Laganà M, Bianchi S, Grisanti S, Consoli F, Conti E, Bossi P, Berruti A. Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic. Front Oncol 2021;11:707346. [PMID: 34722252 DOI: 10.3389/fonc.2021.707346] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
312 Mitsunaga T, Ohtaki Y, Seki Y, Yoshioka M, Mori H, Suzuka M, Mashiko S, Takeda S, Mashiko K. The evaluation of factors affecting antibody response after administration of the BNT162b2 vaccine: a prospective study in Japan. PeerJ 2021;9:e12316. [PMID: 34721989 DOI: 10.7717/peerj.12316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
313 Ullgren H, Camuto A, Rosas S, Pahnke S, Ginman B, Enblad G, Glimelius I, Fransson P, Friesland S, Liu LL. Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study. Acta Oncol 2021;60:1459-65. [PMID: 34334081 DOI: 10.1080/0284186X.2021.1958005] [Reference Citation Analysis]
314 Perez-Johnston R, Araujo-Filho J, Mckenney AS, Gangai N, Plodkowski AJ, Liu CC, Sawan P, Taur Y, Morjaria SM, Ginsberg MS. COVID-19 in patients with cancer: can baseline radiologic severity and early evolution predict clinical outcomes? Eur Radiol 2021. [PMID: 34718846 DOI: 10.1007/s00330-021-08341-7] [Reference Citation Analysis]
315 Ghadamgahi F, Tapak L, Bashirian S, Amiri R, Roshanaei G. The effect of underlying diabetes disease on clinical outcome and survival in patients with Covid-19: a propensity score matching study. J Diabetes Metab Disord 2021;:1-9. [PMID: 34746038 DOI: 10.1007/s40200-021-00922-z] [Reference Citation Analysis]
316 Forster M, Wuerstlein R, Koenig A, Amann N, Beyer S, Kaltofen T, Degenhardt T, Burges A, Trillsch F, Mahner S, Harbeck N, Chelariu-Raicu A. COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective. Breast 2021;60:214-22. [PMID: 34736092 DOI: 10.1016/j.breast.2021.10.012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
317 Zorzi M, Guzzinati S, Avossa F, Fedeli U, Calcinotto A, Rugge M. SARS-CoV-2 Infection in Cancer Patients: A Population-Based Study. Front Oncol 2021;11:730131. [PMID: 34707988 DOI: 10.3389/fonc.2021.730131] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Nomoto H, Suzuki S, Asai Y, Hayakawa K, Gatanaga H, Terada M, Suzuki K, Ohtsu H, Toyoda A, Ohmagari N. Clinical characteristics and prognosis of immunosuppressed inpatients with COVID-19 in Japan. J Infect Chemother 2021:S1341-321X(21)00294-4. [PMID: 34776348 DOI: 10.1016/j.jiac.2021.10.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
319 Chavez-MacGregor M, Lei X, Zhao H, Scheet P, Giordano SH. Evaluation of COVID-19 Mortality and Adverse Outcomes in US Patients With or Without Cancer. JAMA Oncol 2021. [PMID: 34709356 DOI: 10.1001/jamaoncol.2021.5148] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 41.0] [Reference Citation Analysis]
320 Gaspar R, Castelo Branco C, Macedo G. Liver and COVID-19: From care of patients with liver diseases to liver injury. World J Hepatol 2021; 13(10): 1367-1377 [PMID: 34786172 DOI: 10.4254/wjh.v13.i10.1367] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
321 Jafari A, Mahboubi-fooladi Z, Siavashpour Z, Rakhsha A, Mirbaha S, Fatemi A, Forouzanfar MM. Clinical and Imaging Characteristics of Cancer Patients with COVID-19: A Pilot Study. Int J Cancer Manag 2021;14. [DOI: 10.5812/ijcm.115735] [Reference Citation Analysis]
322 Rahav G, Lustig Y, Lavee J, Ohad Benjamini, Magen H, Hod T, Noga Shem-Tov, Shmueli ES, Drorit Merkel, Ben-Ari Z, Halperin R, Indenbaum V, Olmer L, Huppert A, Mor E, Regev-Yochay G, Cohen C, Finesod AW, Levy I. BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study. EClinicalMedicine 2021;41:101158. [PMID: 34693234 DOI: 10.1016/j.eclinm.2021.101158] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
323 Sutjiadi B, McRae J, Silva T, Selleck M, Reeves M, Garberoglio C, Lum S. Redistribution of Outpatient Oncologic Surgical Specialty Referrals During COVID-19. Am Surg 2021;87:1656-60. [PMID: 34693734 DOI: 10.1177/00031348211051699] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
324 Becerril-Gaitan A, Vaca-Cartagena BF, Ferrigno AS, Mesa-Chavez F, Barrientos-Gutiérrez T, Tagliamento M, Lambertini M, Villarreal-Garza C. Immunogenicity and risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection after Coronavirus Disease 2019 (COVID-19) vaccination in patients with cancer: a systematic review and meta-analysis. Eur J Cancer 2021:S0959-8049(21)01168-0. [PMID: 34794855 DOI: 10.1016/j.ejca.2021.10.014] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 35.0] [Reference Citation Analysis]
325 Ahmadian E, Zununi Vahed S, Mammadova S, Abediazar S. Immunosuppressant Management in Renal Transplant Patients with COVID-19. Biomed Res Int 2021;2021:9318725. [PMID: 34692845 DOI: 10.1155/2021/9318725] [Reference Citation Analysis]
326 Ariamanesh M, Porouhan P, PeyroShabany B, Fazilat-Panah D, Dehghani M, Nabavifard M, Hatami F, Fereidouni M, Welsh JS, Javadinia SA. Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients with Malignancy. Cancer Invest 2021;:1-9. [PMID: 34634986 DOI: 10.1080/07357907.2021.1992420] [Cited by in Crossref: 1] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
327 Oz M, Meydanli MM, Altintas MI, Akilli H, Gultekin M, Ozgul N, Salman MC, Taskin S, Yaprak E, Taskiran C, Vatansever D, Giray B, Yetkinel S, Celik H, Onan MA, Ayhan A. The safety of major gynaecologic cancer surgery without routine preoperative COVID-19 testing in the COVID-19 era: a multicentre, retrospective, case-control study. J Obstet Gynaecol 2021;:1-7. [PMID: 34704523 DOI: 10.1080/01443615.2021.1959535] [Reference Citation Analysis]
328 Linehan A, Fitzpatrick O, Cowzer D, Hennessy MA, Coyne ZL, Nolan A, Clarke M, Dhonaill RN, Hennessy BT, Morris PG, Grogan L, Breathnach O. COVID-19-related mortality in cancer patients in an Irish setting. Ir J Med Sci 2021. [PMID: 34697787 DOI: 10.1007/s11845-021-02815-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
329 Guo D, Wang H, Zhu Q, Yuan Y. Clinical Characteristics of Cancer Patients With COVID-19: A Retrospective Multicentric Study in 19 Hospitals Within Hubei, China. Front Med (Lausanne) 2021;8:614057. [PMID: 34676221 DOI: 10.3389/fmed.2021.614057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
330 Cui Y, Chen F, Gao J, Lei M, Wang D, Jin X, Guo Y, Shan L, Chen X. Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2. Int J Biol Sci 2021;17:3795-817. [PMID: 34671200 DOI: 10.7150/ijbs.53312] [Reference Citation Analysis]
331 Popp M, Stegemann M, Riemer M, Metzendorf MI, Romero CS, Mikolajewska A, Kranke P, Meybohm P, Skoetz N, Weibel S. Antibiotics for the treatment of COVID-19. Cochrane Database Syst Rev 2021;10:CD015025. [PMID: 34679203 DOI: 10.1002/14651858.CD015025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
332 Calabrò L, Rossi G, Covre A, Morra A, Maio M. COVID and Lung Cancer. Curr Oncol Rep 2021;23:134. [PMID: 34677721 DOI: 10.1007/s11912-021-01125-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
333 Péron J, Dagonneau T, Conrad A, Pineau F, Calattini S, Freyer G, Perol D, Sajous C, Heiblig M. COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study. Cancers (Basel) 2021;13:5283. [PMID: 34771446 DOI: 10.3390/cancers13215283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
334 Alam SK, Zhang Y, Wang L, Zhu Z, Hernandez CE, Zhou Y, Yang N, Lei J, Chen X, Zeng L, Klein MA, Hoeppner LH. DARPP-32 promotes ERBB3-mediated resistance to molecular targeted therapy in EGFR-mutated lung adenocarcinoma. Oncogene 2021. [PMID: 34675407 DOI: 10.1038/s41388-021-02028-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Manchanda R, Oxley S, Ghaem-Maghami S, Sundar S. COVID-19 and the impact on gynecologic cancer care. Int J Gynaecol Obstet 2021;155 Suppl 1:94-101. [PMID: 34669200 DOI: 10.1002/ijgo.13868] [Reference Citation Analysis]
336 Kang KW, Lee BH, Jeon MJ, Yu ES, Kim DS, Lee SR, Sung HJ, Choi CW, Park Y, Kim BS. The effect of the response to the coronavirus disease pandemic on treatment outcomes in patients with lymphoma and multiple myeloma. Korean J Intern Med 2021;36:1459-70. [PMID: 34666434 DOI: 10.3904/kjim.2021.186] [Reference Citation Analysis]
337 Yang S, Wang J, Xu X. Psychological health status among thyroid cancer patients during the COVID-19 epidemic in China. Support Care Cancer 2021. [PMID: 34671859 DOI: 10.1007/s00520-021-06624-9] [Reference Citation Analysis]
338 Xu C, Li L, Wang W. Challenges in Advanced Lung Cancer Diagnosis During the COVID-19 Pandemic. Technol Cancer Res Treat 2021;20:15330338211050764. [PMID: 34657503 DOI: 10.1177/15330338211050764] [Reference Citation Analysis]
339 Radcliffe E, Khan A, Wright D, Berman R, Demain S, Foster C, Restorick-Banks S, Richardson A, Wagland R, Calman L. 'It feels it's wasting whatever time I've got left': A qualitative study of living with treatable but not curable cancer during the COVID-19 pandemic. Palliat Med 2021;:2692163211049497. [PMID: 34664537 DOI: 10.1177/02692163211049497] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
340 Mikolajewska A, Fischer AL, Piechotta V, Mueller A, Metzendorf MI, Becker M, Dorando E, Pacheco RL, Martimbianco ALC, Riera R, Skoetz N, Stegemann M. Colchicine for the treatment of COVID-19. Cochrane Database Syst Rev 2021;10:CD015045. [PMID: 34658014 DOI: 10.1002/14651858.CD015045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
341 Buttiron Webber T, Giuliano S, Patrone C, Briata IM, Franconeri M, Marceca F, Magnani M, Paciolla F, Provinciali N, Defferrari C, Clavarezza M, D'Amico M, Gozza A, Boitano M, Alessio-Mazzola M, Cevasco I, DeCensi A. Home Se-Cure: A Home Care Service for Cancer Patients during the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:10913. [PMID: 34682650 DOI: 10.3390/ijerph182010913] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
342 Roel E, Pistillo A, Recalde M, Fernández-Bertolín S, Aragón M, Soerjomataram I, Jenab M, Puente D, Prieto-Alhambra D, Burn E, Duarte-Salles T. Cancer and the risk of coronavirus disease 2019 diagnosis, hospitalisation and death: A population-based multistate cohort study including 4 618 377 adults in Catalonia, Spain. Int J Cancer 2021. [PMID: 34655476 DOI: 10.1002/ijc.33846] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
343 Lu H, Shi Y, Chen K, Chen Z, Zhu H, Niu Y, Xia D, Wu Y. Impact of antitumor regimens on the outcomes of cancer patients with COVID-19: a pooled analysis. J Zhejiang Univ Sci B 2021;22:876-84. [PMID: 34636190 DOI: 10.1631/jzus.B2100151] [Reference Citation Analysis]
344 Izadmehr S, Lundon DJ, Mohamed N, Katims A, Patel V, Eilender B, Mehrazin R, Badani KK, Sfakianos JP, Tsao CK, Wiklund P, Oh WK, Cordon-Cardo C, Tewari AK, Galsky MD, Kyprianou N. The Evolving Clinical Management of Genitourinary Cancers Amid the COVID-19 Pandemic. Front Oncol 2021;11:734963. [PMID: 34646777 DOI: 10.3389/fonc.2021.734963] [Reference Citation Analysis]
345 Ali A, Mughal H, Ahmad N, Babar Q, Saeed A, Khalid W, Raza H, Liu A. Novel therapeutic drug strategies to tackle immune-oncological challenges faced by cancer patients during COVID-19. Expert Rev Anticancer Ther 2021;21:1371-83. [PMID: 34643141 DOI: 10.1080/14737140.2021.1991317] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
346 Chiang J, Yang V, Han S, Zhuang Q, Zhou S, Mathur S, Kang ML, Ngeow J, Yap SP, Tham CK. Oncology workload in a tertiary hospital during the COVID-19 pandemic. Proceedings of Singapore Healthcare. [DOI: 10.1177/20101058211051118] [Reference Citation Analysis]
347 Taoufik Y, de Goër de Herve MG, Corgnac S, Durrbach A, Mami-Chouaib F. When Immunity Kills: The Lessons of SARS-CoV-2 Outbreak. Front Immunol 2021;12:692598. [PMID: 34630382 DOI: 10.3389/fimmu.2021.692598] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
348 Cajamarca-Baron J, Guavita-Navarro D, Buitrago-Bohorquez J, Gallego-Cardona L, Navas A, Cubides H, Arredondo AM, Escobar A, Rojas-Villarraga A. [SARS-CoV-2 (COVID-19) in Patients with some Degree of Immunosuppression]. Reumatol Clin 2021;17:408-19. [PMID: 34630575 DOI: 10.1016/j.reuma.2020.08.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
349 Panou E, Nikolaou V, Marinos L, Kallambou S, Sidiropoulou P, Gerochristou M, Stratigos A. Recurrence of cutaneous T-cell lymphoma post viral vector COVID-19 vaccination. J Eur Acad Dermatol Venereol 2021. [PMID: 34628691 DOI: 10.1111/jdv.17736] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
350 Rasschaert M, Vanclooster P, Depauw L, Mertens T, Roelant E, Coenen E, Anguille S, Janssens A, Van Dam P, Peeters M. Meeting the Challenges in Cancer Care Management During the SARS-Cov-2 Pandemic: A Retrospective Analysis. Cancer Control 2021;28:10732748211045275. [PMID: 34623943 DOI: 10.1177/10732748211045275] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
351 Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V. Prognostic factors at admission on patients with cancer and COVID-19: Analysis of HOPE registry data. Med Clin (Engl Ed) 2021;157:318-24. [PMID: 34632069 DOI: 10.1016/j.medcle.2021.02.010] [Reference Citation Analysis]
352 Ho W, Köhler G, Haywood RM, Rosich-Medina A, Masud D. Microsurgical autologous breast reconstruction in the midst of a pandemic: A single-unit COVID-19 experience. J Plast Reconstr Aesthet Surg 2021:S1748-6815(21)00444-7. [PMID: 34756656 DOI: 10.1016/j.bjps.2021.09.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Pileggi GS, Ferreira GA, Reis APMG, Reis-Neto ET, Abreu MM, Albuquerque CP, Araújo NC, Bacchiega AB, Bianchi DV, Bica B, Bonfa ED, Borba EF, Brito DCSE, Duarte ÂLBP, Santo RCE, Fernandes PR, Guimarães MP, Gomes KWP, Kakehasi AM, Klumb EM, Lanna CCD, Marques CDL, Monticielo OA, Mota LMH, Munhoz GA, Paiva ES, Pereira HLA, Provenza JR, Ribeiro SLE, Junior LFR, Sampaio CSJC, Sampaio VS, Sato EI, Skare T, de Souza VA, Valim V, Lacerda MVG, Xavier RM, Pinheiro MM. Chronic use of hydroxychloroquine did not protect against COVID-19 in a large cohort of patients with rheumatic diseases in Brazil. Adv Rheumatol 2021;61:60. [PMID: 34620246 DOI: 10.1186/s42358-021-00217-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
354 Sumi T, Nagahisa Y, Matsuura K, Sekikawa M, Yamada Y, Nakata H, Chiba H. Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech). Thorac Cancer 2021;12:3072-5. [PMID: 34612003 DOI: 10.1111/1759-7714.14179] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
355 Akkuş Y, Karacan Y, Ünlü K, Deniz M, Parlak A. The effect of anxiety and spiritual well-being on the care burden of caregivers of cancer patients during the COVID-19 pandemic. Support Care Cancer 2021. [PMID: 34613473 DOI: 10.1007/s00520-021-06611-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
356 Al-Benna S, Gohritz A. Breast reconstruction during the COVID-19 pandemic in resource-limited settings. GMS Interdiscip Plast Reconstr Surg DGPW 2021;10:Doc10. [PMID: 34595087 DOI: 10.3205/iprs000160] [Reference Citation Analysis]
357 Kjeldsted E, Lindblad KV, Bødtcher H, Sørensen DM, Rosted E, Christensen HG, Svendsen MN, Thomsen LA, Dalton SO. A population-based survey of patients' experiences with teleconsultations in cancer care in Denmark during the COVID-19 pandemic. Acta Oncol 2021;60:1352-60. [PMID: 34338113 DOI: 10.1080/0284186X.2021.1956688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
358 Indini A, Costa S, Ierardi AM, Rijavec E, Passoni E, Grossi F. COVID-19 vaccination mimicking lymph-node progression in a patient with melanoma: a case report. Melanoma Res 2021;31:490-3. [PMID: 34433198 DOI: 10.1097/CMR.0000000000000768] [Reference Citation Analysis]
359 Cardoso ASF, Silva SMR, Rabelo-Silva ER, Umpierre D, Sostizzo LDRZ, Echer IC. Routine workflow in a reference clinical research center in face of COVID-19. Rev Gaucha Enferm 2021;42:e20200389. [PMID: 34586333 DOI: 10.1590/1983-1447.2021.20200389] [Reference Citation Analysis]
360 Hemal K, Boyd CJ, Bekisz JM, Salibian AA, Choi M, Karp NS. Breast Reconstruction during the COVID-19 Pandemic: A Systematic Review. Plast Reconstr Surg Glob Open 2021;9:e3852. [PMID: 34584831 DOI: 10.1097/GOX.0000000000003852] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
361 Bharati J, Rathi M, Ramachandran R, Sharma A, Nada R, Kohli HS. Managing Active Iupus Nephritis During COVID-19 Pandemic. Indian J Nephrol 2021;31:390-3. [PMID: 34584357 DOI: 10.4103/ijn.IJN_301_20] [Reference Citation Analysis]
362 Cecyn KZ, Marques MO, Rodrigues MA, Brito FN, Baiocchi OCCG. Clinical course of COVID-19 in a patient with refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) under ibrutinib therapy: a case report. Blood Res 2021;56:197-201. [PMID: 34400587 DOI: 10.5045/br.2021.2020181] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
363 Patel RH, Vanaparthy R, Greene JN. COVID-19 in Immunocompromised Cancer Patients: A Case Series and Review of the Literature. Cancer Control 2021;28:10732748211044361. [PMID: 34579537 DOI: 10.1177/10732748211044361] [Reference Citation Analysis]
364 Li Y, Chen B, Hong Z, Sun Q, Dai Y, Basta M, Tang X, Qin Q. Insomnia symptoms during the early and late stages of the COVID-19 pandemic in China: a systematic review and meta-analysis. Sleep Med 2021:S1389-9457(21)00494-9. [PMID: 34732293 DOI: 10.1016/j.sleep.2021.09.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
365 Mooghal M, Javaid RH, Khan W, Muneeb M, Khan WA, Ahmad A, Barohi LB, Rahim K, Tahseen H, Gul A. COVID 19 pandemic: Effect on management of patients with breast cancer; single center retrospective cohort study. Int J Surg Open 2021;35:100386. [PMID: 34568622 DOI: 10.1016/j.ijso.2021.100386] [Reference Citation Analysis]
366 Zhang S, Amahong K, Zhang C, Li F, Gao J, Qiu Y, Zhu F. RNA-RNA interactions between SARS-CoV-2 and host benefit viral development and evolution during COVID-19 infection. Brief Bioinform 2021:bbab397. [PMID: 34585235 DOI: 10.1093/bib/bbab397] [Cited by in F6Publishing: 14] [Reference Citation Analysis]
367 Kelemenic-Drazin R, Budisavljevic A, Plavetic ND, Fucak IK, Silovski T, Dobric VT, Nalbani M, Curic Z, Boric-Mikez Z, Ladenhauser T, Trivanovic D, Vojnovic Z, Tomas I, Plestina S. Impact of the coronavirus disease pandemic on cancer care in Croatia: a multicentre cross-sectional study. Ecancermedicalscience 2021;15:1263. [PMID: 34567248 DOI: 10.3332/ecancer.2021.1263] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
368 Meir J, Abid MA, Abid MB. State of the CAR-T: Risk of Infections with Chimeric Antigen Receptor T-Cell Therapy and Determinants of SARS-CoV-2 Vaccine Responses. Transplant Cell Ther 2021:S2666-6367(21)01258-6. [PMID: 34587552 DOI: 10.1016/j.jtct.2021.09.016] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
369 Grinshpun A, Rottenberg Y, Ben-Dov IZ, Djian E, Wolf DG, Kadouri L. Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment. ESMO Open 2021;6:100283. [PMID: 34634634 DOI: 10.1016/j.esmoop.2021.100283] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
370 Cellini F, Di Franco R, Manfrida S, Borzillo V, Maranzano E, Pergolizzi S, Morganti AG, Fusco V, Deodato F, Santarelli M, Arcidiacono F, Rossi R, Reina S, Merlotti A, Jereczek-Fossa BA, Tozzi A, Siepe G, Cacciola A, Russi E, Gambacorta MA, Scorsetti M, Ricardi U, Corvò R, Donato V, Muto P, Valentini V. Palliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model. Radiol Med 2021. [PMID: 34570309 DOI: 10.1007/s11547-021-01414-z] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
371 Sitanggang JS, Siregar KB, Sitanggang HH, Sprinse Vinolina N. Prevalence and characteristics of cancer patients with COVID-19: a meta-analysis study. F1000Res 2021;10:975. [DOI: 10.12688/f1000research.53539.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
372 Chen X, Deng W, Zhou W, Liu Y, Chen J, Gao Y, Xiao K, Man L, Qu W, Zeng H, Ye S. Understanding the experiences of patients with cancers in hospitals during COVID-19 pandemic in China: A qualitative research study. Nurs Open 2021. [PMID: 34569186 DOI: 10.1002/nop2.1073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
373 Taghinejad Z, Asgharzadeh M, Asgharzadeh V, Kazemi A. Risk Factors for Mucormycosis in COVID-19 Patients. Jundishapur J Microbiol 2021;14. [DOI: 10.5812/jjm.117435] [Reference Citation Analysis]
374 Moentmann MR, Johnson J, Chung MT, Yoo OE, Lin HS, Yoo GH. Telemedicine trends at a comprehensive cancer center during the first wave of the COVID-19 pandemic. J Surg Oncol 2021. [PMID: 34562269 DOI: 10.1002/jso.26681] [Reference Citation Analysis]
375 Oderda M, Soria F, Rosi F, Calleris G, Mazzoli S, Giordano A, Pizzuto G, Marquis A, De Bellis M, Vitiello F, Vercelli E, Peretti F, Montefusco G, Gontero P. COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center. World J Urol 2021. [PMID: 34562122 DOI: 10.1007/s00345-021-03842-y] [Reference Citation Analysis]
376 Li Y, Wang X, Wang W. The Impact of COVID-19 on Cancer. Infect Drug Resist 2021;14:3809-16. [PMID: 34557004 DOI: 10.2147/IDR.S324569] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
377 Gupta A, Desai N, Sanjeev, Chauhan P, Nityanand S, Hashim Z, Gupta M. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India. Ann Hematol 2021. [PMID: 34559278 DOI: 10.1007/s00277-021-04644-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
378 Palandri F, Breccia M, De Stefano V, Passamonti F. Philadelphia-Negative Chronic Myeloproliferative Neoplasms during the COVID-19 Pandemic: Challenges and Future Scenarios. Cancers (Basel) 2021;13:4750. [PMID: 34638236 DOI: 10.3390/cancers13194750] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
379 Benderra MA, Aparicio A, Leblanc J, Wassermann D, Kempf E, Galula G, Bernaux M, Canellas A, Moreau T, Bellamine A, Spano JP, Daniel C, Champ J, Canouï-Poitrine F, Gligorov J, On Behalf Of The Ap-Hp/Universities/Inserm Covid-Research Collaboration, Cancer Ap-Hp Group Covid-Task Force, Ap-Hp Covid Cdw Initiative Acci. Clinical Characteristics, Care Trajectories and Mortality Rate of SARS-CoV-2 Infected Cancer Patients: A Multicenter Cohort Study. Cancers (Basel) 2021;13:4749. [PMID: 34638235 DOI: 10.3390/cancers13194749] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
380 Mbugua SN, Njenga LW, Odhiambo RA, Wandiga SO, Onani MO, Ignjatovic N. COVID-19 and Cancer Therapy: Interrelationships and Management of Cancer Cases in the Era of COVID-19. Journal of Chemistry 2021;2021:1-10. [DOI: 10.1155/2021/9923518] [Reference Citation Analysis]
381 Raad M, Gorgis S, Abshire C, Yost M, Dabbagh MF, Chehab O, Aurora L, Patel S, Nona P, Yan J, Singh G, Syrjamaki J, Kaatz S, Parikh S. COVID-19 risk index (CRI): a simple and validated emergency department risk score that predicts mortality and the need for mechanical ventilation. J Thromb Thrombolysis 2021. [PMID: 34554359 DOI: 10.1007/s11239-021-02565-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
382 Gómez-Centurión I, Oarbeascoa G, García MC, López Fresneña MC, Martínez Carreño MJ, Escudero Vilaplana V, González-Haba E, Bailén R, Dorado N, Juárez LM, Rodríguez Macías G, Font López P, Encinas C, Bastos-Oreiro M, Anguita J, Sanjurjo M, Díez-Martin JL, Kwon M. Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility. Int J Hematol 2021. [PMID: 34553338 DOI: 10.1007/s12185-021-03219-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
383 Samanta P, Ghosh AR. Environmental perspectives of COVID-19 outbreaks: A review. World J Gastroenterol 2021; 27(35): 5822-5850 [PMID: 34629805 DOI: 10.3748/wjg.v27.i35.5822] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
384 Cavanna L, Citterio C, Toscani I. COVID-19 Vaccines in Cancer Patients. Seropositivity and Safety. Systematic Review and Meta-Analysis. Vaccines (Basel) 2021;9:1048. [PMID: 34579285 DOI: 10.3390/vaccines9091048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
385 Lauricella E, Cives M, Bracigliano A, Clemente O, Felici V, Lippolis R, Amoruso B, Pelle' E, Mandriani B, Esposto C, Forte C, Perri F, Porta C, Tafuto S. The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability. J Neuroendocrinol 2021;33:e13041. [PMID: 34596289 DOI: 10.1111/jne.13041] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
386 Mishra S, Gupta R, Bhatnagar S, Garg R, Bharati SJ, Kumar V, Gupta N. The COVID-19 pandemic: a new epoch and fresh challenges for cancer patients and caregivers-a descriptive cross-sectional study. Support Care Cancer 2021. [PMID: 34536134 DOI: 10.1007/s00520-021-06564-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
387 Fagundes EM, Neto NN, Caldas LM, Aragão JR, Gloria ABF, Leite LG, Bastos P, Fernandes CM, Chalup M, Arcuri R, Fagundes OG. Mortality by COVID-19 in adults with acute myeloid leukemia: a survey with hematologists in Brazil. Ann Hematol 2021. [PMID: 34533604 DOI: 10.1007/s00277-021-04659-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
388 Buti S, Perrone F, Zielli T, Mazzaschi G, Casartelli C, Leonetti A, Milanese G, Silva M, Eufrasia Ledda R, Musolino A, Pucci F, Bersanelli M, Tiseo M. Clinical Impact of COVID-19 Outbreak on Cancer Patients: A Retrospective Study. Clin Med Insights Oncol 2021;15:11795549211043427. [PMID: 34526833 DOI: 10.1177/11795549211043427] [Reference Citation Analysis]
389 Taurino D, Frigeni M, Grassi A, Cavallaro G, Salmoiraghi S, Spinelli O, Rambaldi A, Lussana F. Concurrent Diagnosis of Acute Myeloid Leukemia and Symptomatic COVID-19 Infection: a Case Report Successfully Treated with Azacitidine-Venetoclax Combination. Mediterr J Hematol Infect Dis 2021;13:e2021057. [PMID: 34527209 DOI: 10.4084/MJHID.2021.057] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
390 Bilgi Z. THORACIC ONCOLOGIC SURGERY IN COVID-19 PANDEMIC: SHORT TERM OUTCOMES. Clinical and Experimental Health Sciences. [DOI: 10.33808/clinexphealthsci.951533] [Reference Citation Analysis]
391 Bilge M, Akilli IK, Karaayvaz EB, Yesilova A, Kart Yasar K. Comparison of systemic immune-inflammation index (SII), early warning score (ANDC) and prognostic nutritional index (PNI) in hospitalized patients with malignancy, and their influence on mortality from COVID-19. Infect Agent Cancer 2021;16:60. [PMID: 34526045 DOI: 10.1186/s13027-021-00400-4] [Reference Citation Analysis]
392 Dang MKM, Bhatt I, Dulu AO, Zhang H, Kostelecky N, Pastores SM. Clinical Characteristics, Management, and Outcomes of Cancer Patients With Coronavirus Disease 2019 Admitted to the ICU. Crit Care Explor 2021;3:e0535. [PMID: 34514429 DOI: 10.1097/CCE.0000000000000535] [Reference Citation Analysis]
393 O'Kelly B, McLaughlin R, O'Doherty R, Carroll H, Murray R, Dilworth R, Corkery L, Cotter AG, McGinty T, Muldoon EG, Cullen W, Avramovic G, Sheehan G, Sadlier D, Higgins M, O'Gorman P, Doran P, Inzitari R, Holden S, O'Meara Y, Ennis S, Lambert JS. Rapid and Laboratory SARS-CoV-2 Antibody Testing in High-Risk Hospital Associated Cohorts of Unknown COVID-19 Exposure, a Validation and Epidemiological Study After the First Wave of the Pandemic. Front Med (Lausanne) 2021;8:642318. [PMID: 34513853 DOI: 10.3389/fmed.2021.642318] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
394 Gupta R, Mishra S, Bhatnagar S, Bharati SJ, Garg R, Kumar V, Gupta N. A Questionnaire-based Survey on Challenges Faced and Strategies Adopted by Pain and Palliative Care Physicians Working in Oncology Setup During Novel COVID-19 Pandemic - A Descriptive Cross-sectional Study. Indian J Palliat Care 2021;27:319-29. [PMID: 34511803 DOI: 10.25259/IJPC_445_20] [Reference Citation Analysis]
395 Moor MB, Suter-Riniker F, Horn MP, Aeberli D, Amsler J, Möller B, Njue LM, Medri C, Angelillo-Scherrer A, Borradori L, Radonjic-Hoesli S, Seyed Jafari SM, Chan A, Hoepner R, Bacher VU, Mani LY, Iype JM, Hirzel C, Maurer B, Sidler D. Humoral and cellular responses to mRNA vaccines against SARS-CoV-2 in patients with a history of CD20 B-cell-depleting therapy (RituxiVac): an investigator-initiated, single-centre, open-label study. Lancet Rheumatol 2021;3:e789-97. [PMID: 34514436 DOI: 10.1016/S2665-9913(21)00251-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 67] [Article Influence: 10.0] [Reference Citation Analysis]
396 Hakim A, Hasan MM, Hasan M, Lokman SM, Azim KF, Raihan T, Chowdhury PA, Azad AK. Major Insights in Dynamics of Host Response to SARS-CoV-2: Impacts and Challenges. Front Microbiol 2021;12:637554. [PMID: 34512561 DOI: 10.3389/fmicb.2021.637554] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
397 Norman S, Ramos A, Giantini Larsen AM, Bander E, Goldberg J, Parker W, Juthani RG. Impact of the COVID-19 pandemic on neuro-oncology outcomes. J Neurooncol 2021;154:375-81. [PMID: 34510329 DOI: 10.1007/s11060-021-03838-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
398 Roy S, Ghosh J, Ganguly S, Mondal D, Dabkara D, Chatterji S, Biswas B. Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India. JCO Glob Oncol 2021;7:1374-9. [PMID: 34506223 DOI: 10.1200/GO.21.00139] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
399 Al-Mozaini M, Noman ASM, Alotaibi J, Karim MR, Zahed ASM, Karim ATMR, Alromiah K, Islam SS. SARS-CoV-2 Viral Load Is Correlated With the Disease Severity and Mortality in Patients With Cancer. Front Oncol 2021;11:715794. [PMID: 34490115 DOI: 10.3389/fonc.2021.715794] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
400 Mehrvar A, Qaddoumi I, Tashvighi M, Naderi A, Mousakhani H, Alasvand R, Shekarchi B, Afsar N, Nourian M, Mehrvar N. Treatment and outcomes of pediatric patients with cancer and COVID-19 at MAHAK pediatric cancer treatment and research center, Tehran, Iran. Semin Oncol 2021:S0093-7754(21)00055-5. [PMID: 34625294 DOI: 10.1053/j.seminoncol.2021.09.003] [Reference Citation Analysis]
401 K PKR, Elagandula J, Patel S, Patidar R, Asati V, Shrivastav SP, Elhence A, Sharma R, Ankit BS, Chitalkar PG. The Impact of COVID-19 Pandemic on Cancer Care in a Tertiary Care Facility. South Asian J Cancer 2021;10:32-5. [PMID: 34485184 DOI: 10.1055/s-0041-1731577] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
402 Lesley GC, Tahmasebi H, Meti N, Wright FC, Thawer A, Cheung M, Singh S. Cancer Treatment During COVID-19: A Qualitative Analysis of Patient-Perceived Risks and Experiences with Virtual Care. J Patient Exp 2021;8:23743735211039328. [PMID: 34485693 DOI: 10.1177/23743735211039328] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
403 Kaltofen T, Hagemann F, Harbeck N, Wuerstlein R, Kost BP, Burges A, Mahner S, Trillsch F. Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany. Arch Gynecol Obstet 2021. [PMID: 34491417 DOI: 10.1007/s00404-021-06211-7] [Reference Citation Analysis]
404 Arayici ME, Sanlav G, Yilmaz S, Hekimci Özdemir H, Başbinar Y, Ellidokuz H. Nutrition and Micronutrients in Cancer Patients Positive for COVID-19. Journal of Basic and Clinical Health Sciences. [DOI: 10.30621/jbachs.979515] [Reference Citation Analysis]
405 Kreuzberger N, Hirsch C, Chai KL, Tomlinson E, Khosravi Z, Popp M, Neidhardt M, Piechotta V, Salomon S, Valk SJ, Monsef I, Schmaderer C, Wood EM, So-Osman C, Roberts DJ, McQuilten Z, Estcourt LJ, Skoetz N. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Cochrane Database Syst Rev 2021;9:CD013825. [PMID: 34473343 DOI: 10.1002/14651858.CD013825.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 34] [Article Influence: 5.0] [Reference Citation Analysis]
406 Hu X, Huang Y, Chen J, Zhu X, Mao Z, Wang Y, Hu R, Chen H. MOFs supported nanonetworks hybrid flower-like catalysts via supramolecular-mediated cascade self-assembly for sensitive sensing of H2O2. Sensors and Actuators B: Chemical 2021;342:130076. [DOI: 10.1016/j.snb.2021.130076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
407 Zhang J, Jiang H, Du K, Xie T, Wang B, Chen C, Cen B, Yuan Y, Ye J. Pan-Cancer Analysis of Genomic and Prognostic Characteristics Associated With Coronavirus Disease 2019 Regulators. Front Med (Lausanne) 2021;8:662460. [PMID: 34458283 DOI: 10.3389/fmed.2021.662460] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
408 Bisceglia I, Gabrielli D, Canale ML, Gallucci G, Parrini I, Turazza FM, Russo G, Maurea N, Quagliariello V, Lestuzzi C, Oliva S, Di Fusco SA, Lucà F, Tarantini L, Trambaiolo P, Gulizia MM, Colivicchi F. ANMCO POSITION PAPER: cardio-oncology in the COVID era (CO and CO). Eur Heart J Suppl 2021;23:C128-53. [PMID: 34456641 DOI: 10.1093/eurheartj/suab067] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
409 Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, Homsi MR, Muniz-Talavera H, Ranadive R, Metzger M, Friedrich P, Agulnik A, Jeha S, Lam C, Dalvi R, Hessissen L, Moreira DC, Santana VM, Sullivan M, Bouffet E, Caniza MA, Devidas M, Pritchard-Jones K, Rodriguez-Galindo C; Global Registry of COVID-19 in Childhood Cancer. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol 2021;22:1416-26. [PMID: 34454651 DOI: 10.1016/S1470-2045(21)00454-X] [Cited by in Crossref: 5] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
410 Budisan L, Zanoaga O, Braicu C, Pirlog R, Covaliu B, Esanu V, Korban SS, Berindan-Neagoe I. Links between Infections, Lung Cancer, and the Immune System. Int J Mol Sci 2021;22:9394. [PMID: 34502312 DOI: 10.3390/ijms22179394] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
411 Pomej K, Scheiner B, Hartl L, Balcar L, Meischl T, Mandorfer M, Reiberger T, Müller C, Trauner M, Pinter M. COVID-19 pandemic: Impact on the management of patients with hepatocellular carcinoma at a tertiary care hospital. PLoS One 2021;16:e0256544. [PMID: 34437610 DOI: 10.1371/journal.pone.0256544] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
412 Lemos AEG, Silva GR, Gimba ERP, Matos ADR. Susceptibility of lung cancer patients to COVID-19: A review of the pandemic data from multiple nationalities. Thorac Cancer 2021;12:2637-47. [PMID: 34435733 DOI: 10.1111/1759-7714.14067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
413 Qiu S, Hu Y. Are COVID-19 susceptibility genes related to lung cancer? J Infect 2021;83:607-35. [PMID: 34437926 DOI: 10.1016/j.jinf.2021.08.032] [Reference Citation Analysis]
414 Teuscher M, Diehl K, Schaarschmidt ML, Weilandt J, Sasama B, Ohletz J, Könnecke A, Harth W, Hillen U, Peitsch WK. Effects of the COVID-19 pandemic on care of melanoma patients in Berlin, Germany: the Mela-COVID survey. Eur J Dermatol 2021. [PMID: 34463283 DOI: 10.1684/ejd.2021.4098] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
415 Hingmire S, Wategaonkar R, Hegde S, Mekha M, Kulkarni R, Rajbhoj A, Deshmukh C, Kulkarni P, Patil T, Kanitkar G, Wanjarkhedkar P, Mane A, Bokil K, Parasnis A, Gawande J, Bhatia J, Khaladkar B, Sirsath N, Melinkeri S, Kashyapi B, Agrawal RK, Prabhakaran A, Desai I, Kelkar D. Outcome of COVID-19 Infection in Cancer Patients in Pune. South Asian J Cancer 2021;10:23-7. [PMID: 34430515 DOI: 10.1055/s-0041-1731910] [Reference Citation Analysis]
416 Vaid AK, Malhotra H, Thirumalairaj R, Nair R, Bapna A, Rajappa SJ, Somashekhar SP, Goswami C, Bajpai J. Indian Expert Opinion on Cancer Care during COVID-19 Pandemic. South Asian J Cancer 2021;10:9-18. [PMID: 34430513 DOI: 10.1055/s-0041-1727560] [Reference Citation Analysis]
417 Kumar R, Patel N, Kodan P, Aggarwal R, Dass C, Soni KD, Trikha A. Clinical Profile and Outcome of Critically Ill COVID-19 Patients With Malignancy Admitted in Intensive Care Unit of a Tertiary COVID Center, India. Cureus 2021;13:e16553. [PMID: 34430160 DOI: 10.7759/cureus.16553] [Reference Citation Analysis]
418 Anoop TM, Prabhakaran PK. Impact of the COVID-19 Pandemic on Indian Cancer Patients. South Asian J Cancer 2021;10:49-50. [PMID: 34430520 DOI: 10.1055/s-0041-1733805] [Reference Citation Analysis]
419 Fraser S, Baranowski R, Patrini D, Nandi J, Al-Sahaf M, Smelt J, Hoffman R, Santhirakumaran G, Lee M, Wali A, Dickinson H, Jadoon M, Harrison-Phipps K, King J, Pilling J, Bille A, Okiror L, Stamenkovic S, Waller D, Wilson H, Jordan S, Begum S, Buderi S, Tan C, Hunt I, Vaughan P, Jenkins M, Hayward M, Lawrence D, Beddow E, Anikin V, Mani A, Finch J, Maheswaran H, Lim E, Routledge T, Lau K, Harling L. Maintaining safe lung cancer surgery during the COVID-19 pandemic in a global city. EClinicalMedicine 2021;39:101085. [PMID: 34430839 DOI: 10.1016/j.eclinm.2021.101085] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
420 Chen L, Zody MC, Di Germanio C, Martinelli R, Mediavilla JR, Cunningham MH, Composto K, Chow KF, Kordalewska M, Corvelo A, Oschwald DM, Fennessey S, Zetkulic M, Dar S, Kramer Y, Mathema B, Germer S, Stone M, Simmons G, Busch MP, Maniatis T, Perlin DS, Kreiswirth BN. Emergence of Multiple SARS-CoV-2 Antibody Escape Variants in an Immunocompromised Host Undergoing Convalescent Plasma Treatment. mSphere 2021;6:e0048021. [PMID: 34431691 DOI: 10.1128/mSphere.00480-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
421 Cona MS, Rulli E, Dalu D, Galli F, Rota S, Ferrario S, Tosca N, Gambaro A, Filipazzi V, Piva S, La Verde N. The emotional impact of the COVID-19 outbreak on cancer outpatients and their caregivers: results of a survey conducted in the midst of the Italian pandemic. Support Care Cancer 2021. [PMID: 34432171 DOI: 10.1007/s00520-021-06489-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
422 Cioffi R, Sabetta G, Rabaiotti E, Bergamini A, Bocciolone L, Candotti G, Candiani M, Valabrega G, Mangili G, Pignata S; MITO group. Impact of COVID-19 on medical treatment patterns in gynecologic oncology: a MITO group survey. Int J Gynecol Cancer 2021;31:1363-8. [PMID: 34426526 DOI: 10.1136/ijgc-2021-002784] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
423 Yamamoto A, Wada H, Ichikawa Y, Mizuno H, Tomida M, Masuda J, Makino K, Kodama S, Yoshida M, Fukui S, Moritani I, Inoue H, Shiraki K, Shimpo H. Evaluation of Biomarkers of Severity in Patients with COVID-19 Infection. J Clin Med 2021;10:3775. [PMID: 34501223 DOI: 10.3390/jcm10173775] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
424 Andreas M, Piechotta V, Skoetz N, Grummich K, Becker M, Joos L, Becker G, Meissner W, Boehlke C. Interventions for palliative symptom control in COVID-19 patients. Cochrane Database Syst Rev 2021;8:CD015061. [PMID: 34425019 DOI: 10.1002/14651858.CD015061] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
425 Lee IH, Koh SA, Lee SJ, Lee SA, Cho YY, Lee JY, Kim JY. Treatment decision for cancer patients with fever during the coronavirus disease 2019 (COVID-19) pandemic. Yeungnam Univ J Med 2021. [PMID: 34420277 DOI: 10.12701/yujm.2021.01144] [Reference Citation Analysis]
426 Sereno M, Jimenez-Gordo AM, Baena-Espinar J, Aguado C, Mielgo X, Pertejo A, Álvarez-Álvarez R, Sánchez A, López JL, Molina R, López-Alfonso A, Hernández B, Chiara LE, Martín AM, López-Martín A, Dorta M, Collazo-Lorduy A, Casado E, de Molina AR, Colmenarejo G. A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis. Cancers (Basel) 2021;13:4205. [PMID: 34439359 DOI: 10.3390/cancers13164205] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
427 Hoang T, Tran Thi Anh T. Comparison of Comorbidities in Relation to Critical Conditions among Coronavirus Disease 2019 Patients: A Network Meta-Analysis. Infect Chemother 2021;53:13-28. [PMID: 34409779 DOI: 10.3947/ic.2020.0136] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
428 Sawyers A, Chou M, Johannet P, Gulati N, Qian Y, Zhong J, Osman I. Clinical outcomes in cancer patients with COVID-19. Cancer Rep (Hoboken) 2021;4:e1413. [PMID: 34409775 DOI: 10.1002/cnr2.1413] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
429 Dell'Isola GB, Felicioni M, Ferraro L, Capolsini I, Cerri C, Gurdo G, Mastrodicasa E, Massei MS, Perruccio K, Brogna M, Mercuri A, Pasqua BL, Gorello P, Caniglia M, Verrotti A, Arcioni F. Case Report: Remdesivir and Convalescent Plasma in a Newly Acute B Lymphoblastic Leukemia Diagnosis With Concomitant Sars-CoV-2 Infection. Front Pediatr 2021;9:712603. [PMID: 34408997 DOI: 10.3389/fped.2021.712603] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
430 Nadkarni AR, Vijayakumaran SC, Gupta S, Divatia JV. Mortality in Cancer Patients With COVID-19 Who Are Admitted to an ICU or Who Have Severe COVID-19: A Systematic Review and Meta-Analysis. JCO Glob Oncol 2021;7:1286-305. [PMID: 34406802 DOI: 10.1200/GO.21.00072] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
431 Wagner C, Griesel M, Mikolajewska A, Mueller A, Nothacker M, Kley K, Metzendorf MI, Fischer AL, Kopp M, Stegemann M, Skoetz N, Fichtner F. Systemic corticosteroids for the treatment of COVID-19. Cochrane Database Syst Rev 2021;8:CD014963. [PMID: 34396514 DOI: 10.1002/14651858.CD014963] [Cited by in Crossref: 1] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
432 Nagarkar R, Roy S, Dhondge R, Adhav A, Manke A, Banswal L, Upwanshi M, Kulkarni N, Tandale R, Bang Y, Pasumarthi LS, Subramaniam A, Rajpari KN, Yajurvedi P, Ansari S, Wankhede B, Ramesh YV. Elective Surgical Experience During COVID Pandemic at a Tertiary Cancer Care Centre in India: A Retrospective Analysis. Indian J Surg Oncol 2021;:1-8. [PMID: 34421277 DOI: 10.1007/s13193-021-01403-8] [Reference Citation Analysis]
433 Russell B, Moss CL, Shah V, Ko TK, Palmer K, Sylva R, George G, Monroy-Iglesias MJ, Patten P, Ceesay MM, Benjamin R, Potter V, Pagliuca A, Papa S, Irshad S, Ross P, Spicer J, Kordasti S, Crawley D, Wylie H, Cahill F, Haire A, Zaki K, Sita-Lumsden A, Josephs D, Enting D, Swampillai A, Sawyer E, D'Souza A, Gomberg S, Harrison C, Fields P, Wrench D, Rigg A, Sullivan R, Kulasekararaj A, Dolly S, Van Hemelrijck M; Guy’s Cancer Real World Evidence. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London. Br J Cancer 2021. [PMID: 34400804 DOI: 10.1038/s41416-021-01500-z] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
434 Lima A, Sousa H, Nobre A, Faria AL, Machado M. The Impact of COVID-19 Pandemic in Portuguese Cancer Patients: A Retrospective Study. Int J Environ Res Public Health 2021;18:8552. [PMID: 34444302 DOI: 10.3390/ijerph18168552] [Reference Citation Analysis]
435 Shahil Feroz A, Ali NA, Feroz R, Akber N, Nazim Meghani S. Exploring community perceptions, attitudes and practices regarding the COVID-19 pandemic in Karachi, Pakistan. BMJ Open 2021;11:e048359. [PMID: 34389572 DOI: 10.1136/bmjopen-2020-048359] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
436 Decker KM, Lambert P, Feely A, Bucher O, Kim JO, Hebbard P, Thiessen M, Fatoye T, Pitz M, Koul R, Czaykowski P. Evaluating the Impact of the COVID-19 Pandemic on New Cancer Diagnoses and Oncology Care in Manitoba. Curr Oncol 2021;28:3081-90. [PMID: 34436035 DOI: 10.3390/curroncol28040269] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
437 Tehrani DM, Wang X, Rafique AM, Hayek SS, Herrmann J, Neilan TG, Desai P, Morgans A, Lopez-Mattei J, Parikh RV, Yang EH. Impact of cancer and cardiovascular disease on in-hospital outcomes of COVID-19 patients: results from the american heart association COVID-19 cardiovascular disease registry. Cardiooncology 2021;7:28. [PMID: 34372948 DOI: 10.1186/s40959-021-00113-y] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
438 Johnson BA, Hui JYC. ASO Author Reflections: The Patient Perspective of Telemedicine in Breast Cancer Care. Ann Surg Oncol 2021. [PMID: 34373966 DOI: 10.1245/s10434-021-10592-z] [Reference Citation Analysis]
439 Manlubatan SIT, Lopez MPJ, Onglao MAS, Monroy Iii HJ. Modifications to Treatment Plan of Rectal Cancer in Response to COVID-19 at the Philippine General Hospital. Ann Coloproctol 2021;37:225-31. [PMID: 34364319 DOI: 10.3393/ac.2021.00381.0054] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
440 Chowdhoury SR, Biswas HS, Raut S, Bhakta S, Roy A, Banerjee S, Nandi M. Pediatric Oncology Patients and COVID-19: An Experience from the Tertiary COVID Care Facility in Eastern India: A Prospective Observational Study. Indian J Med Paediatr Oncol 2021;42:130-4. [DOI: 10.1055/s-0041-1732814] [Reference Citation Analysis]
441 Agarwal A, Baghmar S, Qureshi S, Khurana A, Setia R, Khan MA, Barman P, Kapoor RK, Hasthavaram NR, Kumar R, Singh N, Sarin A, Handoo A. Persistent Antibody Responses to SARS-CoV-2 Infection in Cancer Patients: A Single-Center Retrospective Observational Study. Indian J Med Paediatr Oncol 2021;42:123-9. [DOI: 10.1055/s-0041-1733823] [Reference Citation Analysis]
442 Huang Y, Rivero-Hinojosa S, Ma Y, Yang F, Fu D. RE: Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst 2021;113:1109-10. [PMID: 34341829 DOI: 10.1093/jnci/djab085] [Reference Citation Analysis]
443 Zhou Y, Yang Q, Ye J, Wu X, Hou X, Feng Y, Luo B, Li J, Yang G, Li L, Yang X, Wang B, Zhao S, Li L, Li Q, Xu Z, Wu H, Sun J. Clinical features and death risk factors in COVID-19 patients with cancer: a retrospective study. BMC Infect Dis 2021;21:760. [PMID: 34353293 DOI: 10.1186/s12879-021-06495-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
444 Tlemsani C, Arrondeau J, De Percin S, Gataa I, Bretagne M, Ajgal Z, Huillard O, Wislez M, Coriat R, Alexandre J, Boudou-Rouquette P, Goldwasser F. Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris. Clin Med (Lond) 2021;21:e552-5. [PMID: 34341004 DOI: 10.7861/clinmed.2020-0666] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
445 Safari M, Faradmal J, Bashirian S, Soltanian AR, Khazaei S, Roshanaei G. Identifying the Risk Factors for Mortality in Patients with Cancer and COVID-19 in Hamadan, the West of Iran. J Gastrointest Cancer 2021. [PMID: 34347248 DOI: 10.1007/s12029-021-00677-z] [Reference Citation Analysis]
446 Suárez-García I, Perales-Fraile I, González-García A, Muñoz-Blanco A, Manzano L, Fabregate M, Díez-Manglano J, Aizpuru EF, Fernández FA, García AG, Gómez-Huelgas R, Ramos-Rincón JM; SEMI-COVID-19 Network. In-hospital mortality among immunosuppressed patients with COVID-19: Analysis from a national cohort in Spain. PLoS One 2021;16:e0255524. [PMID: 34343222 DOI: 10.1371/journal.pone.0255524] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
447 Tang M, Daniels B, Aslam M, Schaffer A, Pearson SA. Changes in systemic cancer therapy in Australia during the COVID-19 pandemic: a population-based study. Lancet Reg Health West Pac 2021;:100226. [PMID: 34368796 DOI: 10.1016/j.lanwpc.2021.100226] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
448 Duntas LH, Jonklaas J. COVID-19 and Thyroid Diseases: A Bidirectional Impact. J Endocr Soc 2021;5:bvab076. [PMID: 34189381 DOI: 10.1210/jendso/bvab076] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
449 Hulikal N, Kumar SN, Gopinath KS. Surgery for Cancer in the Wake of Second and Future Waves! Challenges and Opportunities in the Indian Context. Indian J Surg Oncol 2021;:1-5. [PMID: 34345154 DOI: 10.1007/s13193-021-01392-8] [Reference Citation Analysis]
450 Carvalho TP, Trinca F, Cardoso T, Dinis R. Haemodialysed patient with lung cancer in the COVID-19 era: a clinical challenge. BMJ Case Rep 2021;14:e243462. [PMID: 34326113 DOI: 10.1136/bcr-2021-243462] [Reference Citation Analysis]
451 Rashid S, Reeder C, Sahu S, Rashid S. Psychological distress and moral injury to oncologists and their patients during COVID-19 pandemic. Curr Psychol 2021;:1-6. [PMID: 34341650 DOI: 10.1007/s12144-021-02128-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
452 Singh A, Bhardwaj A, Ravichandran N, Malhotra M. Surviving COVID-19 and multiple complications post total laryngectomy. BMJ Case Rep 2021;14:e244277. [PMID: 34321272 DOI: 10.1136/bcr-2021-244277] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
453 Ballatore Z, Merloni F, Ranallo N, Bastianelli L, Vitarelli F, Cantini L, Ricci G, Ferretti B, Alessandroni P, Del Prete M, Chiorrini S, Safi M, Ficarelli R, Benedetti G, Faloppi L, Marcellini M, Stoico R, Berardi R. Cancer patient perspective in the arena of COVID-19 pandemic. Psychooncology 2021. [PMID: 34315188 DOI: 10.1002/pon.5774] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
454 Xie J, Qi W, Cao L, Tan Y, Huang J, Gu X, Chen B, Shen P, Zhao Y, Zhang Y, Zhao Q, Huang H, Wang Y, Fang H, Jin Z, Li H, Zhao X, Qian X, Xu F, Ou D, Wang S, Xu C, Li M, Jiang Z, Wang Y, Huang X, Chen J. Predictors for Fear of Cancer Recurrence in Breast Cancer Patients Referred to Radiation Therapy During the COVID-19 Pandemic: A Multi-Center Cross-Section Survey. Front Oncol 2021;11:650766. [PMID: 34381703 DOI: 10.3389/fonc.2021.650766] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
455 Corvol H, Alimi A, Prevost B, Schnuriger A, Le Pointe HD, Rambaud J, Tabone MD. Atypical severe organizing pneumonia following COVID-19 in an immunocompromised teenager. Clin Infect Dis 2021:ciab657. [PMID: 34309637 DOI: 10.1093/cid/ciab657] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
456 Tang G, Zhang L, Huang W, Wei Z. Could Immunonutrition Help in the Fight against COVID-19 in Cancer Patient? Nutr Cancer 2021;:1-10. [PMID: 34309463 DOI: 10.1080/01635581.2021.1957128] [Reference Citation Analysis]
457 Zhao H, Zhou A, Zhou J, Bi X, Yan S, Jin J, Wei W, Li M, Gong C, Chen Q, Luo Z, Li N, Mao R, Chen X, Chen B, Zheng R, Zhao J, Han Y, Li Z, Che X, Tang Y, Sun Y, Huang Z, Zhang Y, Wang X, Zhang Y, Lu Z, Dang X, Song T, Liu C, Yue P, Yan D, Yue A, Zhang R, Luo S, Tan J, Zhang X, Bai X, Zhang X, He M, Xie Y, Wang W, Yang P, Yang Y, Zhang Y, Li Q, Peng T, Wang Z, Chen Y, Shang C, Liang Y, Zhang B, Zhang F, Wang L, Li D, Liu B, Zhu X, Hu Q, Chen M, Xiu D, Xia F, Zhang Y, Zeng Y, Mao Y, Li X, Ba Y, Liang T, Shen F, Liu L, Cai X, Zhou J, Cai J. Chinese expert recommendations on management of hepatocellular carcinoma during COVID-19 pandemic: a nationwide multicenter survey. HPB (Oxford) 2021:S1365-182X(21)00633-X. [PMID: 34400051 DOI: 10.1016/j.hpb.2021.07.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
458 Sinha S, Kundu CN. Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19? Med Oncol 2021;38:101. [PMID: 34302557 DOI: 10.1007/s12032-021-01553-3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
459 Maio M, Lahn M, Di Giacomo AM, Covre A, Calabrò L, Ibrahim R, Fox B; Siena Think Tank. A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation. J Exp Clin Cancer Res 2021;40:240. [PMID: 34301276 DOI: 10.1186/s13046-021-02023-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
460 García-Granja PE, Veras C, Aparisi Á, Amat-Santos IJ, Catalá P, Marcos M, Cabezón G, Candela J, Gil JF, Uribarri A, Revilla A, Carrasco M, Gómez I, San Román JA. Atrial fibrillation in patients with SARS-CoV-2 infection. Med Clin (Engl Ed) 2021;157:58-63. [PMID: 34307884 DOI: 10.1016/j.medcle.2021.01.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Coelho DB, Santos V, Araújo D, Bastos HN, Magalhães A, Hespanhol V, Queiroga H, Cruz-Martins N, Fernandes MGO. Management of Coronavirus Disease 2019 Patients With Lung Cancer: Experience From a Thoracic Oncology Center. Front Mol Biosci 2021;8:639676. [PMID: 34368223 DOI: 10.3389/fmolb.2021.639676] [Reference Citation Analysis]
462 Chuang YC, Tung TH, Chen JY, Chien CW, Shen KY. Exploration of the Relationship Among Key Risk Factors of Acute Kidney Injury for Elderly Patients Considering Covid-19. Front Med (Lausanne) 2021;8:639250. [PMID: 34368176 DOI: 10.3389/fmed.2021.639250] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
463 Bernstein AN, Talwar R, Handorf E, Syed K, Danella J, Ginzburg S, Belkoff L, Reese AC, Tomaszewski J, Trabulsi E, Singer EA, Jacobs B, Kutikov A, Uzzo R, Raman JD, Guzzo T, Smaldone MC, Correa A. Assessment of Prostate Cancer Treatment Among Black and White Patients During the COVID-19 Pandemic. JAMA Oncol 2021. [PMID: 34292311 DOI: 10.1001/jamaoncol.2021.2755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
464 Mokhtari RB, Sambi M, Qorri B, Baluch N, Ashayeri N, Kumar S, Cheng HM, Yeger H, Das B, Szewczuk MR. The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. Cancers (Basel) 2021;13:3596. [PMID: 34298809 DOI: 10.3390/cancers13143596] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
465 Johnson BA, Lindgren BR, Blaes AH, Parsons HM, LaRocca CJ, Farah R, Hui JYC. The New Normal? Patient Satisfaction and Usability of Telemedicine in Breast Cancer Care. Ann Surg Oncol 2021;28:5668-76. [PMID: 34275045 DOI: 10.1245/s10434-021-10448-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
466 Nigro O, Sironi G, Bergamaschi L, Gattuso G, Puma N, Livellara V, Chiaravalli S, Ferrari A, Massimino M. SARS-CoV-2 vaccination for adolescents and young adult patients treated at a specialist pediatric oncology unit. Pediatr Blood Cancer 2021;68:e29240. [PMID: 34264546 DOI: 10.1002/pbc.29240] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
467 Varettoni M, Mangiacavalli S, Rattotti S, Cartia CS, Cavalloni C, Rossetti F, Ferretti VV, Bergamini F, Trotti C, Fiorelli N, Pagani G, Zerbi C, Ferrari J, Cristinelli C, Muzzi A, Marena C, Baldanti F, Bruno R, Arcaini L. Systematic screening for SARS-CoV-2 in patients with hematological malignancies on active anticancer treatment in the outpatient setting. Leuk Lymphoma 2021;62:3311-2. [PMID: 34261423 DOI: 10.1080/10428194.2021.1953019] [Reference Citation Analysis]
468 Chan WL, Ho YT, Wong CK, Choi HC, Lam KO, Yuen KK, Kwong D, Hung I. Acceptance of COVID-19 Vaccination in Cancer Patients in Hong Kong: Approaches to Improve the Vaccination Rate. Vaccines (Basel) 2021;9:792. [PMID: 34358208 DOI: 10.3390/vaccines9070792] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
469 Li C, He Q, Qian H, Liu J. Overview of the pathogenesis of COVID-19 (Review). Exp Ther Med 2021;22:1011. [PMID: 34345293 DOI: 10.3892/etm.2021.10444] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
470 Galsky MD, Balar AV, Black PC, Campbell MT, Dykstra GS, Grivas P, Gupta S, Hoimes CJ, Lopez LP, Meeks JJ, Plimack ER, Rosenberg JE, Shore N, Steinberg GD, Kamat AM. Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer. J Immunother Cancer 2021;9:e002552. [PMID: 34266883 DOI: 10.1136/jitc-2021-002552] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
471 Ren H, Guo X, Palazón-Bru A, Yang P, Huo N, Wang R, Sun Y, Hu Q, Yang H, Xu G. Regional Differences in Epidemiological and Clinical Characteristics, Treatment, and Clinical Outcomes of COVID-19 in Wuhan and Remote Areas of Hubei Province. Front Med (Lausanne) 2021;8:667623. [PMID: 34336881 DOI: 10.3389/fmed.2021.667623] [Reference Citation Analysis]
472 Aboueshia M, Hussein MH, Attia AS, Swinford A, Miller P, Omar M, Toraih EA, Saba N, Safah H, Duchesne J, Kandil E. Cancer and COVID-19: analysis of patient outcomes. Future Oncol 2021. [PMID: 34263660 DOI: 10.2217/fon-2021-0121] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
473 Estedlal A, Jeddi M, Heydari ST, Jahromi MG, Dabbaghmanesh MH. Impacts of diabetes mellitus on clinical and para-clinical parameters among COVID-19 patients. J Diabetes Metab Disord 2021;:1-9. [PMID: 34277497 DOI: 10.1007/s40200-021-00844-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
474 Reidy-Lagunes D, Saltz L, Postow M, Scordo M, Moskowitz A, Tew W, Zamarin D, Redelman-Sidi G. Recommendations for Testing and Treating Outpatient Cancer Patients in the Era of COVID-19. J Natl Cancer Inst 2021;113:820-2. [PMID: 32797188 DOI: 10.1093/jnci/djaa111] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
475 Lyman GH, Kuderer NM, Aapro M. Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era. Front Oncol 2021;11:697908. [PMID: 34307165 DOI: 10.3389/fonc.2021.697908] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
476 Goshen-Lago T, Waldhorn I, Holland R, Szwarcwort-Cohen M, Reiner-Benaim A, Shachor-Meyouhas Y, Hussein K, Fahoum L, Baruch M, Peer A, Reiter Y, Almog R, Halberthal M, Ben-Aharon I. Serologic Status and Toxic Effects of the SARS-CoV-2 BNT162b2 Vaccine in Patients Undergoing Treatment for Cancer. JAMA Oncol 2021. [PMID: 34236381 DOI: 10.1001/jamaoncol.2021.2675] [Cited by in Crossref: 2] [Cited by in F6Publishing: 59] [Article Influence: 2.0] [Reference Citation Analysis]
477 Inchingolo R, Acquafredda F, Tedeschi M, Laera L, Surico G, Surgo A, Fiorentino A, Spiliopoulos S, de’Angelis N, Memeo R. Worldwide management of hepatocellular carcinoma during the COVID-19 pandemic. World J Gastroenterol 2021; 27(25): 3780-3789 [PMID: 34321843 DOI: 10.3748/wjg.v27.i25.3780] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
478 Wu T, Kang S, Peng W, Zuo C, Zhu Y, Pan L, Fu K, You Y, Yang X, Luo X, Jiang L, Deng M. Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19). Front Med (Lausanne) 2021;8:702066. [PMID: 34295915 DOI: 10.3389/fmed.2021.702066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
479 Raman R, Patel KJ, Ranjan K. COVID-19: Unmasking Emerging SARS-CoV-2 Variants, Vaccines and Therapeutic Strategies. Biomolecules 2021;11:993. [PMID: 34356617 DOI: 10.3390/biom11070993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 48] [Article Influence: 1.0] [Reference Citation Analysis]
480 Kattan J, Assi T. COVID-19 pandemic shakes the trust between oncologists and their patients. Int J Clin Pract 2021;:e14556. [PMID: 34224190 DOI: 10.1111/ijcp.14556] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
481 da Silva HEC, Santos GNM, Leite AF, Mesquita CRM, de Souza Figueiredo PT, Dos Reis PED, Stefani CM, de Melo NS. The role of teledentistry in oral cancer patients during the COVID-19 pandemic: an integrative literature review. Support Care Cancer 2021. [PMID: 34219196 DOI: 10.1007/s00520-021-06398-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
482 Ferrara M, Langiano E, Falese L, De Marco A, De Vito E. Quality of Life and Psychosocial Impacts of the Different Restrictive Measures during One Year into the COVID-19 Pandemic on Patients with Cancer in Italy: An Ecological Study. Int J Environ Res Public Health 2021;18:7161. [PMID: 34281098 DOI: 10.3390/ijerph18137161] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
483 Pan S, Jiang J, Chen Z, Yang L. Management and Thinking on the Treatment of Cancer Patients During the COVID-19. Front Mol Biosci 2021;8:673360. [PMID: 34277701 DOI: 10.3389/fmolb.2021.673360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
484 Ioannou GN, Liang PS, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Fan VS, Dominitz JA. Cirrhosis and Severe Acute Respiratory Syndrome Coronavirus 2 Infection in US Veterans: Risk of Infection, Hospitalization, Ventilation, and Mortality. Hepatology 2021;74:322-35. [PMID: 33219546 DOI: 10.1002/hep.31649] [Cited by in Crossref: 20] [Cited by in F6Publishing: 31] [Article Influence: 20.0] [Reference Citation Analysis]
485 Kirienko M, Telo S, Hustinx R, Bomanji JB, Chiti A, Fanti S. The Impact of COVID-19 on Nuclear Medicine in Europe. Semin Nucl Med 2021:S0001-2998(21)00054-4. [PMID: 34325819 DOI: 10.1053/j.semnuclmed.2021.06.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
486 Unger JM, Xiao H, LeBlanc M, Hershman DL, Blanke CD. Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic. JAMA Netw Open 2021;4:e2118433. [PMID: 34323986 DOI: 10.1001/jamanetworkopen.2021.18433] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
487 Allali S, Beddok A, Kirova Y. Is cancer a prognostic factor for severe COVID-19, especially for breast cancer patients? Cancer Radiother 2021:S1278-3218(21)00114-1. [PMID: 34274225 DOI: 10.1016/j.canrad.2021.06.015] [Reference Citation Analysis]
488 Lara Gongora AB, Werutsky G, Jardim DL, Nogueira-Rodrigues A, Barrios CH, Mathias C, Maluf F, Riechelmann R, Fraga M, Gomes H, William WN, Yamada CAF, de Castro G Jr, Rosa DD, de Melo AC, Sala R, Bustamante E, Bretel D, Arrieta O, Cardona AF, Bastos DA. Impact of the COVID-19 Pandemic on Oncology Clinical Research in Latin America (LACOG 0420). JCO Glob Oncol 2021;7:649-58. [PMID: 33956499 DOI: 10.1200/GO.20.00663] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
489 Vasiliadou I, Noble D, Hartley A, Moleron R, Sanghera P, Urbano TG, Schipani S, Gujral D, Foran B, Bhide S, Haridass A, Nathan K, Michaelidou A, Sen M, Geropantas K, Joseph M, O'Toole L, Griffin M, Pettit L, Chambers J, Jankowska P, De Winton E, Goranova R, Singh N, Shah K, Kong Conceptualisation A. A multi-centre survey reveals variations in the standard treatments and treatment modifications for head and neck cancer patients during Covid-19 pandemic. Clin Transl Radiat Oncol 2021;30:50-9. [PMID: 34226880 DOI: 10.1016/j.ctro.2021.06.002] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
490 Rades D, Narvaez CA, Schild SE, Tvilsted S, Kjaer TW. Sleep Disorders Before and During the COVID-19 Pandemic in Patients Assigned to Adjuvant Radiotherapy for Breast Cancer. In Vivo 2021;35:2253-60. [PMID: 34182504 DOI: 10.21873/invivo.12498] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
491 Pişkin E, Kadri Çolakoglu M, Öter V, Mehmet Özgün Y, Aydın O, Güven A, Ahmet Sürel A, Özmen MM, Birol Bostancı E. How can surgical continuity be maintained during the COVID-19 pandemic? A quality improvement study in the pre-vaccination period. Turk J Surg 2021;37:156-61. [DOI: 10.47717/turkjsurg.2021.5226] [Reference Citation Analysis]
492 Liu L, She J, Bai Y, Liu W. SARS-CoV-2 Infection: Differences in Hematological Parameters Between Adults and Children. Int J Gen Med 2021;14:3035-47. [PMID: 34234532 DOI: 10.2147/IJGM.S313860] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
493 Benedicto A, García-Kamiruaga I, Arteta B. Neuropilin-1: A feasible link between liver pathologies and COVID-19. World J Gastroenterol 2021; 27(24): 3516-3529 [PMID: 34239266 DOI: 10.3748/wjg.v27.i24.3516] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 3] [Article Influence: 7.0] [Reference Citation Analysis]
494 Gaitzsch E, Passerini V, Khatamzas E, Strobl CD, Muenchhoff M, Scherer C, Osterman A, Heide M, Reischer A, Subklewe M, Leutbecher A, Tast B, Ruhle A, Weiglein T, Stecher SS, Stemmler HJ, Dreyling M, Girl P, Georgi E, Wölfel R, Mateyka L, D'Ippolito E, Schober K, Busch DH, Kager J, Spinner CD, Treiber M, Rasch S, Lahmer T, Iakoubov R, Schneider J, Protzer U, Winter C, Ruland J, Quante M, Keppler OT, von Bergwelt-Baildon M, Hellmuth J, Weigert O. COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma. Hemasphere 2021;5:e603. [PMID: 34235400 DOI: 10.1097/HS9.0000000000000603] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
495 Reddy R. Imaging diagnosis of bronchogenic carcinoma (the forgotten disease) during times of COVID-19 pandemic: Current and future perspectives. World J Clin Oncol 2021; 12(6): 437-457 [PMID: 34189068 DOI: 10.5306/wjco.v12.i6.437] [Reference Citation Analysis]
496 Haghani M, Varamini P. Temporal evolution, most influential studies and sleeping beauties of the coronavirus literature. Scientometrics 2021;:1-46. [PMID: 34188334 DOI: 10.1007/s11192-021-04036-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
497 Hanna E. How fragile we are. Head Neck 2020;42:1355-60. [PMID: 32633092 DOI: 10.1002/hed.26366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
498 Turkdogan S, Schnitman G, Wang T, Gotlieb R, How J, Gotlieb WH. Development of a Digital Patient Education Tool for Patients With Cancer During the COVID-19 Pandemic. JMIR Cancer 2021;7:e23637. [PMID: 34101611 DOI: 10.2196/23637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
499 Zheng JY, Mixon AC, McLarney MD. Safety, Precautions, and Modalities in Cancer Rehabilitation: an Updated Review. Curr Phys Med Rehabil Rep 2021;:1-12. [PMID: 34178432 DOI: 10.1007/s40141-021-00312-9] [Reference Citation Analysis]
500 Lozano-Sanchez F, Ursu R, Di-Stefano AL, Ducray F, Younan N, Touat M, Groh M, Agguini H, Belin C, Garnier L, Delattre JY, Carpentier A, Idbaih A. Descriptive and retrospective analysis of diffuse glioma patients with symptomatic SARS-CoV2 infection during the first wave of the pandemic. Neurooncol Adv 2021;3:vdab078. [PMID: 34396128 DOI: 10.1093/noajnl/vdab078] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
501 Perkons NR, Kim C, Boedec C, Keele LJ, Schneider C, Teitelbaum UR, Ben-Josef E, Gabriel PE, Plastaras JP, Shulman LN, Wojcieszynski AP. Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery. Cancer Rep (Hoboken) 2021;:e1427. [PMID: 34137216 DOI: 10.1002/cnr2.1427] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
502 Liberale G, Van Veer H, Lemaitre J, Duinslager M, Ysebaert D, De Roover A, de Gheldere C, Komen N. Impact of the first wave of the SARS-CoV-2/Covid-19 pandemic on digestive surgical activities: a Belgian National Survey. Acta Chir Belg 2021;:1-7. [PMID: 34077296 DOI: 10.1080/00015458.2021.1894735] [Reference Citation Analysis]
503 Samper Ots PM, Zapatero Ortuño J, Pedraza Fernández S, Mayrata Canellas E, González San Segundo C, Campo Vargas M, Caballero B, Ramos Albiac M, Vázquez Masedo G, Álvarez B, Rodríguez Villalba S, Muñoz Miguelañez T, Diezhandino Garcia P, Sancho G, Guzmán Gómez L, Tripero J, Rico Oses MR, Ibañez Villoslada C, Soler Rodríguez AMS, Chust ML, Fondevilla Soler A, Lozano Martin EM, Morillo Macias V, Fuentes Sánchez C, Torrado Moya L, Fernández López J, Solé JM, Guijarro Verdú M, Mira Flores M, Wals A, Expósito Hernández J. Impact of covid-19 on patients in radiotherapy oncology departaments in Spain. Radiother Oncol 2021;161:148-51. [PMID: 34118358 DOI: 10.1016/j.radonc.2021.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
504 Kiani A, Roesch R, Wendtner CM, Kullmann F, Kubin T, Südhoff T, Augustin M, Schaich M, Müller-Naendrup C, Illerhaus G, Hartmann F, Hebart H, Seggewiss-Bernhardt R, Bentz M, Späth-Schwalbe E, Reimer P, Kaiser U, Kapp M, Graeven U, Chemnitz JM, Baesecke J, Lambertz H, Naumann R. Preinfection laboratory parameters may predict COVID-19 severity in tumor patients. Cancer Med 2021;10:4424-36. [PMID: 34121360 DOI: 10.1002/cam4.4023] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
505 Clerico M, Dogliotti I, Calcagno A, Grimaldi D, Leone S, Ragaini S, Boffini M, Caracciolo D, Ferrero S, Barbero C, Zanotto E, Stroffolini G, Cavallo R, Rinaldi M, Bruno B, Cavallo F. COVID-19 in a Post-transplant Heart Recipient Who Developed Aggressive Lymphoma: A Biphasic Course During Rituximab Treatment. Hemasphere 2021;5:e592. [PMID: 34131632 DOI: 10.1097/HS9.0000000000000592] [Reference Citation Analysis]
506 Shumilov E, Hoffknecht P, Koch R, Peceny R, Voigt S, Schmidt N, Peeck M, Bacher U, Scheithauer S, Trümper L, Lenz G, Kerkhoff A, Bleckmann A. Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers. Cancers (Basel) 2021;13:2917. [PMID: 34208007 DOI: 10.3390/cancers13122917] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
507 Alkadi MM, Al-Malki HA, Asim M, Fituri OM, Hamdi AF, Elidrisi RI, Abdul Rahiman R, Elshirbeny MF, Othman MA, Nauman A, Ashour A, Ghonimi TA, Tohid H, Jarman ME, Hamad A, Elshazly MB, Abuhelaiqa E. Kidney Transplant Recipients Infected With Coronavirus Disease 2019: Retrospective Qatar Experience. Transplant Proc 2021:S0041-1345(21)00405-X. [PMID: 34275597 DOI: 10.1016/j.transproceed.2021.06.001] [Reference Citation Analysis]
508 Yue J, Jin W, Yang H, Faulkner J, Song X, Qiu H, Teng M, Azadi P, Zhang F, Linhardt RJ, Wang L. Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer. Front Mol Biosci 2021;8:649575. [PMID: 34179075 DOI: 10.3389/fmolb.2021.649575] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
509 Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Patients with hematologic cancers are more vulnerable to COVID-19 compared to patients with solid cancers. Intern Emerg Med 2021. [PMID: 34110562 DOI: 10.1007/s11739-021-02784-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
510 Kuryba A, Boyle JM, Blake HA, Aggarwal A, van der Meulen J, Braun M, Walker K, Fearnhead NS. Surgical Treatment and Outcomes of Colorectal Cancer Patients During the COVID-19 Pandemic: A National Population-based Study in England. Ann Surg Open 2021;2:e071. [PMID: 34240077 DOI: 10.1097/AS9.0000000000000071] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
511 Payet E, Perez J, Sarria G, Neciosup S, Berrospi F, Vilchez S, Dunstan J, Perez R, Vassallo M, Salgado S, Caparachín N, Pinto JA, Holguin A. Characteristics of COVID-19 in cancer patients: a cross-sectional study in Peru. Ecancermedicalscience 2021;15:1246. [PMID: 34267802 DOI: 10.3332/ecancer.2021.1246] [Reference Citation Analysis]
512 El Cheikh J, El Warrak S, Ghaoui N, Al Chami F, Shahbaz M, Chehayeb S, Saghir N, Bazarbachi A, Taher A. Implemented Interventions at the Naef K. Basile Cancer Institute to Protect Patients and Medical Personnel From COVID Infections: Effectiveness and Patient Satisfaction. Front Oncol 2021;11:685107. [PMID: 34195088 DOI: 10.3389/fonc.2021.685107] [Reference Citation Analysis]
513 Cen C, Shiau MC, Adams S, Schnabel F, Guth A. A case report of COVID-19 in an asymptomatic patient with newly diagnosed breast cancer. Clin Case Rep 2021;9:e03532. [PMID: 34136222 DOI: 10.1002/ccr3.3532] [Reference Citation Analysis]
514 Heimes D, Müller LK, Schellin A, Naujokat H, Graetz C, Schwendicke F, Goedecke M, Beck-Broichsitter B, Kämmerer PW. Consequences of the COVID-19 Pandemic and Governmental Containment Policies on the Detection and Therapy of Oral Malignant Lesions-A Retrospective, Multicenter Cohort Study from Germany. Cancers (Basel) 2021;13:2892. [PMID: 34207863 DOI: 10.3390/cancers13122892] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
515 Emard N, Lynch KA, Liou KT, Atkinson T, Green AK, Daly B, Trevino K, Mao JJ. Virtual Mind-Body Programming for Patients With Cancer During the COVID-19 Pandemic: Qualitative Study. JMIR Cancer 2021;7:e27384. [PMID: 33882018 DOI: 10.2196/27384] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
516 Aciksari G, Cetinkal G, Kocak M, Cag Y, Atici A, Altunal LN, Barman HA, Aydın M, Kocas BB, Cam G, Guclu KG, Caliskan M. Evaluation of Modified ATRIA Risk Score in Predicting Mortality in Hospitalized Patients with COVID-19. Am J Med Sci 2021:S0002-9629(21)00214-7. [PMID: 34107275 DOI: 10.1016/j.amjms.2021.06.001] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
517 Akama-Garren EH, Li JX. Unbiased identification of clinical characteristics predictive of COVID-19 severity. Clin Exp Med 2021. [PMID: 34089403 DOI: 10.1007/s10238-021-00730-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
518 Sharafeldin N, Bates B, Song Q, Madhira V, Yan Y, Dong S, Lee E, Kuhrt N, Shao YR, Liu F, Bergquist T, Guinney J, Su J, Topaloglu U. Outcomes of COVID-19 in Patients With Cancer: Report From the National COVID Cohort Collaborative (N3C). J Clin Oncol 2021;39:2232-46. [PMID: 34085538 DOI: 10.1200/JCO.21.01074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
519 Fillmore NR, La J, Szalat RE, Tuck DP, Nguyen V, Yildirim C, Do NV, Brophy MT, Munshi NC. Prevalence and outcome of COVID-19 infection in cancer patients: a national Veterans Affairs study. J Natl Cancer Inst. 2020;. [PMID: 33031532 DOI: 10.1093/jnci/djaa159] [Cited by in Crossref: 12] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
520 Marcacci G, Fiorentino G, Volzone F, Falcone U, Parrella R, Donnarumma D, D'Ovidio S, Annunziata A, Micallo G, Portella G, De Chiara A, De Filippi R, Crisci S, Pinto A. Atypical COVID-19 dynamics in a patient with mantle cell lymphoma exposed to rituximab. Infect Agent Cancer 2021;16:38. [PMID: 34078415 DOI: 10.1186/s13027-021-00376-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
521 Chen YJ, Jian WH, Liang ZY, Guan WJ, Liang WH, Chen RC, Tang CL, Wang T, Liang HR, Li YM, Liu XQ, Sang L, Cheng LL, Ye F, Li SY, Zhang NF, Zhang Z, Fang Y, He JX, Zhong NS, Zheng JP. Earlier diagnosis improves COVID-19 prognosis: a nationwide retrospective cohort analysis. Ann Transl Med 2021;9:941. [PMID: 34350256 DOI: 10.21037/atm-20-7210] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
522 Martinez MA, Franco S. Impact of COVID-19 in Liver Disease Progression. Hepatol Commun 2021. [PMID: 34222744 DOI: 10.1002/hep4.1745] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
523 Stöss C, Steffani M, Pergolini I, Hartmann D, Radenkovic D, Novotny A, Friess H, Müller MW. Impact of the COVID-19 Pandemic on Surgical Oncology in Europe: Results of a European Survey. Dig Surg 2021;:1-7. [PMID: 34058733 DOI: 10.1159/000515186] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
524 Almas T, Goraya MHN, Tarar ZI, Khedro T, Ehtesham M, Malik U, Al-Awaid AH, Niaz MA, Alshaikh L, Rifai A. The travails of therapeutic modifications in cancer care amidst the COVID-19 pandemic: Future directions and lessons learned. Ann Med Surg (Lond) 2021;66:102411. [PMID: 34094529 DOI: 10.1016/j.amsu.2021.102411] [Reference Citation Analysis]
525 Viansone AA, Ammari S, Dercle L, Arnedos M. Optimizing the Management of Cancer Patients Treated With Systemic Therapies During the COVID-19 Pandemic: The New Role of PCR and CT Scan. Front Oncol 2021;11:560585. [PMID: 34123768 DOI: 10.3389/fonc.2021.560585] [Reference Citation Analysis]
526 Signorello A, Lenci I, Milana M, Grassi G, Baiocchi L. COVID-19 in normal, diseased and transplanted liver. World J Gastroenterol 2021; 27(20): 2576-2585 [PMID: 34092976 DOI: 10.3748/wjg.v27.i20.2576] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
527 Drury A, Eicher M, Dowling M. Experiences of cancer care during COVID-19: Phase 1 results of a longitudinal qualitative study. Int J Nurs Stud Adv 2021;3:100030. [PMID: 34075361 DOI: 10.1016/j.ijnsa.2021.100030] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
528 Fancellu A, Sanna V, Scognamillo F, Feo CF, Vidili G, Nigri G, Porcu A. Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations. World J Clin Cases 2021; 9(15): 3517-3530 [PMID: 34046452 DOI: 10.12998/wjcc.v9.i15.3517] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
529 Dehghan M, Namjoo Z, Zarei A, Tajedini H, Bahrami A, Zakeri MA. The Relationship between Coronavirus Anxiety, Mindfulness and Spiritual Health in Patients with Cancer: A Survey in Southeast Iran. Psychiatry Investig 2021;18:443-52. [PMID: 34053210 DOI: 10.30773/pi.2020.0441] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
530 Riches JC. Impact of COVID-19 in patients with lymphoid malignancies. World J Virol 2021; 10(3): 97-110 [PMID: 34079692 DOI: 10.5501/wjv.v10.i3.97] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
531 Li H, Li J, Xiao W, Zhang Y, Lv Y, Yu X, Zheng J. The Therapeutic Potential of Galectin-3 in the Treatment of Intrahepatic Cholangiocarcinoma Patients and Those Compromised With COVID-19. Front Mol Biosci 2021;8:666054. [PMID: 34109213 DOI: 10.3389/fmolb.2021.666054] [Reference Citation Analysis]
532 Stroehlein JK, Wallqvist J, Iannizzi C, Mikolajewska A, Metzendorf MI, Benstoem C, Meybohm P, Becker M, Skoetz N, Stegemann M, Piechotta V. Vitamin D supplementation for the treatment of COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;5:CD015043. [PMID: 34029377 DOI: 10.1002/14651858.CD015043] [Cited by in Crossref: 5] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
533 Greco R, Alexander T, Burman J, Del Papa N, de Vries-Bouwstra J, Farge D, Henes J, Kazmi M, Kirgizov K, Muraro PA, Ricart E, Rovira M, Saccardi R, Sharrack B, Snarski E, Withers B, Jessop H, Boglione C, Kramer E, Badoglio M, Labopin M, Orchard K, Corbacioglu S, Ljungman P, Mikulska M, De la Camara R, Snowden JA; European Society for Blood and Marrow Transplantation (EBMT) Autoimmune Diseases Working Party (ADWP), Infectious Diseases Working Party (IDWP), Pediatric Working Party (PWP), Joint Accreditation Committee of the International Society for Cellular Therapy (ISCT) and EBMT (JACIE), EBMT Nurses Group and Patient Advocacy Committee. Hematopoietic stem cell transplantation for autoimmune diseases in the time of COVID-19: EBMT guidelines and recommendations. Bone Marrow Transplant 2021;56:1493-508. [PMID: 34031556 DOI: 10.1038/s41409-021-01326-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
534 Batra A, Mehta P, Patel A, Bhethanabhotla S, Biswas B, Pramanik R, Das CK. Breast Cancer Treatment during the COVID-19 Pandemic. Indian Journal of Medical and Paediatric Oncology 2021;41:135-7. [DOI: 10.4103/ijmpo.ijmpo_111_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
535 Salehi O, Alarcon SV, Vega EA, Kutlu OC, Kozyreva O, Chan JA, Kazakova V, Harz D, Conrad C. COVID-19's Impact on Cancer Care: Increased Emotional Stress in Patients and High Risk of Provider Burnout. J Gastrointest Surg 2021. [PMID: 34027579 DOI: 10.1007/s11605-021-05032-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
536 Pandy JG, Maaño O, Balolong-Garcia JC, Datukan JTY. Risk factors and clinical outcomes of systemic cancer treatment delays in Filipino patients with solid tumor malignancy during the COVID-19 pandemic: A single tertiary center study. Cancer Rep (Hoboken) 2021;:e1426. [PMID: 34021716 DOI: 10.1002/cnr2.1426] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
537 Wang Q, Li L, Qu T, Li J, Wu L, Li K, Wang Z, Zhu M, Huang B, Wu W, Wu M, Ding R, Zhang Z, Wang Q, Xia X, Li P, Zhang Z, Guo R. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Front Oncol 2021;11:644575. [PMID: 34094930 DOI: 10.3389/fonc.2021.644575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
538 Woo SH, Rios-Diaz AJ, Kubey AA, Cheney-Peters DR, Ackermann LL, Chalikonda DM, Venkataraman CM, Riley JM, Baram M. Development and Validation of a Web-Based Severe COVID-19 Risk Prediction Model. Am J Med Sci 2021:S0002-9629(21)00112-9. [PMID: 34029558 DOI: 10.1016/j.amjms.2021.04.001] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
539 Piechotta V, Iannizzi C, Chai KL, Valk SJ, Kimber C, Dorando E, Monsef I, Wood EM, Lamikanra AA, Roberts DJ, McQuilten Z, So-Osman C, Estcourt LJ, Skoetz N. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Cochrane Database Syst Rev 2021;5:CD013600. [PMID: 34013969 DOI: 10.1002/14651858.CD013600.pub4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
540 Calvo V, Fernandez-Cruz A, Nuñez B, Blanco M, Morito A, Martínez M, Traseira C, Garitaonaindía Y, Aguado R, Ramos A, Royuela A, Franco FF, Provencio M. Cancer and SARS-CoV-2 Infection: A Third-Level Hospital Experience. Clin Epidemiol 2021;13:317-24. [PMID: 34040447 DOI: 10.2147/CLEP.S308437] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
541 Hwang C, Izano MA, Thompson MA, Gadgeel SM, Weese JL, Mikkelsen T, Schrag A, Teka M, Walters S, Wolf FM, Hirsch J, Rivera DR, Kluetz PG, Singh H, Brown TD. Rapid real-world data analysis of patients with cancer, with and without COVID-19, across distinct health systems. Cancer Rep (Hoboken) 2021;:e1388. [PMID: 34014037 DOI: 10.1002/cnr2.1388] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
542 Asghar K, Abu Bakar M, Akram MJ, Farooq A, Siddique K, Rana IA, Ali J, Rashid MU, Khan AA, Loya A. Clinical Characteristics of COVID-19-Infected Cancer Patients in Pakistan: Differences Between Survivors and Non-Survivors. Front Oncol 2021;11:655634. [PMID: 34094950 DOI: 10.3389/fonc.2021.655634] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
543 van Marcke C, Honoré N, van der Elst A, Beyaert S, Derouane F, Dumont C, Aboubakar Nana F, Baurain JF, Borbath I, Collard P, Cornélis F, De Cuyper A, Duhoux FP, Filleul B, Galot R, Gizzi M, Mazzeo F, Pieters T, Seront E, Sinapi I, Van den Eynde M, Whenham N, Yombi JC, Scohy A, van Maanen A, Machiels JP. Safety of systemic anti-cancer treatment in oncology patients with non-severe COVID-19: a cohort study. BMC Cancer 2021;21:578. [PMID: 34016086 DOI: 10.1186/s12885-021-08349-8] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
544 Bondeelle L, Chevret S, Cassonnet S, Harel S, Denis B, de Castro N, Bergeron A; Saint Louis CORE Team Group. Profiles and outcomes in patients with COVID-19 admitted to wards of a French oncohematological hospital: A clustering approach. PLoS One 2021;16:e0250569. [PMID: 34010331 DOI: 10.1371/journal.pone.0250569] [Reference Citation Analysis]
545 Li H, Baldwin E, Zhang X, Kenost C, Luo W, Calhoun EA, An L, Bennett CL, Lussier YA. Comparison and impact of COVID-19 for patients with cancer: a survival analysis of fatality rate controlling for age, sex and cancer type. BMJ Health Care Inform 2021;28:e100341. [PMID: 33980502 DOI: 10.1136/bmjhci-2021-100341] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
546 Casas MGE, Rosario M, Battad G, Mercado AC, Hermogenes TA, Hernandez A, Dy-Ledesma J, Alomesen A, Valera JL, Dy AC. Challenge of treating skeletal muscle metastasis during the COVID-19 pandemic in a low-resource setting. Ecancermedicalscience 2021;15:1235. [PMID: 34221118 DOI: 10.3332/ecancer.2021.1235] [Reference Citation Analysis]
547 Cao Y, Zhong X, Diao W, Mu J, Cheng Y, Jia Z. Radiomics in Differentiated Thyroid Cancer and Nodules: Explorations, Application, and Limitations. Cancers (Basel) 2021;13:2436. [PMID: 34069887 DOI: 10.3390/cancers13102436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
548 Wang SH, Yeh SH, Chen PJ. Unique Features of Hepatitis B Virus-Related Hepatocellular Carcinoma in Pathogenesis and Clinical Significance. Cancers (Basel) 2021;13:2454. [PMID: 34070067 DOI: 10.3390/cancers13102454] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
549 Puricelli Perin DM, Christensen T, Burón A, Haas JS, Kamineni A, Pashayan N, Rabeneck L, Smith R, Elfström M, Broeders MJM; International Cancer Screening Network ICSN. Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters. Prev Med Rep 2021;23:101399. [PMID: 34026465 DOI: 10.1016/j.pmedr.2021.101399] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
550 Freeman MC, Rapsinski GJ, Zilla ML, Wheeler SE. Immunocompromised Seroprevalence and Course of Illness of SARS-CoV-2 in One Pediatric Quaternary Care Center. J Pediatric Infect Dis Soc 2021;10:426-31. [PMID: 33049042 DOI: 10.1093/jpids/piaa123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
551 Baldassarre LA, Yang EH, Cheng RK, DeCara JM, Dent S, Liu JE, Rudski LG, Strom JB, Thavendiranathan P, Barac A, Zaha VG, Bucciarelli-Ducci C, Ellahham S, Deswal A, Lenneman C, Villarraga HR, Blaes AH, Ismail-Khan R, Ky B, Leja MJ, Scherrer-Crosbie M. Cardiovascular Care of the Oncology Patient During COVID-19: An Expert Consensus Document From the ACC Cardio-Oncology and Imaging Councils. J Natl Cancer Inst 2021;113:513-22. [PMID: 33179744 DOI: 10.1093/jnci/djaa177] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
552 Zong Z, Wei Y, Ren J, Zhang L, Zhou F. The intersection of COVID-19 and cancer: signaling pathways and treatment implications. Mol Cancer 2021;20:76. [PMID: 34001144 DOI: 10.1186/s12943-021-01363-1] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
553 Mamedov MN, Rodionova YV, Yavelov IS, Smirnova MI, Dudinskaya EN, Potievskaya VI. COVID-19 from the interdisciplinary standpoint. Round table. Cardiovasc Ther Prev 2021;20:2849. [DOI: 10.15829/1728-8800-2021-2849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
554 Sgherza N, Curci P, Strafella V, Rizzi R, Musto P. Implications of Interleukin-6 (IL-6)-blockade for severe COVID-19 infection in patients with Multiple Myeloma. Acta Biomed 2021;92:e2021205. [PMID: 33988136 DOI: 10.23750/abm.v92i2.11395] [Reference Citation Analysis]
555 Song J, Park DW, Cha JH, Seok H, Kim JY, Park J, Cho H. Clinical course and risk factors of fatal adverse outcomes in COVID-19 patients in Korea: a nationwide retrospective cohort study. Sci Rep 2021;11:10066. [PMID: 33980912 DOI: 10.1038/s41598-021-89548-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
556 Ciriaco P, Carretta A, Bandiera A, Muriana P, Negri G. Perspective: Did Covid-19 Change Non-small Cell Lung Cancer Surgery Approach? Front Surg 2021;8:662592. [PMID: 34055870 DOI: 10.3389/fsurg.2021.662592] [Reference Citation Analysis]
557 Nowroozi A, Razi S, Sahu KK, Grizzi F, Arends J, Keshavarz-Fathi M, Rezaei N. COVID-19 in Patients with Cancer. Adv Exp Med Biol 2021;1318:315-31. [PMID: 33973186 DOI: 10.1007/978-3-030-63761-3_18] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
558 Round T, L'Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, Haswell T, Hiley C, Lovell N, McAdam J, McCutchan G, Nair A, Newsom-Davis T, Sage EK, Navani N. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. Br J Cancer 2021;125:629-40. [PMID: 33972746 DOI: 10.1038/s41416-021-01361-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
559 Sahu KK, Ailawadhi S, Malvik N, Cerny J. Challenges of Cellular Therapy During the COVID-19 Pandemic. Adv Exp Med Biol 2021;1318:657-72. [PMID: 33973204 DOI: 10.1007/978-3-030-63761-3_36] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
560 Tang Q, Wang Y, Ou L, Li J, Zheng K, Zhan H, Gu J, Zhou G, Xie S, Zhang J, Huang W, Wang S, Wang X. Downregulation of ACE2 expression by SARS-CoV-2 worsens the prognosis of KIRC and KIRP patients via metabolism and immunoregulation. Int J Biol Sci 2021;17:1925-39. [PMID: 34131396 DOI: 10.7150/ijbs.57802] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
561 Li XP, Huang X, Qin YM, Wu GY, Liang CC, Dai YJ, Zhang WN. SARS-CoV-2-related IFITM3 in immune dysfunction and tumor microenvironment: An integrative analysis in pan-cancers. Clin Transl Med 2021;11:e345. [PMID: 33634992 DOI: 10.1002/ctm2.345] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
562 Round T, L'Esperance V, Bayly J, Brain K, Dallas L, Edwards JG, Haswell T, Hiley C, Lovell N, McAdam J, McCutchan G, Nair A, Newsom-Davis T, Sage EK, Navani N. COVID-19 and the multidisciplinary care of patients with lung cancer: an evidence-based review and commentary. Br J Cancer 2021;125:629-40. [PMID: 33972746 DOI: 10.1038/s41416-021-01361-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
563 Monari C, Sagnelli C, Maggi P, Sangiovanni V, Numis FG, Gentile I, Masullo A, Rescigno C, Calabria G, Megna AS, Gambardella M, Manzillo E, Russo G, Esposito V, Camaioni C, Messina V, Pisaturo M, Allegorico E, Pinchera B, Pisapia R, Catalano M, Salzillo A, Porta G, Signoriello G, Coppola N. More Severe COVID-19 in Patients With Active Cancer: Results of a Multicenter Cohort Study. Front Oncol 2021;11:662746. [PMID: 34026639 DOI: 10.3389/fonc.2021.662746] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
564 Ayhan M, Laçin Ş, Özyükseler DT, Sürmeli H, Doğan A, Turan M, Odabas H, Turan N, Yıldırım ME. Does systemic anti-tumor therapy increase COVID-19 risk in patients with cancer? J Oncol Pharm Pract 2021;:10781552211015762. [PMID: 33961521 DOI: 10.1177/10781552211015762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
565 Shin EK, Choi HY, Hayes N. The anatomy of COVID-19 comorbidity networks among hospitalized Korean patients. Epidemiol Health 2021;43:e2021035. [PMID: 33971700 DOI: 10.4178/epih.e2021035] [Reference Citation Analysis]
566 Jin ZC, Chen L, Zhong BY, Zhu HD, Zeng CH, Li R, Guo JH, He SC, Deng G, Zhu XL, Ni CF, Teng GJ. Impact of COVID-19 Pandemic on Intervals and Outcomes of Repeated Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma. Front Oncol 2021;11:602700. [PMID: 34026598 DOI: 10.3389/fonc.2021.602700] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
567 Pérez-Segura P, Paz-Cabezas M, Núñez-Gil IJ, Arroyo-Espliguero R, Maroun Eid C, Romero R, Fernández Rozas I, Uribarri A, Becerra-Muñoz VM, García Aguado M, Huang J, Rondano E, Cerrato E, Rodríguez EA, Ortega-Armas ME, Raposeiras Roubin S, Pepe M, Feltes G, Gonzalez A, Cortese B, Buzón L, El-Battrawy I, Estrada V. Prognostic factors at admission on patients with cancer COVID-19: Analysis of hope registry data. Med Clin (Barc) 2021:S0025-7753(21)00211-6. [PMID: 34154809 DOI: 10.1016/j.medcli.2021.02.021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
568 Zhou J, Liu Y, Xu M, Mei L, Ruan S, Zhang N, Yi P, Chen Q, Tan J. Management of Breast Cancer Patients During the Coronavirus Disease 2019 Pandemic: The Experience From the Epicenter of China, Wuhan. Clin Breast Cancer 2021:S1526-8209(21)00114-2. [PMID: 34078565 DOI: 10.1016/j.clbc.2021.04.014] [Reference Citation Analysis]
569 Gasper H, Ahern E, Roberts N, Chan B, Hughes B, Kennedy G, Wyld D, Eastgate M, Lwin Z. Semiqualitative research protocol to explore cancer care workforce perceptions of the health system response to COVID-19 preparations in Southeast Queensland, Australia. BMJ Open 2021;11:e044655. [PMID: 33958340 DOI: 10.1136/bmjopen-2020-044655] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
570 Rodler S, Schütz JM, Styn A, Weinhold P, Casucelli J, Eismann L, Bauer RM, Staehler M, Stief C, Buchner A, Mumm JN. Mapping Telemedicine in German Private Practice Urological Care: Implications for Transitioning beyond the COVID-19 Pandemic. Urol Int 2021;105:650-6. [PMID: 33951666 DOI: 10.1159/000515982] [Reference Citation Analysis]
571 Dincer B, Yıldırım Ayaz E, Oğuz A. Changes in Sexual Functions and Alexithymia Levels of Patients with Type 2 Diabetes During the COVID-19 Pandemic. Sex Disabil 2021;:1-18. [PMID: 33967358 DOI: 10.1007/s11195-021-09693-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
572 Hemmati PG, Fischer D, Breywisch F, Wohlfarth S, Kramer M, Paland M, Tometten L, Badakhshi H, Ripberger G, Maschmeyer G. Maintaining an Adult Hematology/Oncology Service at a Tertiary Care Center during the SARS-CoV-2 Pandemic: An Eight-Week-Experience with a Newly Implemented Procedural Plan. Oncol Res Treat 2021;44:354-9. [PMID: 33940575 DOI: 10.1159/000515828] [Reference Citation Analysis]
573 Zhang H, Han H, He T, Labbe KE, Hernandez AV, Chen H, Velcheti V, Stebbing J, Wong KK. Clinical Characteristics and Outcomes of COVID-19-Infected Cancer Patients: A Systematic Review and Meta-Analysis. J Natl Cancer Inst 2021;113:371-80. [PMID: 33136163 DOI: 10.1093/jnci/djaa168] [Cited by in Crossref: 31] [Cited by in F6Publishing: 60] [Article Influence: 31.0] [Reference Citation Analysis]
574 Grudlewska-Buda K, Wiktorczyk-Kapischke N, Wałecka-Zacharska E, Kwiecińska-Piróg J, Buszko K, Leis K, Juszczuk K, Gospodarek-Komkowska E, Skowron K. SARS-CoV-2-Morphology, Transmission and Diagnosis during Pandemic, Review with Element of Meta-Analysis. J Clin Med 2021;10:1962. [PMID: 34063654 DOI: 10.3390/jcm10091962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
575 Testa RS, Praça APA, Nassar Junior AP, Santana PV, Okamoto VN, Costa RT, Caruso P. Mortality and Life-Sustaining Therapy Decisions in Patients With Cancer and Acute Respiratory Failure Due to COVID-19 or Other Causes: An Observational Study. Front Med (Lausanne) 2021;8:620818. [PMID: 34012970 DOI: 10.3389/fmed.2021.620818] [Reference Citation Analysis]
576 Rocque GB, Williams CP, Andrews C, Childers TC, Wiseman KD, Gallagher K, Tung N, Balch A, Lawhon VM, Ingram SA, Brown T, Kaufmann T, Smith ML, DeMichele A, Wolff AC, Wagner L. Patient perspectives on chemotherapy de-escalation in breast cancer. Cancer Med 2021;10:3288-98. [PMID: 33932097 DOI: 10.1002/cam4.3891] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
577 Xu B, Song KH, Yao Y, Dong XR, Li LJ, Wang Q, Yang JY, Hu WD, Xie ZB, Luo ZG, Luo XL, Liu J, Rao ZG, Zhang HB, Wu J, Li L, Gong HY, Chu Q, Song QB, Wang J. Individualized model for predicting COVID-19 deterioration in patients with cancer: A multicenter retrospective study. Cancer Sci 2021;112:2522-32. [PMID: 33728806 DOI: 10.1111/cas.14882] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
578 Thery L, Vaflard P, Vuagnat P, Soulie O, Dolbeault S, Burnod A, Laouisset C, Marchal T, Massiani MA, Bozec L, Bidard FC, Cottu P, Angellier E, Bouleuc C. Advanced cancer and COVID-19 comorbidity: medical oncology-palliative medicine ethics meetings in a comprehensive cancer centre. BMJ Support Palliat Care 2021:bmjspcare-2021-002946. [PMID: 33927013 DOI: 10.1136/bmjspcare-2021-002946] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
579 Chen F, Zhan W, Xu H, Wu Y, Jia Y, Liang X, Chen W. Changes in the Psychological State of Medical Personnel in the Department of Radiotherapy at a Tertiary Care Teaching Hospital in China during the Epidemic. Ann Work Expo Health 2021:wxab015. [PMID: 33907794 DOI: 10.1093/annweh/wxab015] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
580 Suzaki I, Kobayashi H. Coronavirus Disease 2019 and Nasal Conditions: A Review of Current Evidence. In Vivo 2021;35:1409-17. [PMID: 33910818 DOI: 10.21873/invivo.12393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
581 Seven M, Bagcivan G, Pasalak SI, Oz G, Aydin Y, Selcukbiricik F. Experiences of breast cancer survivors during the COVID-19 pandemic: a qualitative study. Support Care Cancer 2021. [PMID: 33905013 DOI: 10.1007/s00520-021-06243-4] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
582 Frasquilho D, Matias R, Grácio J, Sousa B, Luís-Ferreira F, Leal J, Cardoso F, Oliveira-Maia AJ. Protocol for the Implementation and Assessment of "MoodUP": A Stepped Care Model Assisted by a Digital Platform to Accelerate Access to Mental Health Care for Cancer Patients Amid the COVID-19 Pandemic. Int J Environ Res Public Health 2021;18:4629. [PMID: 33925412 DOI: 10.3390/ijerph18094629] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
583 Rykers K, Tacey M, Bowes J, Brown K, Yuen E, Wilson C, Khor R, Foroudi F. Victoria (Australia) radiotherapy response to working through the first and second wave of COVID-19: Strategies and staffing. J Med Imaging Radiat Oncol 2021;65:374-83. [PMID: 33908186 DOI: 10.1111/1754-9485.13186] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
584 Poon DM, Chan CK, Chan TW, Cheung FY, Ho LY, Kwong PW, Lee EK, Leung AK, Leung SY, So HS, Tam PC, Ma WK. Prostate cancer management in the era of COVID-19: Recommendations from the Hong Kong Urological Association and Hong Kong Society of Uro-oncology. Asia Pac J Clin Oncol 2021;17 Suppl 3:48-54. [PMID: 33860643 DOI: 10.1111/ajco.13579] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
585 Al-Rahimi JS, Nass NM, Hassoubah SA, Wazqar DY, Alamoudi SA. Levels and predictors of fear and health anxiety during the current outbreak of COVID-19 in immunocompromised and chronic disease patients in Saudi Arabia: A cross-sectional correlational study. PLoS One 2021;16:e0250554. [PMID: 33901260 DOI: 10.1371/journal.pone.0250554] [Cited by in Crossref: 2] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
586 Liu C, Wang K, Li L, Lv Q, Liu Y, Hu T, Trent JC, Sun B, Hu Q. Severity of COVID-19 in Cancer patients versus patients without Cancer: A Propensity Score Matching Analysis. J Cancer 2021;12:3558-65. [PMID: 33995633 DOI: 10.7150/jca.54205] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
587 Zhao X, Cong S, Guo Q, Cheng Y, Liang T, Wang J, Zhang G. Combination of Immune-Related Genomic Alterations Reveals Immune Characterization and Prediction of Different Prognostic Risks in Ovarian Cancer. Front Cell Dev Biol 2021;9:653357. [PMID: 33968933 DOI: 10.3389/fcell.2021.653357] [Reference Citation Analysis]
588 Lozahic C, Maddock H, Sandhu H. Anti-cancer Therapy Leads to Increased Cardiovascular Susceptibility to COVID-19. Front Cardiovasc Med 2021;8:634291. [PMID: 33969006 DOI: 10.3389/fcvm.2021.634291] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
589 Lee H, Choi H, Yang B, Lee SK, Park TS, Park DW, Moon JY, Kim TH, Sohn JW, Yoon HJ, Kim SH. Interstitial lung disease increases susceptibility to and severity of COVID-19. Eur Respir J 2021:2004125. [PMID: 33888524 DOI: 10.1183/13993003.04125-2020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
590 Goyal AK, Bakshi J, Panda NK, Kapoor R, Vir D, Kumar K, Aneja P. Stigmatic Impact of COVID-19 Pandemic on Head & Neck Cancers Survivors. Indian J Otolaryngol Head Neck Surg 2021;:1-5. [PMID: 33907679 DOI: 10.1007/s12070-021-02545-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
591 Ali FEM, Mohammedsaleh ZM, Ali MM, Ghogar OM. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challenges. World J Gastroenterol 2021; 27(15): 1531-1552 [PMID: 33958841 DOI: 10.3748/wjg.v27.i15.1531] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
592 Blache G, El Hajj H, Jauffret C, Houvenaeghel G, Sabiani L, Barrou J, Masquin I, Le Saout J, Mokart D, Faucher M, Lambaudie E. Care as Usual: An Acceptable Strategy to Apply During the COVID-19 Pandemic in a French Tertiary Gynecologic Oncology Department. Front Oncol 2021;11:653009. [PMID: 33968755 DOI: 10.3389/fonc.2021.653009] [Reference Citation Analysis]
593 Xu Y, Huang ZH, Zheng CZ, Li C, Zhang YQ, Guo TA, Liu FQ, Xu Y. The impact of COVID-19 pandemic on colorectal cancer patients: a single-center retrospective study. BMC Gastroenterol 2021;21:185. [PMID: 33879095 DOI: 10.1186/s12876-021-01768-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
594 Giordano FM, Ippolito E, Quattrocchi CC, Greco C, Mallio CA, Santo B, D'Alessio P, Crucitti P, Fiore M, Zobel BB, D'Angelillo RM, Ramella S. Radiation-Induced Pneumonitis in the Era of the COVID-19 Pandemic: Artificial Intelligence for Differential Diagnosis. Cancers (Basel) 2021;13:1960. [PMID: 33921652 DOI: 10.3390/cancers13081960] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
595 Sahin M, Haymana C, Demirci I, Tasci I, Rıfat E, Unluturk U, Satman I, Demir T, Cakal E, Ata N, Ertugrul D, Salman S, Sahin I, Dagdelen S, Celik O, Caglayan M, Atmaca A, Sonmez A. The clinical outcomes of COVID-19 infection in patients with a history of thyroid cancer: A nationwide study. Clin Endocrinol (Oxf) 2021. [PMID: 33872399 DOI: 10.1111/cen.14486] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
596 Han Z, Zhang Y, Wang P, Tang Q, Zhang K. Is acupuncture effective in the treatment of COVID-19 related symptoms? Based on bioinformatics/network topology strategy. Brief Bioinform 2021:bbab110. [PMID: 33866350 DOI: 10.1093/bib/bbab110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
597 Osei E, Francis R, Mohamed A, Sheraz L, Soltani-mayvan F. Impact of COVID-19 pandemic on the oncologic care continuum: urgent need to restore patients care to pre-COVID-19 era. J Radiother Pract. [DOI: 10.1017/s1460396921000303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
598 Hirsch JS, Ikizler TA, Sharma S, Mohammed A. Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium. Kidney Med 2021;3:426-32. [PMID: 33898966 DOI: 10.1016/j.xkme.2021.03.003] [Reference Citation Analysis]
599 Yoke LH, Lee JM, Krantz EM, Morris J, Marquis S, Bhattacharyya P, So L, Riedo FX, Simmons J, Khaki AR, Cheng GS, Greninger AL, Pergam SA, Waghmare A, Ogimi C, Liu C. Clinical and Virologic Characteristics and Outcomes of Coronavirus Disease 2019 at a Cancer Center. Open Forum Infect Dis 2021;8:ofab193. [PMID: 34183982 DOI: 10.1093/ofid/ofab193] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
600 Mangone L, Gioia F, Mancuso P, Bisceglia I, Ottone M, Vicentini M, Pinto C, Giorgi Rossi P. Cumulative COVID-19 incidence, mortality and prognosis in cancer survivors: A population-based study in Reggio Emilia, Northern Italy. Int J Cancer 2021. [PMID: 33861870 DOI: 10.1002/ijc.33601] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
601 Nakano H, Shiina K, Tomiyama H. Cardiovascular Outcomes in the Acute Phase of COVID-19. Int J Mol Sci 2021;22:4071. [PMID: 33920790 DOI: 10.3390/ijms22084071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
602 Wang H, Yang J. Colorectal Cancer that Highly Express Both ACE2 and TMPRSS2, Suggesting Severe Symptoms to SARS-CoV-2 Infection. Pathol Oncol Res 2021;27:612969. [PMID: 34257580 DOI: 10.3389/pore.2021.612969] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
603 Gallo O, Bruno C, Locatello LG, Martelli F, Cilona M, Orlando P, Fancello G, Maggiore G, Viberti F, Ciabatti P, Boccuzzi S, Mandalà M. The impact of the COVID-19 pandemic on the quality of life of head and neck cancer survivors. Support Care Cancer 2021. [PMID: 33860361 DOI: 10.1007/s00520-021-06198-6] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
604 Romero J, Benlloch R, Obeso J, Engel O, Gil B, Córdoba S, Zapata I, López M, Portero F. Impact of COVID-19 pandemic on patients and health professionals of a radiation oncology department at a Spanish tertiary hospital. Rep Pract Oncol Radiother 2021;26:237-41. [PMID: 34211774 DOI: 10.5603/RPOR.a2021.0036] [Reference Citation Analysis]
605 Wang LQ, Tan Su Yin E, Wei GQ, Hu YX, Nagler A, Huang H. Weathering the storm: COVID-19 infection in patients with hematological malignancies. J Zhejiang Univ Sci B 2020;21:921-39. [PMID: 33843158 DOI: 10.1631/jzus.B2000423] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
606 Memon W, Popli K, Akram A, Bobba S, Muthusamy S. Myeloma Cast Nephropathy and COVID-19: A Case Report of Multiple Myeloma Presenting as Acute Kidney Injury in the Setting of COVID-19. Cureus 2021;13:e14461. [PMID: 33996321 DOI: 10.7759/cureus.14461] [Reference Citation Analysis]
607 Konieczny M, Cipora E, Sawicka J, Fal A. Patient Satisfaction with Oncological Care during the SARS-CoV-2 Virus Pandemic. Int J Environ Res Public Health 2021;18:4122. [PMID: 33924702 DOI: 10.3390/ijerph18084122] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 Taghizadeh-hesary F, Porouhan P, Soroosh D, Peyroshabany B, Shahidsales S, Keykhosravi B, Rahimi F, Houshyari M, Forouzanfar MM, Javadinia SA. COVID-19 in Cancer and Non-cancer Patients. Int J Cancer Manag 2021;14. [DOI: 10.5812/ijcm.110907] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
609 Theoharides TC, Cholevas C, Polyzoidis K, Politis A. Long-COVID syndrome-associated brain fog and chemofog: Luteolin to the rescue. Biofactors 2021;47:232-41. [PMID: 33847020 DOI: 10.1002/biof.1726] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 29.0] [Reference Citation Analysis]
610 Woźniak K, Sachs W, Boguradzki P, Basak GW, Stec R. Chemotherapy During Active SARS-CoV2 Infection: A Case Report and Review of the Literature. Front Oncol 2021;11:662211. [PMID: 33912468 DOI: 10.3389/fonc.2021.662211] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
611 Flook M, Jackson C, Vasileiou E, Simpson CR, Muckian MD, Agrawal U, McCowan C, Jia Y, Murray JLK, Ritchie LD, Robertson C, Stock SJ, Wang X, Woolhouse MEJ, Sheikh A, Stagg HR. Informing the public health response to COVID-19: a systematic review of risk factors for disease, severity, and mortality. BMC Infect Dis 2021;21:342. [PMID: 33845766 DOI: 10.1186/s12879-021-05992-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
612 Bora VR, Patel BM. The Deadly Duo of COVID-19 and Cancer! Front Mol Biosci 2021;8:643004. [PMID: 33912588 DOI: 10.3389/fmolb.2021.643004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
613 Di Lalla V, Patrick H, Siriani-Ayoub N, Kildea J, Hijal T, Alfieri J. Satisfaction among Cancer Patients Undergoing Radiotherapy during the COVID-19 Pandemic: An Institutional Experience. Curr Oncol 2021;28:1507-17. [PMID: 33920247 DOI: 10.3390/curroncol28020142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
614 Hiam-Galvez KJ, Allen BM, Spitzer MH. Systemic immunity in cancer. Nat Rev Cancer 2021;21:345-59. [PMID: 33837297 DOI: 10.1038/s41568-021-00347-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 144] [Article Influence: 13.0] [Reference Citation Analysis]
615 Borgstein ABJ, Brunner S, Hayami M, Moons J, Fuchs H, Eshuis WJ, Gisbertz SS, Bruns CJ, Nafteux P, Nilsson M, Schröder W, van Berge Henegouwen MI. Safety of Esophageal Cancer Surgery During the First Wave of the COVID-19 Pandemic in Europe: A Multicenter Study. Ann Surg Oncol 2021;28:4805-13. [PMID: 33830357 DOI: 10.1245/s10434-021-09886-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
616 Bandinelli L, Ornell F, von Diemen L, Kessler FHP. The Sum of Fears in Cancer Patients Inside the Context of the COVID-19. Front Psychiatry 2021;12:557834. [PMID: 33897477 DOI: 10.3389/fpsyt.2021.557834] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
617 Wang A, Chang SH, Kim EJ, Bessich JL, Sabari JK, Cooper B, Geraci TC, Cerfolio RJ. Dynamic Management of Lung Cancer Care During Surging COVID-19. Front Surg 2021;8:663364. [PMID: 33898509 DOI: 10.3389/fsurg.2021.663364] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
618 Tulchiner G, Staudacher N, Fritz J, Radmayr C, Culig Z, Horninger W, Pichler R. The "COVID-19 Pandemic Gap" and Its Influence on Oncologic Outcomes of Bladder Cancer. Cancers (Basel) 2021;13:1754. [PMID: 33916962 DOI: 10.3390/cancers13081754] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
619 Nardone V, Reginelli A, Vinciguerra C, Correale P, Calvanese MG, Falivene S, Sangiovanni A, Grassi R, Di Biase A, Polifrone MA, Caraglia M, Cappabianca S, Guida C. Mood Disorder in Cancer Patients Undergoing Radiotherapy During the COVID-19 Outbreak. Front Psychol 2021;12:568839. [PMID: 33815186 DOI: 10.3389/fpsyg.2021.568839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
620 Cantini L, Bastianelli L, Lupi A, Pinterpe G, Pecci F, Belletti G, Stoico R, Vitarelli F, Moretti M, Onori N, Giampieri R, Rocchi MBL, Berardi R. Seroprevalence of SARS-CoV-2-Specific Antibodies in Cancer Patients Undergoing Active Systemic Treatment: A Single-Center Experience from the Marche Region, Italy. J Clin Med 2021;10:1503. [PMID: 33916569 DOI: 10.3390/jcm10071503] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
621 Baba MA, Adali N. The Management of Glioblastomas during the SARS-CoV-19 Pandemic: A Narrative Overview. EUR J BASIC MED SCI 2021;11:19-22. [DOI: 10.21601/ejbms/10819] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
622 Kutsuna S. Clinical Manifestations of Coronavirus Disease 2019. JMA J 2021;4:76-80. [PMID: 33997439 DOI: 10.31662/jmaj.2021-0013] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
623 Pous A, Izquierdo C, Cucurull M, Sánchez S, Lezcano C, Domenech M, Llobera L, Plaja A, Moran T. Immune-checkpoint inhibitors for lung cancer patients amid the COVID-19 pandemic: a case report of severe meningoencephalitis after switching to an extended-interval higher flat-dose nivolumab regimen. Transl Lung Cancer Res 2021;10:1917-23. [PMID: 34012801 DOI: 10.21037/tlcr-20-1315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
624 Wong LP, Lai LL, See MH, Alias H, Danaee M, Ting CY, Tok PSK. Psychological distress among cancer survivors during implementation of a nationwide Movement Control Order over the COVID-19 pandemic. Support Care Cancer 2021;29:6087-97. [PMID: 33796935 DOI: 10.1007/s00520-021-06182-0] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
625 García-rojo E, Manfredi C, Santos-pérez-de-la-blanca R, Tejido-sánchez Á, García-gómez B, Aliaga-benítez M, Romero-otero J, Rodriguez-antolín A. Impact of COVID-19 outbreak on urology surgical waiting lists and waiting lists prioritization strategies in the post-COVID-19 era. Actas Urológicas Españolas (English Edition) 2021;45:207-14. [DOI: 10.1016/j.acuroe.2021.02.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
626 Saeed BQ, Al-Shahrabi R, Bolarinwa OA. Socio-demographic correlate of knowledge and practice toward COVID-19 among people living in Mosul-Iraq: A cross-sectional study. PLoS One 2021;16:e0249310. [PMID: 33788835 DOI: 10.1371/journal.pone.0249310] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
627 Isgrò MA, Vitale MG, Celentano E, Nocerino F, Porciello G, Curvietto M, Mallardo D, Montagnese C, Russo L, Zanaletti N, Avallone A, Pensabene M, De Laurentiis M, Centonze S, Pignata S, Cannella L, Morabito A, Caponigro F, Botti G, Masucci GV, Giannarelli D, Cavalcanti E, Ascierto PA. Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis. J Transl Med 2021;19:132. [PMID: 33789686 DOI: 10.1186/s12967-021-02798-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
628 Taylor B, Tod A, Gardiner C, Creech L, Forde F, Darlison L. Effects of the COVID-19 pandemic on people with mesothelioma and their carers. Cancer Nursing Practice 2021;20:22-8. [DOI: 10.7748/cnp.2021.e1773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
629 Mathelin C, Ame S, Anyanwu S, Avisar E, Boubnider WM, Breitling K, Anie HA, Conceição JC, Dupont V, Elder E, Elfgen C, Elonge T, Iglesias E, Imoto S, Ioannidou-Mouzaka L, Kappos EA, Kaufmann M, Knauer M, Luzuy F, Margaritoni M, Mbodj M, Mundinger A, Orda R, Ostapenko V, Özbaş S, Özmen V, Pagani O, Pieńkowski T, Schneebaum S, Shmalts E, Selim A, Pavel Z, Lodi M, Maghales-Costa M. Breast Cancer Management During the COVID-19 Pandemic: The Senologic International Society Survey. Eur J Breast Health 2021;17:188-96. [PMID: 33870120 DOI: 10.4274/ejbh.galenos.2021.2021-1-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
630 Cavanna L, Zaffignani E, Citterio C, De Amicis S, Scarpioni R. A Rare Case of Coronavirus Disease 2019 Survival in an Elderly Patient With Atheroembolic Renal Disease. Cureus 2021;13:e14201. [PMID: 33948397 DOI: 10.7759/cureus.14201] [Reference Citation Analysis]
631 Gallegos H, Rojas PA, Sepúlveda F, Zúñiga Á, San Francisco IF. Protective role of intravesical BCG in COVID-19 severity. BMC Urol 2021;21:50. [PMID: 33785004 DOI: 10.1186/s12894-021-00823-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
632 Ye C, Qi L, Wang J, Zheng S. COVID-19 Pandemic: Advances in Diagnosis, Treatment, Organoid Applications and Impacts on Cancer Patient Management. Front Med (Lausanne) 2021;8:606755. [PMID: 33855032 DOI: 10.3389/fmed.2021.606755] [Reference Citation Analysis]
633 Geng HW, Yin FY, Zhang ZF, Gong X, Yang Y. Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy. Front Mol Biosci 2021;8:634874. [PMID: 33855046 DOI: 10.3389/fmolb.2021.634874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
634 Passaro A, Bestvina C, Velez Velez M, Garassino MC, Garon E, Peters S. Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer 2021;9:e002266. [PMID: 33737345 DOI: 10.1136/jitc-2020-002266] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
635 Nurczyk K, Chan CE, Nowak N, Skoczylas T. COVID-19 Pneumonia on Post-Operative Day 2 after Esophagectomy: Performing Esophago-Gastric Junction Cancer Surgery during the SARS-Cov-2 Second Wave. Curr Oncol 2021;28:1348-53. [PMID: 33801652 DOI: 10.3390/curroncol28020128] [Reference Citation Analysis]
636 Vici P, Krasniqi E, Pizzuti L, Ciliberto G, Mazzotta M, Marinelli D, Barba M. Burnout of health care providers during the COVID-19 pandemic: Focus on Medical Oncologists. Int J Med Sci 2021;18:2235-8. [PMID: 33859532 DOI: 10.7150/ijms.54025] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
637 Das R, Nahak SR, Parija J, Das PK, Sarangi L, Devi P, Pathy PC. Optimising Cancer Surgery During COVID-19: Experience of Tertiary Cancer Centre in Eastern India. Indian J Gynecol Oncol 2021;19:29. [PMID: 33786366 DOI: 10.1007/s40944-021-00502-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
638 Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å. COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway. Front Oncol 2021;11:652535. [PMID: 33842366 DOI: 10.3389/fonc.2021.652535] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
639 Lee SF, Nikšić M, Rachet B, Sanchez MJ, Luque-Fernandez MA. Socioeconomic Inequalities and Ethnicity Are Associated with a Positive COVID-19 Test among Cancer Patients in the UK Biobank Cohort. Cancers (Basel) 2021;13:1514. [PMID: 33806016 DOI: 10.3390/cancers13071514] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
640 Fujii H, Tsuji T, Sugitani M, Matsumoto Y, Yuba T, Tanaka S, Suga Y, Matsuyama A, Goda S, Omura A, Shiotsu S, Takumi C, Ono S, Hiraoka N. Prolonged persistence of SARS-CoV-2 infection during A+AVD therapy for classical Hodgkin's lymphoma: A case report. Curr Probl Cancer 2021;:100739. [PMID: 33810911 DOI: 10.1016/j.currproblcancer.2021.100739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
641 Ndlovu N, Ndarukwa S, Nyamhunga A, Musiwa-Mba P, Nyakabau AM, Kadzatsa W, Mushonga M. Education and training of clinical oncologists-experience from a low-resource setting in Zimbabwe. Ecancermedicalscience 2021;15:1208. [PMID: 33912233 DOI: 10.3332/ecancer.2021.1208] [Reference Citation Analysis]
642 Cori L, Curzio O, Adorni F, Prinelli F, Noale M, Trevisan C, Fortunato L, Giacomelli A, Bianchi F. Fear of COVID-19 for Individuals and Family Members: Indications from the National Cross-Sectional Study of the EPICOVID19 Web-Based Survey. Int J Environ Res Public Health 2021;18:3248. [PMID: 33801074 DOI: 10.3390/ijerph18063248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
643 Bernard A, Cottenet J, Bonniaud P, Piroth L, Arveux P, Tubert-Bitter P, Quantin C. Comparison of Cancer Patients to Non-Cancer Patients among COVID-19 Inpatients at a National Level. Cancers (Basel) 2021;13:1436. [PMID: 33801131 DOI: 10.3390/cancers13061436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
644 Boutros M, Moujaess E, Kourie HR. Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea. Crit Rev Oncol Hematol 2021;167:103273. [PMID: 33737160 DOI: 10.1016/j.critrevonc.2021.103273] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
645 Sipahi Karslı Z, Kurt B, Karadağ İ, Çakmak Öksüzoğlu B. Evaluation of Cancer Patients with Older Adult for Awareness and Hospital Arrival Process of COVID-19 Pandemic During: A Cross-Sectional Study. Gerontol Geriatr Med 2021;7:2333721421997666. [PMID: 33796629 DOI: 10.1177/2333721421997666] [Reference Citation Analysis]
646 Grivas P, Khaki AR, Wise-Draper TM, French B, Hennessy C, Hsu CY, Shyr Y, Li X, Choueiri TK, Painter CA, Peters S, Rini BI, Thompson MA, Mishra S, Rivera DR, Acoba JD, Abidi MZ, Bakouny Z, Bashir B, Bekaii-Saab T, Berg S, Bernicker EH, Bilen MA, Bindal P, Bishnoi R, Bouganim N, Bowles DW, Cabal A, Caimi PF, Chism DD, Crowell J, Curran C, Desai A, Dixon B, Doroshow DB, Durbin EB, Elkrief A, Farmakiotis D, Fazio A, Fecher LA, Flora DB, Friese CR, Fu J, Gadgeel SM, Galsky MD, Gill DM, Glover MJ, Goyal S, Grover P, Gulati S, Gupta S, Halabi S, Halfdanarson TR, Halmos B, Hausrath DJ, Hawley JE, Hsu E, Huynh-Le M, Hwang C, Jani C, Jayaraj A, Johnson DB, Kasi A, Khan H, Koshkin VS, Kuderer NM, Kwon DH, Lammers PE, Li A, Loaiza-Bonilla A, Low CA, Lustberg MB, Lyman GH, McKay RR, McNair C, Menon H, Mesa RA, Mico V, Mundt D, Nagaraj G, Nakasone ES, Nakayama J, Nizam A, Nock NL, Park C, Patel JM, Patel KG, Peddi P, Pennell NA, Piper-Vallillo AJ, Puc M, Ravindranathan D, Reeves ME, Reuben DY, Rosenstein L, Rosovsky RP, Rubinstein SM, Salazar M, Schmidt AL, Schwartz GK, Shah MR, Shah SA, Shah C, Shaya JA, Singh SRK, Smits M, Stockerl-Goldstein KE, Stover DG, Streckfuss M, Subbiah S, Tachiki L, Tadesse E, Thakkar A, Tucker MD, Verma AK, Vinh DC, Weiss M, Wu JT, Wulff-Burchfield E, Xie Z, Yu PP, Zhang T, Zhou AY, Zhu H, Zubiri L, Shah DP, Warner JL, Lopes G. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium. Ann Oncol 2021;32:787-800. [PMID: 33746047 DOI: 10.1016/j.annonc.2021.02.024] [Cited by in Crossref: 24] [Cited by in F6Publishing: 86] [Article Influence: 24.0] [Reference Citation Analysis]
647 Han Q, Wang J, Luo H, Li L, Lu X, Liu A, Deng Y, Jiang Y. TMBIM6, a potential virus target protein identified by integrated multiomics data analysis in SARS-CoV-2-infected host cells. Aging (Albany NY) 2021;13:9160-85. [PMID: 33744846 DOI: 10.18632/aging.202718] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
648 Ghidini M, Indini A, Rijavec E, Bareggi C, Cattaneo M, Tomasello G, Galassi B, Gambini D, Grossi F. The Appropriateness of Invasive Ventilation in COVID-19 Positive Cancer Patients: Proposal of a New Prognostic Score. Viruses 2021;13:508. [PMID: 33808623 DOI: 10.3390/v13030508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
649 Bestilleiro RS, Señaris DM, Rodríguez MJP, Vázquez RG, Rodríguez RG, Rodriguez MTG, Martín CG, Pillado MTS, Barreiro VB, Valiña VV, Díaz SP. Nosocomial Infection Outbreak due to SARS-COV-2 in a Hospital Unit of Particularly Vulnerable Patients. Int J Med Sci 2021;18:2146-54. [PMID: 33859521 DOI: 10.7150/ijms.53270] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
650 Yonal-Hindilerden I, Hindilerden F, Mastanzade M, Tiryaki TO, Tasan-Yenigun S, Bilen Y, Aksoz S, Cagatay AA, Nalcaci M. Case Report: Severe COVID-19 Pneumonia in a Patient With Relapsed/Refractory Hodgkin's Lymphoma. Front Oncol 2021;11:601709. [PMID: 33816231 DOI: 10.3389/fonc.2021.601709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
651 Zhang W, Gao Y, Hu G, Chu Q, Yuan X. Lymphocyte may be a reference index of the outcome of cancer patients with COVID-19. Aging (Albany NY) 2021;13:7733-44. [PMID: 33735106 DOI: 10.18632/aging.202741] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
652 Chernyshov SV, Romanova EM, Tarasov MA, Frolov SA, Rybakov EG, Vaganov YE. Organization of medical care for patients with colorectal cancer during coronavirus-19 pandemic (review). Koloproktologiâ 2021;20:53-8. [DOI: 10.33878/2073-7556-2021-20-1-53-58] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
653 Bumiller-Bini V, de Freitas Oliveira-Toré C, Carvalho TM, Kretzschmar GC, Gonçalves LB, Alencar NM, Gasparetto Filho MA, Beltrame MH, Winter Boldt AB. MASPs at the crossroad between the complement and the coagulation cascades - the case for COVID-19. Genet Mol Biol 2021;44:e20200199. [PMID: 33729332 DOI: 10.1590/1678-4685-GMB-2020-0199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
654 Carosi G, Morelli V, Del Sindaco G, Serban AL, Cremaschi A, Frigerio S, Rodari G, Profka E, Indirli R, Mungari R, Resi V, Orsi E, Ferrante E, Dolci A, Giavoli C, Arosio M, Mantovani G. Adrenal Insufficiency at the Time of COVID-19: A Retrospective Study in Patients Referring to a Tertiary Center. J Clin Endocrinol Metab 2021;106:e1354-61. [PMID: 33107576 DOI: 10.1210/clinem/dgaa793] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
655 Pigozzi E, Tregnago D, Costa L, Insolda J, Turati E, Rimondini M, Donisi V, Madera P, Fiorica F, Giuliani J, Greco F, Mercanti A, Trolese A, Furlani L, Piacentini P, Durante E, Mandarà M, Pilotto S, Avancini A, Trestini I, Zaninelli M, Moretti F, Milella M, Bonetti A. Psychological impact of Covid-19 pandemic on oncological patients: A survey in Northern Italy. PLoS One 2021;16:e0248714. [PMID: 33724999 DOI: 10.1371/journal.pone.0248714] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
656 Di Cosimo S, Tagliaferri B, Generali D, Giudici F, Agustoni F, Bernardo A, Borgonovo K, Farina G, Luchena G, Luciani A, Nolè F, Palmeri L, Pietrantonio F, Poggi G, Zucali PA, Balletti E, Catania G, Bernocchi O, D'Antonio F, Giordano M, Grossi F, Lasagna A, La Verde N, Manzoni M, Montagna B, Olgiati A, Raimondi A, Rampinelli I, Verri E, Zaniboni A, Di Maio M, Beretta G, Danova M. Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study. Cancers (Basel) 2021;13:1324. [PMID: 33809465 DOI: 10.3390/cancers13061324] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
657 Ye T, Xu R, Yu W, Chen Z, Guo Y, Li S. Vulnerability and Burden of All-Cause Mortality Associated with Particulate Air Pollution during COVID-19 Pandemic: A Nationwide Observed Study in Italy. Toxics 2021;9:56. [PMID: 33804264 DOI: 10.3390/toxics9030056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
658 Amere Subbarao S. Cancer vs. SARS-CoV-2 induced inflammation, overlapping functions, and pharmacological targeting. Inflammopharmacology 2021;29:343-66. [PMID: 33723711 DOI: 10.1007/s10787-021-00796-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
659 Singh B, Ayad S, Kaur P, Reid RJ, Gupta S, Maroules M. COVID-19-Induced Hyperleucocytosis in Chronic Lymphocytic Leukaemia. Eur J Case Rep Intern Med 2021;8:002348. [PMID: 33869094 DOI: 10.12890/2021_002348] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
660 Yashavantha Rao HC, Siddeeqh S, Taqui SN. Caring for cancer patients during COVID-19 global pandemic: Risk factors and precautionary principle. Int J Clin Pract 2021;75:e14141. [PMID: 33715304 DOI: 10.1111/ijcp.14141] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
661 Ralli M, Arcangeli A, Soave PM, Carbone L, Ercoli L, De-Giorgio F. Impact of COVID-19 pandemic on the medical activities of the Directorate of Health and Hygiene, Vatican City State. J Intern Med 2021;290:213-9. [PMID: 33713500 DOI: 10.1111/joim.13251] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
662 Elliott A, Saul M, Zeng J, Marshall JL, Kim ES, Nagasaka M, Lenz HJ, Schwartzberg L, Spetzler D, Abraham J, Xiu J, Stafford P, Michael Korn W. Pan-cancer analysis of RNA expression of ANGIOTENSIN-I-CONVERTING ENZYME 2 reveals high variability and possible impact on COVID-19 clinical outcomes. Sci Rep 2021;11:5639. [PMID: 33707526 DOI: 10.1038/s41598-021-84731-7] [Reference Citation Analysis]
663 Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, Halfon-Domenech C, Leblanc T, Leverger G, Michel G, Petit A, Ray-Lunven AF, Rohrlich PS, Schneider P, Sirvent N, Strullu M, Baruchel A; Leukemia Committee of the SFCE. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bull Cancer 2021;108:490-500. [PMID: 33781551 DOI: 10.1016/j.bulcan.2021.02.004] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
664 He C, Hua X, Sun S, Li S, Wang J, Huang X. Integrated Bioinformatic Analysis of SARS-CoV-2 Infection Related Genes ACE2, BSG and TMPRSS2 in Aerodigestive Cancers. J Inflamm Res 2021;14:791-802. [PMID: 33732005 DOI: 10.2147/JIR.S300127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
665 Pendyala P, Goglia AG, Mattes MD, Grann A, Huang D, Wagman RT, Yehia ZA, Yoon J, Ennis RD. Impact of the Coronavirus Disease of 2019 Pandemic on Radiation Oncology Clinical Decision Making in a High-Prevalence Environment. Adv Radiat Oncol 2021;6:100680. [PMID: 33686375 DOI: 10.1016/j.adro.2021.100680] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
666 Finn RS, Rugo HS, Gelmon KA, Cristofanilli M, Colleoni M, Loi S, Schnell P, Lu DR, Theall KP, Mori A, Gauthier E, Bananis E, Turner NC, Diéras V. Long-Term Pooled Safety Analysis of Palbociclib in Combination with Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Updated Analysis with up to 5 Years of Follow-Up. Oncologist 2021;26:e749-55. [PMID: 33486783 DOI: 10.1002/onco.13684] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
667 Xiao H, Luo Y, Shi J, Jin A, Mohty M, Nagler A, Gale RP, Huang H. How Do We Manage Hematopoietic Cell Transplant during the SARS-CoV-2 Pandemic? Acta Haematol 2021;144:500-7. [PMID: 33690228 DOI: 10.1159/000513036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
668 Barik SK, Dhar SS, Majumdar SKD, Parida DK. Tweaking of radiation and chemotherapy schedules is the new normal during the COVID-19 crisis: perspective from oncologists at a tertiary care health institute. Ecancermedicalscience 2021;15:1177. [PMID: 33680091 DOI: 10.3332/ecancer.2021.1177] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
669 Cavanna L, Citterio C, Di Nunzio C, Biasini C, Palladino MA, Ambroggi M, Madaro S, Bidin L, Porzio R, Proietto M. Prevalence of COVID-19 Infection in Asymptomatic Cancer Patients in a District With High Prevalence of SARS-CoV-2 in Italy. Cureus 2021;13:e13774. [PMID: 33842150 DOI: 10.7759/cureus.13774] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
670 Rashid HU, Rashid M, Khan N, Ansari SS, Bibi N. Taking a step down on the reconstruction ladder for head and neck reconstruction during the COVID-19 pandemic. BMC Surg 2021;21:120. [PMID: 33685447 DOI: 10.1186/s12893-021-01134-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
671 Eshagh Hossaini SK, Movahedi Z, Hormati A, Heydari H, Eshagh Hosseini SJ, Khodadust F, Afifian M, Ahmadpour S. Coronavirus disease 2019 in a 13-year-old patient with acute lymphoblastic leukemia. Clin Exp Pediatr 2021;64:247-50. [PMID: 33705634 DOI: 10.3345/cep.2020.01711] [Reference Citation Analysis]
672 Cortinovis D, Bidoli P, Canova S, Colonese F, Gemelli M, Lavitrano ML, Banna GL, Liu SV, Morabito A. Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma. Cancers (Basel) 2021;13:1152. [PMID: 33800236 DOI: 10.3390/cancers13051152] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
673 Yang L, Chai P, Yu J, Fan X. Effects of cancer on patients with COVID-19: a systematic review and meta-analysis of 63,019 participants. Cancer Biol Med 2021;18:298-307. [PMID: 33628602 DOI: 10.20892/j.issn.2095-3941.2020.0559] [Cited by in Crossref: 6] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
674 Yuen KCJ, Mortensen MJ, Azadi A, Fonkem E, Findling JW. Rethinking the management of immune checkpoint inhibitor-related adrenal insufficiency in cancer patients during the COVID-19 pandemic. Endocrinol Diabetes Metab 2021;4:e00246. [PMID: 34268454 DOI: 10.1002/edm2.246] [Reference Citation Analysis]
675 de Cássio Zequi S, Franca Silva ILA, Duprat JP, Coimbra FJF, Gross JL, Vartanian JG, Makdissi FBA, Leite FPM, Costa WHD, Yazbek G, Joaquim EHG, Bussolotti RM, Caruso P, de Ávila Lima MC, Nakagawa SA, Aguiar S Jr, Baiocchi G, Lopes A, Kowalski LP. Informed consent and a risk-based approach to oncologic surgery in a cancer center during the COVID-19 pandemic. J Surg Oncol 2021;123:1659-68. [PMID: 33684245 DOI: 10.1002/jso.26452] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
676 Bacalbasa N, Diaconu C, Savu C, Savu C, Stiru O, Balescu I. The Impact of COVID-19 Infection on the Postoperative Outcomes in Pancreatic Cancer Patients. In Vivo 2021;35:1307-11. [PMID: 33622935 DOI: 10.21873/invivo.12383] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
677 Pombo AAM, Lenz L, Paulo GA, Santos MA, Tamae PK, Santos ALDR, Rezende DT, Martins B, Kawaguti FS, Pennachi CMPS, Gusmon-Oliveira CC, Uemura RS, Geiger S, Lima MS, Baba ER, Figueiredo VR, Safatle-Ribeiro A, Maluf-Filho F, Ribeiro-Júnior U. Endoscopy infection control strategy during the COVID-19 pandemic: experience from a tertiary cancer center in Brazil. Clinics (Sao Paulo) 2021;76:e2280. [PMID: 33681942 DOI: 10.6061/clinics/2021/e2280] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
678 Barba M, Krasniqi E, Pizzuti L, Mazzotta M, Marinelli D, Giuliano G, Di Liso FS, Cappuzzo F, Landi L, Tomao S, Ciliberto G, Vici P. COVID-19 risk in breast cancer patients receiving CDK4/6 inhibitors: literature data and a monocentric experience. Breast J 2021;27:359-62. [PMID: 33677841 DOI: 10.1111/tbj.14204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
679 Estiri H, Strasser ZH, Murphy SN. Individualized prediction of COVID-19 adverse outcomes with MLHO. Sci Rep 2021;11:5322. [PMID: 33674708 DOI: 10.1038/s41598-021-84781-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
680 Mittaine-Marzac B, Zogo A, Crusson JC, Cheneau V, Pinel MC, Brandely-Piat ML, Amrani F, Havard L, Balladur E, Louissaint T, Nivet L, Ankri J, Aegerter P, De Stampa M. COVID-19 outbreak: An experience to reappraise the role of hospital at home in the anti-cancer drug injection. Cancer Med 2021;10:2242-9. [PMID: 33665971 DOI: 10.1002/cam4.3682] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
681 Granata V, Fusco R, Izzo F, Venanzio Setola S, Coppola M, Grassi R, Reginelli A, Cappabianca S, Grassi R, Petrillo A. Covid-19 infection in cancer patients: the management in a diagnostic unit. Radiol Oncol 2021;55:121-9. [PMID: 33675200 DOI: 10.2478/raon-2021-0010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
682 Li Z, Jiang Y, Yu Y, Kang Q. Effect of COVID-19 Pandemic on Diagnosis and Treatment Delays in Urological Disease: Single-Institution Experience. Risk Manag Healthc Policy 2021;14:895-900. [PMID: 33692641 DOI: 10.2147/RMHP.S299233] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Souchelnytskyi S, Nera A, Souchelnytskyi N. COVID-19 engages clinical markers for the management of cancer and cancer-relevant regulators of cell proliferation, death, migration, and immune response. Sci Rep 2021;11:5228. [PMID: 33664395 DOI: 10.1038/s41598-021-84780-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
684 Skladany L, Koller T, Adamcova Selcanova S, Vnencakova J, Jancekova D, Durajova V, Laffers L, Svac J, Janickova K, Palkovič M, Kohout P, Golubnitschaja O. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context. EPMA J 2021;:1-14. [PMID: 33680218 DOI: 10.1007/s13167-021-00231-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
685 Francolini G, Desideri I, Stocchi G, Ciccone LP, Salvestrini V, Garlatti P, Aquilano M, Greto D, Bonomo P, Meattini I, Scotti V, Scoccianti S, Simontacchi G, Livi L. Impact of COVID-19 on workload burden of a complex radiotherapy facility. Radiol Med 2021;126:717-21. [PMID: 33646520 DOI: 10.1007/s11547-021-01338-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
686 Fu Z, Jiang M, Wang K, Li J. Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital. J Med Internet Res 2021;23:e26799. [PMID: 33591924 DOI: 10.2196/26799] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
687 Tassone D, Thompson A, Connell W, Lee T, Ungaro R, An P, Ding Y, Ding NS. Immunosuppression as a risk factor for COVID-19: a meta-analysis. Intern Med J 2021;51:199-205. [PMID: 33631862 DOI: 10.1111/imj.15142] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
688 Khalifeh YI, Tfayli AH. Managing Lung Cancer during Coronavirus Disease 2019 Pandemic. Turk Thorac J 2021;22:163-8. [PMID: 33871341 DOI: 10.5152/TurkThoracJ.2021.20110] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
689 Zhu A, Chen Z, Wang Y, Zeng Q, Sun J, Zhuang Z, Li F, Zhao J, Zhao J, Zhong N. Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice. Fundamental Research 2021;1:124-30. [DOI: 10.1016/j.fmre.2021.03.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
690 Tabrizi S, Trippa L, Cagney D, Aizer AA, Tanguturi S, Ventz S, Fell G, Bellon JR, Mamon H, Nguyen PL, D'Amico AV, Haas-Kogan D, Alexander BM, Rahman R. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. JAMA Netw Open 2021;4:e213304. [PMID: 33779742 DOI: 10.1001/jamanetworkopen.2021.3304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
691 Høyer M, Grau C. Research in radiation oncology and the Covid-19 pandemic. Acta Oncol 2021;60:275-6. [PMID: 33651648 DOI: 10.1080/0284186X.2021.1890334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
692 Wadasadawala T, Sen S, Watekar R, Rane P, Sarin R, Gupta S, Parmar V, Kannan S, Mohanty SK. Economic Distress of Breast Cancer Patients Seeking Treatment at a Tertiary Cancer Center in Mumbai during COVID-19 Pandemic: A Cohort Study. Asian Pac J Cancer Prev 2021;22:793-800. [PMID: 33773543 DOI: 10.31557/APJCP.2021.22.3.793] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
693 Mandala M, Lorigan P, De Luca M, Bianchetti A, Merelli B, Bettini AC, Bonomi L, Nahm S, Vitale MG, Negrini G, Di Croce A, Ascierto PA, Rulli E, Tondini CA. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study. J Immunother Cancer 2021;9:e001694. [PMID: 33593827 DOI: 10.1136/jitc-2020-001694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
694 De B, Kaiser KW, Ludmir EB, Yeboa DN, Tang C, Hoffman KE, Liao Z, Koong AC, Smith BD. Radiotherapy clinical trial enrollment during the COVID-19 pandemic. Acta Oncol 2021;60:312-5. [PMID: 33356801 DOI: 10.1080/0284186X.2020.1865564] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
695 Durand M, Bentellis I, Barthe F, Tibi B, Shaikh A, Mellouki A, Berthet JP, Legueult K, Pradier C, Piche T, Ahallal Y, Chevallier D. [Outcomes following the triage of patients for urological cancer and non-cancer surgery during Covid-19 pandemic peak]. Prog Urol 2021:S1166-7087(21)00031-2. [PMID: 34256992 DOI: 10.1016/j.purol.2021.02.007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
696 Becerra-Muñoz VM, Núñez-Gil IJ, Eid CM, García Aguado M, Romero R, Huang J, Mulet A, Ugo F, Rametta F, Liebetrau C, Aparisi A, Fernández-Rozas I, Viana-Llamas MC, Feltes G, Pepe M, Moreno-Rondón LA, Cerrato E, Raposeiras-Roubín S, Alfonso E, Carrero-Fernández A, Buzón-Martín L, Abumayyaleh M, Gonzalez A, Fernández Ortiz A, Macaya C, Estrada V, Fernández-Pérez C, Gómez-Doblas JJ. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing 2021;50:326-34. [PMID: 33201181 DOI: 10.1093/ageing/afaa258] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 23.0] [Reference Citation Analysis]
697 Yildirim OA, Poyraz K, Erdur E. Depression and anxiety in cancer patients before and during the SARS-CoV-2 pandemic: association with treatment delays. Qual Life Res 2021;30:1903-12. [PMID: 33635508 DOI: 10.1007/s11136-021-02795-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
698 Bäuerle A, Musche V, Schmidt K, Schweda A, Fink M, Weismüller B, Kohler H, Herrmann K, Tewes M, Schadendorf D, Skoda EM, Teufel M. Mental Health Burden of German Cancer Patients before and after the Outbreak of COVID-19: Predictors of Mental Health Impairment. Int J Environ Res Public Health 2021;18:2318. [PMID: 33652949 DOI: 10.3390/ijerph18052318] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
699 Kwan JYY, Lin LT, Bell R, Bruce JP, Richardson C, Pugh TJ, Liu FF. Elevation in viral entry genes and innate immunity compromise underlying increased infectivity and severity of COVID-19 in cancer patients. Sci Rep 2021;11:4533. [PMID: 33633121 DOI: 10.1038/s41598-021-83366-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
700 Kaikani W, Mohammed SH. Challenges posed by COVID -19 to patients with cancer: lessons from a Moroccan experience. Pan Afr Med J 2020;35:62. [PMID: 33623586 DOI: 10.11604/pamj.supp.2020.35.2.22585] [Reference Citation Analysis]
701 Yin Y, Liu XZ, He X, Zhou LQ. Exogenous Coronavirus Interacts With Endogenous Retrotransposon in Human Cells. Front Cell Infect Microbiol 2021;11:609160. [PMID: 33732659 DOI: 10.3389/fcimb.2021.609160] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
702 Chaudhari S, Dey Pereira S, Asare-Warehene M, Naha R, Kabekkodu SP, Tsang BK, Satyamoorthy K. Comorbidities and inflammation associated with ovarian cancer and its influence on SARS-CoV-2 infection. J Ovarian Res 2021;14:39. [PMID: 33632295 DOI: 10.1186/s13048-021-00787-z] [Reference Citation Analysis]
703 Appel S, Lawrence YR, Symon Z, Kaidar-Person O. COVID-RO study: the radiation oncology practice at times of COVID-19 outbreak - international survey. Rep Pract Oncol Radiother 2021;26:20-8. [PMID: 33948298 DOI: 10.5603/RPOR.a2021.0003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
704 Moreira DC, Sniderman E, Mukkada S, Chantada G, Bhakta N, Foster W, Avula M, Homsi MR, Faughnan L, Happ B, Andujar A, Sonnenfelt J, Dalvi R, Frazier AL, Hessissen L, Kearns PR, Luna-Fineman S, Moreno A, Saghir Khan M, Sullivan M, Devidas M, Santana V, Caniza M, Pritchard-Jones K, Rodriguez-Galindo C. The Global COVID-19 Observatory and Resource Center for Childhood Cancer: A response for the pediatric oncology community by SIOP and St. Jude Global. Pediatr Blood Cancer 2021;68:e28962. [PMID: 33629507 DOI: 10.1002/pbc.28962] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
705 Moslim MA, Hall MJ, Meyer JE, Reddy SS. Pancreatic cancer in the era of COVID-19 pandemic: Which one is the lesser of two evils? World J Clin Oncol 2021; 12(2): 54-60 [PMID: 33680873 DOI: 10.5306/wjco.v12.i2.54] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
706 Kaddu-Mulindwa D, Thurner L, Bewarder M, Murawski N, Ahlgrimm M, Pfuhl T, Gärtner B, Smola S, Stilgenbauer S. Protection strategy against outbreak of COVID-19 at a tertiary hematology-oncology: strengths and pitfalls. Infect Agent Cancer 2021;16:17. [PMID: 33627114 DOI: 10.1186/s13027-021-00356-5] [Reference Citation Analysis]
707 Venkatesulu BP, Chandrasekar VT, Girdhar P, Advani P, Sharma A, Elumalai T, Hsieh CE, Elghazawy HI, Verma V, Krishnan S. A Systematic Review and Meta-Analysis of Cancer Patients Affected by a Novel Coronavirus. JNCI Cancer Spectr 2021;5:pkaa102. [PMID: 33875976 DOI: 10.1093/jncics/pkaa102] [Cited by in Crossref: 4] [Cited by in F6Publishing: 28] [Article Influence: 4.0] [Reference Citation Analysis]
708 Li Z, Chen Y, Yang B, Song H, Chen W, Zhou H. Successful recovery of a patient with multiple myeloma from severe coronavirus disease 2019 (COVID-19) pneumonia during the first chemotherapy cycle: A case report. Exp Ther Med 2021;21:392. [PMID: 33680114 DOI: 10.3892/etm.2021.9823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
709 Donamou J, Touré A, Camara AY, Camara D, Camara ML, Traoré AD, Camara MM, Bangoura A, Dramé BA, Sossa LK, Abékan JR, Edemessi AI, Saliou SM. Predictive factors of mortality in patients with COVID-19 in Guinea: analysis of the first 140 cases admitted to intensive care unit. Pan Afr Med J 2021;38:205. [PMID: 33995811 DOI: 10.11604/pamj.2021.38.205.27078] [Reference Citation Analysis]
710 Brosey CA, Houl JH, Katsonis P, Balapiti-Modarage LPF, Bommagani S, Arvai A, Moiani D, Bacolla A, Link T, Warden LS, Lichtarge O, Jones DE, Ahmed Z, Tainer JA. Targeting SARS-CoV-2 Nsp3 macrodomain structure with insights from human poly(ADP-ribose) glycohydrolase (PARG) structures with inhibitors. Prog Biophys Mol Biol 2021;163:171-86. [PMID: 33636189 DOI: 10.1016/j.pbiomolbio.2021.02.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
711 Benbrahim Z, Mula-Hussain L, Al-Shamsi HO, El Saghir N, Al Asiri M, Al Bahrani B, Al Nassar M, Bounedjar A, Fahed Z, Khatib S, Khorshid O, Labidi S, Mellas N, Saleh A, Jazieh A. National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemic. Ecancermedicalscience 2021;15:1189. [PMID: 33889198 DOI: 10.3332/ecancer.2021.1189] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
712 Wang W, Guo B, Cui C, Sun T, Liu S. Management of early-stage breast cancer patients during the coronavirus disease 2019 (COVID-19) pandemic: The experience in China from a surgical standpoint. J Cancer 2021;12:2190-8. [PMID: 33758597 DOI: 10.7150/jca.50501] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
713 Yin T, Li Y, Ying Y, Luo Z. Prevalence of comorbidity in Chinese patients with COVID-19: systematic review and meta-analysis of risk factors. BMC Infect Dis 2021;21:200. [PMID: 33618678 DOI: 10.1186/s12879-021-05915-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
714 Zhan GF, Wang Y, Yang N, Luo AL, Li SY. Digestive system involvement of infections with SARS-CoV-2 and other coronaviruses: Clinical manifestations and potential mechanisms. World J Gastroenterol 2021; 27(7): 561-575 [PMID: 33642829 DOI: 10.3748/wjg.v27.i7.561] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
715 Hoffmann MS. Towards Better Understanding of COVID-19 Infection in Cancer Patients. JNCI Cancer Spectr 2021;5:pkaa091. [PMID: 33604510 DOI: 10.1093/jncics/pkaa091] [Reference Citation Analysis]
716 Bai J, Chu H, Ma S, Ge Q. Clinical features and prognosis of patients with COVID-19 after lung surgery: A retrospective clinical study. Asia Pac J Clin Oncol 2021. [PMID: 33609000 DOI: 10.1111/ajco.13517] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
717 Chen Z, Zhang C, Yin J, Xin X, Li H, Wang Y, Tsang BK, Zhang Q. Challenges and opportunities for ovarian cancer management in the epidemic of Covid-19: lessons learned from Wuhan, China. J Ovarian Res 2021;14:35. [PMID: 33602258 DOI: 10.1186/s13048-021-00784-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
718 Maurer K, Saucier A, Kim HT, Acharya U, Mo CC, Porter J, Albert C, Cutler C, Antin JH, Koreth J, Gooptu M, Romee R, Wu CJ, Soiffer RJ, Nikiforow S, Jacobson C, Ho VT. COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience. Blood Adv 2021;5:861-71. [PMID: 33560397 DOI: 10.1182/bloodadvances.2020003883] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
719 Fu J, Wei C, He J, Zhang L, Zhou J, Balaji KS, Shen S, Peng J, Sharma A, Fu J. Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19. Int J Biol Sci 2021;17:897-910. [PMID: 33767597 DOI: 10.7150/ijbs.54055] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
720 Pezeshki PS, Rezaei N. Immune checkpoint inhibition in COVID-19: risks and benefits. Expert Opin Biol Ther 2021;:1-7. [PMID: 33543652 DOI: 10.1080/14712598.2021.1887131] [Cited by in Crossref: 4] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
721 Ningombam SS, Kumar R, Tanwar P. Mutant strains of SARS-CoV-2 are more prone to infect obese patient: a review. Wien Klin Wochenschr 2021;133:383-92. [PMID: 33595720 DOI: 10.1007/s00508-021-01819-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
722 Tomacruz ID, So PN, Pasilan RM, Camenforte JK, Duavit MI. Clinical Characteristics and Short-Term Outcomes of Chronic Dialysis Patients Admitted for COVID-19 in Metro Manila, Philippines. Int J Nephrol Renovasc Dis 2021;14:41-51. [PMID: 33628044 DOI: 10.2147/IJNRD.S287455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
723 Onesti CE, Tagliamento M, Curigliano G, Harbeck N, Bartsch R, Wildiers H, Tjan-Heijnen V, Martin M, Rottey S, Generali D, Campone M, Cristofanilli M, Pusztai L, Peeters M, Berchem G, Cortes J, Ruhstaller T, Ciruelos E, Rugo HS, Jerusalem G. Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology. JCO Glob Oncol 2021;7:162-72. [PMID: 33529077 DOI: 10.1200/GO.20.00589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
724 Singh B, Ayad S, Kaur P, Kumar V, Gupta S, Maroules M. COVID-19-Induced Pancytopenia in a Major Molecular Response CML Patient on Dasatinib: A Case Report and Review of the Literature. Eur J Case Rep Intern Med 2021;8:002233. [PMID: 33585346 DOI: 10.12890/2021_002233] [Reference Citation Analysis]
725 Derruau S, Bouchet J, Nassif A, Baudet A, Yasukawa K, Lorimier S, Prêcheur I, Bloch-Zupan A, Pellat B, Chardin H, Jung S, On Behalf Of Task Force Covid-Collège National des EnseignantS En Biologie Orale Cnesbo-France. COVID-19 and Dentistry in 72 Questions: An Overview of the Literature. J Clin Med 2021;10:779. [PMID: 33669185 DOI: 10.3390/jcm10040779] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
726 Lin DD, Wu Y, Toom S, Sheth N, Becker K, Burdette-Radoux S, D'Silva J, Huang Y, Lipshitz J, Meghal T, Mo L, Murthy P, Rubin P, Natarajan V, Donahue B, Xu Y. Clinical Determinants Differentiating the Severity of SARS-CoV-2 Infection in Cancer Patients: Hospital Care or Home Recovery. Front Med (Lausanne) 2021;8:604221. [PMID: 33665196 DOI: 10.3389/fmed.2021.604221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
727 Goel D, Kumar S. Co-morbid conditions in COVID-19 patients in Uttarakhand state of India. J Glob Health 2021;11:03029. [PMID: 33692884 DOI: 10.7189/jogh.11.03029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
728 Siqueira JD, Goes LR, Alves BM, da Silva ACP, de Carvalho PS, Cicala C, Arthos J, Viola JPB, Soares MA. Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation. Infect Genet Evol 2021;90:104772. [PMID: 33592317 DOI: 10.1016/j.meegid.2021.104772] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
729 Shang J, Du L, Han N, Lv D, Wang J, Yang H, Bai L, Tang H. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review). Mol Med Rep 2021;23:262. [PMID: 33576464 DOI: 10.3892/mmr.2021.11901] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
730 Naveed M, Naeem M, Ur Rahman M, Gul Hilal M, Kakakhel MA, Ali G, Hassan A. Review of potential risk groups for coronavirus disease 2019 (COVID-19). New Microbes New Infect 2021;41:100849. [PMID: 33614041 DOI: 10.1016/j.nmni.2021.100849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
731 Wimberly CE, Towry L, Caudill C, Johnston EE, Walsh KM. Impacts of COVID-19 on caregivers of childhood cancer survivors. Pediatr Blood Cancer 2021;68:e28943. [PMID: 33565259 DOI: 10.1002/pbc.28943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
732 Ferry OR, Moloney EC, Spratt OT, Whiting GFM, Bennett CJ. A Virtual Ward Model of Care for Patients With COVID-19: Retrospective Single-Center Clinical Study. J Med Internet Res 2021;23:e25518. [PMID: 33529157 DOI: 10.2196/25518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
733 Gozzi-Silva SC, Benard G, Alberca RW, Yendo TM, Teixeira FME, Oliveira LM, Beserra DR, Pietrobon AJ, Oliveira EA, Branco ACCC, Andrade MMS, Fernandes IG, Pereira NZ, Ramos YÁL, Lima JC, Provenci B, Mangini S, Duarte AJDS, Sato MN. SARS-CoV-2 Infection and CMV Dissemination in Transplant Recipients as a Treatment for Chagas Cardiomyopathy: A Case Report. Trop Med Infect Dis 2021;6:22. [PMID: 33579042 DOI: 10.3390/tropicalmed6010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
734 Regalado-Artamendi I, Jiménez-Ubieto A, Hernández-Rivas JÁ, Navarro B, Núñez L, Alaez C, Córdoba R, Peñalver FJ, Cannata J, Estival P, Quiroz-Cervantes K, Riaza Grau R, Velasco A, Martos R, Domingo-González A, Benito-Parra L, Gómez-Sanz E, López-Jiménez J, Matilla A, Herraez MR, Penalva MJ, García-Suárez J, Díez-Martín JL, Bastos-Oreiro M. Risk Factors and Mortality of COVID-19 in Patients With Lymphoma: A Multicenter Study. Hemasphere 2021;5:e538. [PMID: 33604516 DOI: 10.1097/HS9.0000000000000538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
735 Duzagac F, Saorin G, Memeo L, Canzonieri V, Rizzolio F. Microfluidic Organoids-on-a-Chip: Quantum Leap in Cancer Research. Cancers (Basel) 2021;13:737. [PMID: 33578886 DOI: 10.3390/cancers13040737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
736 Palka-Kotlowska M, Custodio-Cabello S, Oliveros-Acebes E, Khosravi-Shahi P, Cabezón-Gutierrez L. Review of risk of COVID-19 in cancer patients and their cohabitants. Int J Infect Dis 2021;105:15-20. [PMID: 33556611 DOI: 10.1016/j.ijid.2021.01.072] [Reference Citation Analysis]
737 Li P, Li L, Wang S, Liu Y, Li Z, Xia S. Effect of antitumor therapy on cancer patients infected by SARS-CoV-2: A systematic review and meta-analysis. Cancer Med 2021;10:1644-55. [PMID: 33547886 DOI: 10.1002/cam4.3754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
738 Takeda FR, Obregon CA, Navarro YP, Santo Filho MA, Ribeiro Junior U, Sallum RAA, Cecconello I. Management of Respiratory Failure Caused by COVID-19 after Thoracoscopic Esophagectomy. Clinics (Sao Paulo) 2021;76:e2483. [PMID: 33567049 DOI: 10.6061/clinics/2021/e2483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
739 Shu L, Liu Y, Li J, Wu X, Li Y, Huang H. Landscape Profiling Analysis of DPP4 in Malignancies: Therapeutic Implication for Tumor Patients With Coronavirus Disease 2019. Front Oncol 2021;11:624899. [PMID: 33614513 DOI: 10.3389/fonc.2021.624899] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
740 Srithumsuk W, Wangnum K. "New Normal" Home Chemotherapy in Thailand: How the Challenging Roles of Nurses Are Changing? Asia Pac J Oncol Nurs 2021;8:340-3. [PMID: 33850969 DOI: 10.4103/apjon.apjon_54_20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
741 Ramani VK, Naik R. A narrative review of the pathophysiology of COVID-19 infection among cancer patients: Current evidence and research perspectives. Health Sci Rep 2021;4:e237. [PMID: 33532600 DOI: 10.1002/hsr2.237] [Reference Citation Analysis]
742 Belsky JA, Tullius BP, Lamb MG, Sayegh R, Stanek JR, Auletta JJ. COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients. J Infect 2021;82:329-38. [PMID: 33549624 DOI: 10.1016/j.jinf.2021.01.022] [Cited by in Crossref: 11] [Cited by in F6Publishing: 51] [Article Influence: 11.0] [Reference Citation Analysis]
743 Vohra LM, Jabeen D, Asif N, Ahad A. COVID-19 pandemic and breast cancer management: A retrospective observational clinical study from Pakistan. Ann Med Surg (Lond) 2021;63:102151. [PMID: 33564461 DOI: 10.1016/j.amsu.2021.01.099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
744 Ren W, Liang P, Ma Y, Sun Q, Pu Q, Dong L, Luo G, Mazhar M, Liu J, Wang R, Yang S. Research progress of traditional Chinese medicine against COVID-19. Biomed Pharmacother 2021;137:111310. [PMID: 33761591 DOI: 10.1016/j.biopha.2021.111310] [Cited by in Crossref: 9] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
745 Faro JM, Mattocks KM, Nagawa CS, Lemon SC, Wang B, Cutrona SL, Sadasivam RS. Physical Activity, Mental Health, and Technology Preferences to Support Cancer Survivors During the COVID-19 Pandemic: Cross-sectional Study. JMIR Cancer 2021;7:e25317. [PMID: 33471776 DOI: 10.2196/25317] [Cited by in Crossref: 2] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
746 Elgohary S, Elkhodiry AA, Amin NS, Stein U, El Tayebi HM. Thymoquinone: A Tie-Breaker in SARS-CoV2-Infected Cancer Patients? Cells 2021;10:302. [PMID: 33540625 DOI: 10.3390/cells10020302] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
747 Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy 2021;76:428-55. [PMID: 33185910 DOI: 10.1111/all.14657] [Cited by in Crossref: 282] [Cited by in F6Publishing: 270] [Article Influence: 282.0] [Reference Citation Analysis]
748 Imamura R, Bento RF, Matos LL, William WN Jr, Marta GN, Chaves ALF, Castro G Jr, Kowalski LP. Impact of the COVID-19 Pandemic on Physicians Working in the Head and Neck Field. Int Arch Otorhinolaryngol 2021;25:e150-9. [PMID: 33542765 DOI: 10.1055/s-0040-1722254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
749 Khusid JA, Becerra AZ, Gallante B, Sadiq AS, Atallah WM, Badani KK, Gupta M. Cancer, Mortality, and Acute Kidney Injury among Hospitalized Patients with SARS-CoV-2 Infection. Asian Pac J Cancer Prev 2021;22:517-22. [PMID: 33639668 DOI: 10.31557/APJCP.2021.22.2.517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
750 Dziedzic R, Marjański T, Rzyman W. A narrative review of invasive diagnostics and treatment of early lung cancer. Transl Lung Cancer Res 2021;10:1110-23. [PMID: 33718049 DOI: 10.21037/tlcr-20-728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
751 Fernandes GA, Feriani D, França E Silva ILA, Mendonça E Silva DR, Arantes PE, Canteras JDS, da Silva RR, Curado MP. Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center. Semin Oncol 2021:S0093-7754(21)00003-8. [PMID: 33573780 DOI: 10.1053/j.seminoncol.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
752 Dong G, Du Z, Zhu J, Guo Y, Gao W, Guo W, Wang T, Jiang B. The clinical characteristics and prognosis of COVID-19 patients with comorbidities: a retrospective analysis of the infection peak in Wuhan. Ann Transl Med 2021;9:280. [PMID: 33708907 DOI: 10.21037/atm-20-4052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
753 Mirgh S, Gokarn A, Punatar S, Chichra A, Singh A, Rajendra A, Babu Goli V, Trivedi B, Joshi A, Patkar N, Tembhare P, Subramanian PG, Shetty N, Chavan P, Bhat V, Gupta S, Khattry N. Clinical course of severe COVID19 treated with tocilizumab and antivirals post-allogeneic stem cell transplant with extensive chronic GVHD. Transpl Infect Dis 2021;:e13576. [PMID: 33523551 DOI: 10.1111/tid.13576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
754 Chia JMX, Goh ZZS, Chua ZY, Ng KYY, Ishak D, Fung SM, Ngeow JYY, Griva K. Managing cancer in context of pandemic: a qualitative study to explore the emotional and behavioural responses of patients with cancer and their caregivers to COVID-19. BMJ Open 2021;11:e041070. [PMID: 33518518 DOI: 10.1136/bmjopen-2020-041070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
755 Waqar M, Ong K, Moubasher A, Rehman OF, Bhopal KF, Makanjuola J. Triage of urology service to cope with COVID-19 pandemic: A single institution study. EXCLI J 2021;20:46-51. [PMID: 33510591 DOI: 10.17179/excli2020-3135] [Reference Citation Analysis]
756 Yousefi Sharami SR, Yousefnezhad A, Nokhostin F. An immune-centric investigation of Coronavirus in the women with cancers; A review article. J Family Med Prim Care 2021;10:56-61. [PMID: 34017703 DOI: 10.4103/jfmpc.jfmpc_989_20] [Reference Citation Analysis]
757 Mardani M. Should Cancer Patients Be Prioritized for Covid-19 Vaccination? Arch Clin Infect Dis 2021;15. [DOI: 10.5812/archcid.113263] [Reference Citation Analysis]
758 Montopoli M, Zorzi M, Cocetta V, Prayer-Galetti T, Guzzinati S, Bovo E, Rugge M, Calcinotto A. Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy. Ann Oncol 2021;32:676-7. [PMID: 33524477 DOI: 10.1016/j.annonc.2021.01.069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
759 Liu J, Ouyang L, Yang D, Han X, Cao Y, Alwalid O, Wu H, Shi H, Yang F, Zheng C. Epidemiological, Clinical, Radiological Characteristics and Outcomes of Medical Staff with COVID-19 in Wuhan, China: Analysis of 101 Cases. Int J Med Sci 2021;18:1492-501. [PMID: 33628107 DOI: 10.7150/ijms.54257] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
760 Tominaga K, Sugaya T, Tanaka T, Kanazawa M, Iijima M, Irisawa A. Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases. Front Pharmacol 2020;11:582291. [PMID: 33584261 DOI: 10.3389/fphar.2020.582291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
761 Martín-Bravo C, Quirós R, Blancas I, Villatoro-Roldán R, Robles M, Alcaide J, Navarro V, Pérez D, Zarcos I, Rivas-Ruiz F, Pérez-Ruiz E, Quero C. Incidence of COVID-19 in outpatients with cancer receiving active treatment in the context of a pandemic: An Andalusian cohort study. Semin Oncol 2021:S0093-7754(21)00002-6. [PMID: 33832767 DOI: 10.1053/j.seminoncol.2021.01.002] [Reference Citation Analysis]
762 Chamilos G, Lionakis MS, Kontoyiannis DP. Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)? Clin Infect Dis 2021;72:351-6. [PMID: 33501958 DOI: 10.1093/cid/ciaa1079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
763 Piciu A, Manole S, Piciu D, Dreve T, Roman A. Asymptomatic COVID-19 cancer patients incidentally discovered during F18-FDG PET/CT monitoring. Med Pharm Rep 2021;94:58-64. [PMID: 33629050 DOI: 10.15386/mpr-1776] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
764 Fung M, Babik JM. COVID-19 in Immunocompromised Hosts: What We Know So Far. Clin Infect Dis. 2021;72:340-350. [PMID: 33501974 DOI: 10.1093/cid/ciaa863] [Cited by in Crossref: 95] [Cited by in F6Publishing: 186] [Article Influence: 95.0] [Reference Citation Analysis]
765 Blanc T, Pinar U, Anract J, Assouad J, Audenet F, Borghese B, De La Taille A, El Ghoneimi A, Mongiat-Artus P, Mordant P, Penna C, Roupret M. Impact of the COVID-19 pandemic on oncological and functional robotic-assisted surgical procedures. J Robot Surg 2021. [PMID: 33511526 DOI: 10.1007/s11701-021-01201-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
766 Kurniawan A, Halim DA, Giselvania A, Sutandyo N, Panigoro SS, Adisasmita A, Hatma RD. Breast Cancer Management during Coronavirus Disease 2019 Pandemic: A Literature Review. Asian Journal of Oncology 2021;07:052-9. [DOI: 10.1055/s-0040-1722809] [Reference Citation Analysis]
767 Lassau N, Ammari S, Chouzenoux E, Gortais H, Herent P, Devilder M, Soliman S, Meyrignac O, Talabard MP, Lamarque JP, Dubois R, Loiseau N, Trichelair P, Bendjebbar E, Garcia G, Balleyguier C, Merad M, Stoclin A, Jegou S, Griscelli F, Tetelboum N, Li Y, Verma S, Terris M, Dardouri T, Gupta K, Neacsu A, Chemouni F, Sefta M, Jehanno P, Bousaid I, Boursin Y, Planchet E, Azoulay M, Dachary J, Brulport F, Gonzalez A, Dehaene O, Schiratti JB, Schutte K, Pesquet JC, Talbot H, Pronier E, Wainrib G, Clozel T, Barlesi F, Bellin MF, Blum MGB. Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients. Nat Commun 2021;12:634. [PMID: 33504775 DOI: 10.1038/s41467-020-20657-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 45] [Article Influence: 19.0] [Reference Citation Analysis]
768 Li H, Lu W, Li Y, Lu Y, Li F. Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2. SAGE Open Med 2021;9:2050312121989504. [PMID: 33552515 DOI: 10.1177/2050312121989504] [Reference Citation Analysis]
769 Liu C, Zhao Y, Okwan-Duodu D, Basho R, Cui X. COVID-19 in cancer patients: risk, clinical features, and management. Cancer Biol Med 2020;17:519-27. [PMID: 32944387 DOI: 10.20892/j.issn.2095-3941.2020.0289] [Cited by in Crossref: 7] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
770 Tian J, Miao X. Challenges and recommendations for cancer care in the COVID-19 pandemic. Cancer Biol Med 2020;17:515-8. [PMID: 32944386 DOI: 10.20892/j.issn.2095-3941.2020.0300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
771 Leso V, Fontana L, Iavicoli I. Susceptibility to Coronavirus (COVID-19) in Occupational Settings: The Complex Interplay between Individual and Workplace Factors. Int J Environ Res Public Health 2021;18:1030. [PMID: 33503829 DOI: 10.3390/ijerph18031030] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
772 Cortés-Guiral D, Sgarbura O, Alyami M, Yoshida K, Doki Y, Ishigami H, Grass F, Hübner M. Priorities, actions and risks in the COVID-19 pandemic: a flash SoMe survey among surgical oncologists. Pleura Peritoneum 2021;6:7-12. [PMID: 34222646 DOI: 10.1515/pp-2020-0142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
773 Baffert KA, Darbas T, Lebrun-Ly V, Pestre-Munier J, Peyramaure C, Descours C, Mondoly M, Latrouite S, Bignon E, Nicouleau S, Geyl S, Leobon S, Deluche E. Quality of Life of Patients With Cancer During the COVID-19 Pandemic. In Vivo 2021;35:663-70. [PMID: 33402524 DOI: 10.21873/invivo.12306] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
774 Valencia GA, Neciosup S, Gómez HL, Benites MDP, Falcón S, Moron D, Veliz K, Maldonado M, Auqui R. Adaptation of international coronavirus disease 2019 and breast cancer guidelines to local context. World J Clin Oncol 2021; 12(1): 31-42 [PMID: 33552937 DOI: 10.5306/wjco.v12.i1.31] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
775 Malkani N, Rashid MU. SARS-COV-2 infection and lung tumor microenvironment. Mol Biol Rep 2021;48:1925-34. [PMID: 33486674 DOI: 10.1007/s11033-021-06149-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
776 Fernando S, Veli M, Mohammadi B, Millar A, Khan K. COVID-19 and Its Impact on Upper Gastrointestinal (GI) Cancer Management. Cancers (Basel) 2021;13:397. [PMID: 33494406 DOI: 10.3390/cancers13030397] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
777 Chen ZJ, Liang WT, Liu Q, He R, Chen QC, Li QF, Zhang Y, Du XD, Pan Y, Liu S, Li XY, Wei X, Huang H, Huang HB, Liu T. Use of a Remote Oncology Pharmacy Service Platform for Patients With Cancer During the COVID-19 Pandemic: Implementation and User Acceptance Evaluation. J Med Internet Res 2021;23:e24619. [PMID: 33395398 DOI: 10.2196/24619] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
778 Liu C, Wang K, Zhang M, Hu X, Hu T, Liu Y, Hu Q, Wu S, Yue J. High expression of ACE2 and TMPRSS2 and clinical characteristics of COVID-19 in colorectal cancer patients. NPJ Precis Oncol 2021;5:1. [PMID: 33479506 DOI: 10.1038/s41698-020-00139-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 24] [Article Influence: 5.0] [Reference Citation Analysis]
779 Mehta A, Vasudevan S, Parkash A, Sharma A, Vashist T, Krishna V. COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India. PeerJ 2021;9:e10599. [PMID: 33552716 DOI: 10.7717/peerj.10599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
780 Sun L, Surya S, Le AN, Desai H, Doucette A, Gabriel P, Ritchie MD, Rader D, Maillard I, Bange E, Huang AC, Vonderheide RH, DeMichele A, Verma A, Mamtani R, Maxwell KN. Rates of COVID-19-Related Outcomes in Cancer Compared With Noncancer Patients. JNCI Cancer Spectr 2021;5:pkaa120. [PMID: 33554040 DOI: 10.1093/jncics/pkaa120] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
781 Ferrua M, Mathivon D, Duflot-Boukobza A, Abbas M, Charles C, Barrais A, Legendre J, Mendes C, Pons M, Merad M, Minvielle E, Mir O, Scotté F. Nurse navigators' telemonitoring for cancer patients with COVID-19: a French case study. Support Care Cancer 2021;29:4485-92. [PMID: 33462724 DOI: 10.1007/s00520-020-05968-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
782 Ahmad S, Manzoor S, Siddiqui S, Mariappan N, Zafar I, Ahmad A, Ahmad A. Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19. Semin Cancer Biol 2021:S1044-579X(21)00008-0. [PMID: 33484868 DOI: 10.1016/j.semcancer.2021.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
783 Wang Y, Zhang Y, Bao F, Hao X, Yu F, Lin B, Gu Z, Fang W. The Feasibility and Safety of Routine Thoracic Surgeries in the Low-Risk Areas During the Coronavirus Disease 2019 Pandemic. JTO Clin Res Rep 2021;2:100144. [PMID: 33495755 DOI: 10.1016/j.jtocrr.2021.100144] [Reference Citation Analysis]
784 Sharma A, Bhatt NS, St Martin A, Abid MB, Bloomquist J, Chemaly RF, Dandoy C, Gauthier J, Gowda L, Perales MA, Seropian S, Shaw BE, Tuschl EE, Zeidan AM, Riches ML, Shah GL. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study. Lancet Haematol. 2021;8:e185-e193. [PMID: 33482113 DOI: 10.1016/s2352-3026(20)30429-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 107] [Article Influence: 40.0] [Reference Citation Analysis]
785 Bhattacharyya A, Seth A, Srivast N, Imeokparia M, Rai S. Coronavirus (COVID-19): A Systematic Review and Meta-analysis to Evaluate the Significance of Demographics and Comorbidities. Res Sq 2021:rs. [PMID: 33469575 DOI: 10.21203/rs.3.rs-144684/v1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 6.0] [Reference Citation Analysis]
786 Hameed NUF, Ma Y, Zhen Z, Wu S, Feng R, Li W, Huang G, Wu J, Chen Z. Impact of a pandemic on surgical neuro-oncology-maintaining functionality in the early phase of crisis. BMC Surg 2021;21:40. [PMID: 33461509 DOI: 10.1186/s12893-021-01055-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
787 Ferrari BL, Ferreira CG, Menezes M, De Marchi P, Canedo J, Melo AC, Jácome AA, Reinert T, Paes RD, Sodré B, Barrios CH, Dienstmann R. Determinants of COVID-19 Mortality in Patients With Cancer From a Community Oncology Practice in Brazil. JCO Glob Oncol 2021;7:46-55. [PMID: 33434066 DOI: 10.1200/GO.20.00444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
788 Yadav SK, Yadav N. Continuity of cancer care in the era of COVID-19 pandemic: Role of social media in low- and middle-income countries. World J Clin Cases 2021; 9(2): 291-295 [PMID: 33521097 DOI: 10.12998/wjcc.v9.i2.291] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
789 Hennessy MA, Linehan A, Cowzer D, Coyne ZL, Fitzpatrick O, Barrett F, Ni Dhonaill R, Hennessy BT, Grogan L, Morris PG, Breathnach OS. Chemotherapy in the Covid-19 era: the patient's perception. Ir J Med Sci 2021. [PMID: 33449325 DOI: 10.1007/s11845-020-02457-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [